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Chronic inflammatory and neuropathic pain states are poorly understood, and 
currently inadequately treated. Clinically, the symptoms of such pain states include 
allodynia (interpretation of innocuous stimuli as noxious), hyperalgesia (increased 
sensitivity to noxious stimuli) and spontaneous (non-evoked) pain. Additionally, 
chronic pain states are often associated with affective disorders such as anxiety and 
depression which can further reduce the individual’s quality of life. It is highly likely 
that neuropathic pain could occur in combination with chronic inflammation, for 
example as a result of post-surgical infection. When such injuries occur in early life, 
during the continuing development of the nervous system, it is possible that long-
term adverse changes in sensory processing may occur.  
To investigate this, we have developed a rodent model of chronic pain with both a 
neuropathic and inflammatory component, designed to investigate the consequence 
of these to injuries coinciding. Furthermore, we are also investigating the effect of 
gestational stress, which has been shown to alter the stress responsiveness of the 
offspring and may also affect pain processing. To study the effect that prenatal stress 
may have on pain processing, we have utilised the rodent resident/intruder paradigm 
as a model of social stress to determine the outcomes of the combination of these 
adverse perinatal events.  
We find that a combined inflammatory and neuropathic injury in the adult rat 
increases sensitivity to both mechanical and thermal stimuli and also increases 
spontaneous pain, when compared to inflammation or nerve injury alone. We show 
that neuropathic pain can be induced in neonatal (P8) rats; however there is little 
response to inflammation at P8 and a combination of these two injuries does not have 
the additive effect on sensitivity that occurs in the adult. Upon recovery from 
neonatal nerve injury, we find that a subsequent noxious challenge (formalin) alters 
nocifensive behaviour, when compared to the formalin response of naïve (no prior 
injury) animals, indicating long-lasting changes to nociceptive processing. 
Interestingly, when nerve injury is carried out in adult animals, nocifensive 
behaviour in response to formalin is not altered compared to naïve controls. Calcium 




been implicated as a crucial factor in long term potentiation (LTP) and the 
maintenance of sensitised states. In adult models of chronic pain, which may involve 
LTP mechanisms, we have shown an increased association of CaM Kinase IIα with 
NR2A/B spinal immunoprecipitates ipsilateral to injury. Furthermore, a different 
mechanism may be involved in neonatal pain states, as we have shown that spinal 
CaM Kinase IIα expression increases with development and is present at very low 
levels at the time of surgery in our pain models. Additionally, a number of other 
proteins associated with the NMDA receptor complex are developmentally regulated, 
and their involvement in the initiation and maintenance of chronic pain is likely to 
differ between the adult and the neonate.  
We further show that exposure to prenatal stress does not alter the thresholds to 
mechanical stimuli in adult or early life pain models, however the combination of 
prenatal stress and postnatal injury results in an enhanced response to formalin in 
later life, indicating that programming of stress and/or pain pathways has occurred as 
a result of these early life events.  
In addition to the development of a novel model of chronic pain, this study highlights 
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CHAPTER 1: INTRODUCTION 
1.1 Pain  
“An unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage. The inability to communicate 
verbally does not negate the possibility that an individual is experiencing pain and is 
in need of appropriate pain-relieving treatment. Pain is always subjective. Each 
individual learns the application of the word through experiences related to injury in 
early life.” (Merskey and Bogduk, 1994) 
 
This definition of pain is important as it highlights the need to consider animals and 
human infants who cannot describe their pain or seek out appropriate treatment or 
relief. Many invasive procedures are carried out on human preterm infants, which 
may have adverse consequences in later life. It is therefore important that we study 
the consequences of potentially painful procedures in early life, in animals and 
humans, with a view to avoid pain and protect them from potentially adverse long-
term changes to sensory processing. 
It is important to differentiate between the terms “pain” and “nociception”, as both 
will be used throughout this thesis. Pain encompasses both an unpleasant emotional 
or physical experience and involves higher processing and an awareness of the 
stimulus, whereas nociception involves only the neural detection of a noxious 
stimulus, which may then cause pain, together with any reflex motor responses. 
Under normal, non-pathological conditions, pain results from activation of high 
threshold Aδ and C-fibres to warn of potential tissue damage. Chronic pain states 
(those persisting following recovery from initial injury) are a result of 
pathophysiological changes within the nervous system which can occur following 
nerve damage (neuropathic pain) or chronic inflammation and are currently difficult 
to treat (Scholz and Woolf, 2002). Broadly speaking, chronic pain is manifest as 
hyperalgesia (increased sensitivity to noxious stimuli), allodynia (interpretation of 
innocuous stimuli as noxious), and also dysethesias such as shooting pains, burning 
or itching which may be spontaneous or evoked. The current lack of effective 
treatments for chronic pain states and an estimated prevalence of 6-8% of the 
European population poses a major socio-economic problem. This is due to the high 




patients unable to work because of chronic pain and/or its associated comorbidities 
(see 1.2.5). 
 
1.2 Chronic Pain 
 
1.2.1  Inflammation and chronic inflammatory pain 
 
As with all types of acute pain, acute inflammation is an important physiological 
response that protects an organism from potential tissue damage. Inflammatory pain 
occurs when sensory nerve endings in the inflamed area are exposed to inflammatory 
mediators such as histamine and bradykinin (see 1.4.3). Once the initial stimulus or 
infection has been cleared, acute inflammation and the associated pain will subside. 
In cases of chronic inflammation the initial stimulus is not cleared quickly and the 
response continues. This can result in persistent activation of sensory neurons due to 
their increased excitability in the presence of inflammatory mediators, even in 
response to innocuous stimuli. In addition to this primary hyperalgesia, secondary 
hyperalgesia may also occur due to central sensitisation as a result of the persistent 
afferent input (see 1.8).  
The innate immune system is responsible for defending the body in a non-specific 
manner, by recruiting immune mediators such as cytokines and initiating the 
complement cascade at the site of inflammation/infection. Timing of the maturation 
of the immune system is species specific, in offspring from precocious species (e.g. 
humans, pigs) most immune system development occurs in utero whereas in 
offspring from non-precocious species (rats and mice), immune development occurs 
late in gestation/early postnatally (Merlot, 2008). The cellular component of the 
immune response consists of mast-cells and macrophages whilst the soluble 
component is the complement cascade, both of these components of the 
inflammatory response have been implicated in chronic pain (Twining et al., 2005) 
and their developmental profile is important to consider with respect to the 






1.2.2 Neuropathic pain 
 
Neuropathic pain may arise as a result of damage to peripheral nerves or to the 
central nervous system. Such damage can occur in response to various injuries such 
as compression, stretch or transection of the nerve which may occur accidentally, as 
a result of major surgery or as a result of diseases such as diabetes (diabetic 
neuropathy), viral infection, alcoholism or stroke (Sadosky et al., 2008). Traditional 
analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) or opiates are 
thought to be less effective in treating neuropathic pain compared to nociceptive 
pain, and current treatments such as tricyclic antidepressants or anticonvulsant drugs 
vary in efficacy and have undesirable side-effects as well as unclear mechanisms of 
action (Finnerup et al., 2005; Dworkin et al., 2007).  
 
1.2.3 Chronic pain and affective disorders  
 
Chronic pain conditions are often accompanied by affective disorders such as 
depression and anxiety (Greden, 2009; Wiech and Tracey, 2009). Higher processing 
of noxious stimuli allows integration of these signals with memory and may result in 
recall of adverse experiences which can result in their association with negative 
mood, thus enhancing the affective nature of a given stimulus. The affective-emotive 
components of pain pathways are considered to be conferred by the 
spinoparabrachial pathway, as well as by ascending dorsal horn pathways connecting 
directly to limbic areas known to be involved in emotion and affect, such as the 
hypothalamus (spinohypothalamic) and amygdala (spinopontoamygdaloid) (Price, 
2000). In addition to the difficulty in treating the underlying chronic pain state, these 
associated comorbidities further reduce the sufferers’ quality of life. Limbic 
disturbances, resulting in depression and anxiety, associated with chronic pain are 
well documented (Blackburn-Munro and Blackburn-Munro, 2001; Ulrich-Lai et al., 
2006). Sleep deprivation is another common problem in chronic pain patients and as 
well as adding to a depressed state, there is also evidence that it can exacerbate 
symptoms by reducing pain thresholds, making it more difficult to treat patients 




1.2.4 Neuropathic versus inflammatory pain  
 
In clinical situations, nerve injury may often be accompanied by some degree of 
acute or chronic inflammation, for example as a result of post surgical infection. 
Here, the inflammatory mediators responsible for chronic inflammation may 
potentiate the mechanisms involved in the development and maintenance of 
neuropathic pain. It  has been suggested that the pathways involved in mediating pain 
associated with inflammation are quite different from those in neuropathic pain states 
and that the latter have a stronger affective component (Apkarian et al., 2008). It is 
therefore interesting to speculate on the outcome of a combination of these two types 
of injury and the potential synergistic effect this may have.  
The molecular and physical changes involved in converting sensory neurons from a 
normal to a sensitised state differ between inflammatory and neuropathic conditions.  
One of the major mechanisms responsible and common to both conditions is the 
phosphorylation of receptors and ion channels in primary sensory neurons and in 
second order dorsal horn neurons that contribute to central sensitisation, discussed in 
detail below (1.8). Two important neurotransmitters differentially expressed in 
primary sensory neurons in inflammatory versus neuropathic pain states are 
substance P (SP) and calcitonin gene-related peptide (CGRP). These neuropeptides 
are released from the central terminals of primary sensory neurons to facilitate 
transmission in the dorsal horn and also from the peripheral terminals to exert local 
actions (see 1.7.1). SP and CGRP are upregulated in primary sensory neurons 
following inflammation (Smith et al., 1992) and can be released from the peripheral 
terminals to further increase the number of mast cells and macrophages (via 
vasodilation), adding to the “inflammatory soup” (Costigan and Woolf, 2000), which 
contains mediators responsible for peripheral sensitisation (see Figure 1.3). 
Following peripheral axotomy (Hokfelt et al., 1994) and chronic constriction injury 
(CCI) (Nahin et al., 1994) SP and CGRP mRNA levels are downregulated in primary 
sensory neurons and interestingly, the maximal decrease in SP mRNA has been 
shown to occur between 7-14 days which is around the time of peak sensitisation 
(Nahin et al., 1994), and is possibly due to C-fibre cell death as well as changes in 




that a switch occurs which converts some Aβ and Aδ fibres into a C-fibre-like 
phenotype (see 1.3.1), as they subsequently begin to express SP and CGRP, amongst 
other factors usually expressed only by small, unmyelinated C-fibres (Miki et al., 
1998; Malcangio et al., 2000). In addition to this phenotypic switch, there is some 
evidence to suggest that central terminals of A-fibres may begin to sprout into the 
superficial lamina of the dorsal horn, an area which usually receives only nociceptive 
input from C-fibres (Woolf et al., 1992), although the validity and reliability of the 
tracing techniques used in these studies has been questioned (Tong et al., 1999; 
Hughes et al., 2003).  Central sprouting of myelinated afferents might suggest that 
SP and CGRP would be released onto dorsal horn neurons in lamina II following 
activation of the large, myelinated fibres, which are activated by innocuous stimuli 
such as light touch or brushing of the skin. Therefore, innocuous stimuli may be 
perceived as noxious, thus contributing to the tactile/mechanical allodynia phenotype 
observed in pain clinics and in experimental pain models. However, conflicting 
studies (Hughes et al., 2007) find that there is no detectable increase in SP release 
from Aβ fibres following nerve injury. The authors suggest that discrepancies 
between studies on the involvement of SP from Aβ fibres in allodynia can be 
partially explained by the two different forms of allodynia that exist. Static allodynia 
is pain in response to light touch or pressure, which is mediated by TRPV1-positive 
(transient receptor potential vanilloid receptor 1, see 1.4.1) small to medium diameter 
C and Aδ fibres, whereas dynamic allodynia occurs in response to brushing the skin 
(Ochoa and Yarnitsky, 1993), which is mediated by TRPV1-negative medium to 
large Aδ and Aβ (Yamamoto et al., 2008). Studies that report analgesia in response 
to antagonists of the SP receptor, NK1 (neurokinin 1) and therefore indicate SP 
involvement, have used von Frey filaments to measure allodynia and are therefore 
measuring static allodynia, which is mediated by C and Aδ fibres (Cahill and 
Coderre, 2002). Also, it is important to realise that although there may be expression 
changes in the DRG, this may not necessarily translate to changes in SP release from 
central terminals. 
There is some evidence to suggest that sodium channels are also altered differently in 
inflammatory versus neuropathic pain states; specifically, the voltage-gated sodium 




utilising conditional knockouts for this channel suggests that Nav1.8 is important in 
the generation of pain behaviour following inflammation, as both the formalin 
response, and thermal hyperalgesia associated with injection of complete Freund’s 
adjuvant are attenuated, whereas neuropathic pain is unaffected (Abrahamsen et al., 
2008). Other groups have shown that Nav1.8 is significantly downregulated 
following nerve injury, which is considered to be due to its replacement by Nav1.3 
(Dib-Hajj et al., 1999) (See 1.4.4). 
The changes discussed above and the many other changes at the peripheral level in 
inflammatory and neuropathic pain states all result in increased activity of primary 
sensory neurons (Millan, 1999; Zimmermann, 2001). The increased firing of these 
neurons will in turn increase excitatory synaptic transmission between dorsal horn 
neurons and activate postsynaptic glutamate receptors to generate a cascade of 
postsynaptic pathways which lead to phosphorylation of the AMPA (α-amino-3-
hydroxyl-5-methyl-4-isoxazole-propionate) and NMDA (N-methyl-D-asparate) 
glutamate receptors, lowering their activation thresholds and therefore increasing 
excitability in the dorsal horn (central sensitisation) (Raymond et al., 1994; Lee, 
2006). 
 
1.2.5 Animal models of chronic pain  
 
The subjective nature of pain makes it very difficult to achieve reliable results from 
studies on human subjects. Furthermore, it is impossible, both ethically and 
practically, to accurately investigate the mechanisms responsible for the broad range 
of symptoms associated with chronic pain in humans. For these reasons, animal 
models of chronic pain are widely used, although it is often difficult to directly 
translate experimental results to effective clinical treatments due to the differences in 
physiology between rodent and human subjects, and also the differences in the 
duration and symptoms associated with clinical neuropathic or inflammatory pain 
states, which can rarely be accurately encompassed by animal models. Nevertheless, 
there have been a number of important discoveries in the chronic pain field, which 
have utilised animal models to increase our understanding of these complex 




peripheral nerve injuries, which include the chronic constriction injury (CCI), a loose 
ligation of the sciatic nerve to induce intraneural oedema and physical axonal 
damage (Bennett and Xie, 1988), spinal nerve (L5 and 6) ligation, (Kim and Chung, 
1992), partial sciatic nerve ligation, (Seltzer et al., 1990) and more recently the 
spared nerve injury, in which the tibial and common peroneal nerve are ligated and 
the sural branch of the sciatic nerve left intact (Decosterd and Woolf, 2000). In 
addition to these nerve injuries, animal models have also been produced to mimic 
specific disease-induced neuropathies, such as diabetic neuropathy (Malcangio and 
Tomlinson, 1998) and postherpetic neuralgia (Fleetwood-Walker et al., 1999).  
In addition to neuropathies, chronic inflammatory pain is also problematic clinically. 
A number of animal models of inflammatory pain exist which vary in duration and 
mechanism. The formalin test is a well-defined acute (usually up to 60 mins) 
nociceptive test (Dubuisson and Dennis, 1977), which is now know to directly 
activate TRPA1 receptors (McNamara et al., 2007) thought to be responsible for the 
first wave of pain behaviours observed upon injection into the hindpaw. The second 
phase of the formalin response is longer in duration and thought to be due to ongoing 
inflammatory input as well as central sensitisation induced by activation of 
nociceptors during the first phase (McNamara et al., 2007). The formalin test is a 
useful test to investigate central sensitisation and changes in central processing which 
may have occurred as a result of a prior injury. Capsaicin is a similar noxious 
inflammatory agent that directly activates TRPV1 receptors (Caterina et al., 1997) to 
produce an acute behavioural response. Longer-lasting inflammatory agents include 
immune system activators such as carrageenan and complete Freund’s adjuvant 
(CFA). These agents are often used to model arthritis by injecting into the knee or 
ankle joints but are also use for studying chronic inflammation and inflammatory 
processes following an intraplantar injection in the hindpaw.    
These animal models all differ in the duration and extent of the nociceptive 
behaviours observed and it is important to select the most appropriate model for a 
particular study. Although many peripheral neuropathies have an inflammatory 
component at the site of injury, a more direct combined model of neuropathic and 
inflammatory pain has not yet been investigated and may in fact, be a more realistic 




those experienced by piglets following tail-docking and also by human adults or 
neonates experiencing post-surgical infection. Tail-docking is currently carried out 
routinely in new-born piglets and results in obvious damage to the peripheral nerves 
and wounds are often prone to infection and inflammation. Clinically similar 
coincident nerve damage and inflammation is likely to occur following surgery in 
both adult humans and also pre-term infants. A synergistic effect of these two 
injuries is a likely outcome and the resulting pain experienced acutely and in the 
long-term warrants further investigation, not least in younger subjects where 
development of the nervous system is incomplete at the time of injury and could 
potentially be adversely affected long-term. 
 
1.2.6 Measures of pain: Evoked versus spontaneous behaviour 
 
Due to the emotional and subjective nature of pain, quantifying a painful experience 
accurately in laboratory animals is extremely difficult, if not impossible. Therefore 
most animal models of chronic pain are tested using spinally-mediated reflex 
responses to noxious stimuli such as von Frey filaments, to measure mechanical 
allodynia or the Hargreaves’ plantar test to measure thermal hyperalgesia. These tests 
measure stimulus-evoked responses to noxious stimuli, which we can refer to as 
nociceptive behaviour, as only the sensory pathways at the peripheral and spinal 
level are considered due to the reflex nature of the response (see definition 1.1). 
However, spinally mediated reflex withdrawal responses do not require higher 
processing at the level of the cortex and therefore the affective-emotive nature of 
pain is not considered in such tests. Furthermore, there have been a number of 
reports which show differential responses to reflex-based measures when compared 
to operant and stimulus-response based assessments, which require cortical 
processing (Vierck et al., 2002; Vierck, Jr. et al., 2004; Vierck et al., 2008).  
Data from clinical studies show that spontaneous pain makes up a large part of the 
symptoms of chronic pain patients (Backonja and Stacey, 2004). Much of the current 
research using animal models of chronic pain focuses on evoked responses, when in 
fact, the prevalence of symptoms in human patients shows that perhaps there should 




measure spontaneous pain, and recently, conditioned place preference tests have 
been used to show ongoing pain following peripheral nerve injury in rats. In these 
tests, injured rats will actively seek out chambers with which they have been pre-
conditioned to associate with pain relief (King et al., 2009). Additionally, preclinical 
trials utilising stimulus-evoked measures of hypersensitivity, do not always translate 
to drugs that are effective in human patients. For these reasons, it may be helpful if 
novel preclinical drugs were also tested for their effectiveness in alleviating 
spontaneous pain, in ways which consider whole animal behaviour and allow for 
assessments which can be more directly translated to the human experience of pain.  
 
1.3 Pain Pathways: Organisation of the somatosensory system 
  
1.3.1 Primary sensory neurons 
 
Primary sensory neurons have their cell bodies in the dorsal root ganglia (DRG) or 
trigeminal ganglia. From each cell body a single axon arises, which then bifurcates to 
give rise to a distal branch which extends out to the periphery and a proximal branch 
which terminates at second order neurons within the dorsal horn of the spinal cord to 
relay sensory information to central synapses. The peripheral terminals of primary 
sensory neurons are able to detect and transduce a wide range of sensory modalities 
which can be of a thermal, chemical or mechanical nature. To allow for such wide 
variety of potential stimuli, many primary sensory neurons are polymodal and their 
afferents can be divided into three main types depending on size and conduction 
velocity. Aβ fibres are large-diameter, myelinated axons with a high conduction 
velocity and respond to tactile, non-nociceptive, stimuli but may be involved in 
pathological pain states in contributing to allodynia (Woolf and Doubell, 1994). Aδ 
fibres are medium-diameter and thinly myelinated with a conduction velocity in the 
range of 2.2-8 ms-1 and C-fibres are small-diameter, unmyelinated axons and conduct 
slowly at <2.2 ms-1 in the rat (Harper and Lawson, 1985). It is the Aδ and C-fibre 
terminals that respond to noxious stimuli and make up the majority of nociceptors, 
although they are also responsible for innocuous temperature perception and itch 




sub-divided according to their protein expression profiles. The peptidergic C-fibre 
population expresses the TrkA (tyrosine kinase A) receptor for nerve growth factor 
(NGF), and the peptide neurotransmitters SP and CGRP and BDNF (brain-derived 
neurotropic factor) which binds to TrkB receptors on dorsal horn neurons (Malcangio 
and Lessmann, 2003). The non-peptidergic population can be selectively labelled by 
isolectin B4 (IB4) and expresses the Ret receptor for the growth factor glial-derived 
neurotrophic factor (GDNF) (Bennett et al., 1998). In the perinatal period this 
classification of C-fibres is not so straight-forward, as developing neurons require 
NGF for survival and therefore a higher proportion of C-fibres will express its 
receptor, TrkA, which decreases to adult levels by postnatal day 14, whilst IB4 
binding increases (Bennett et al., 1996).  
Nociceptive mechanical and thermal information is transduced primarily by the high-
threshold Aδ and C-fibres upon activation of one or more of the many types of 
receptors (see 1.4) located on their terminals. The majority of the sensory receptors 
located on the terminals of primary sensory neurons are ionotropic cation channels 
(Lee et al., 2005), which upon activation lead to depolarisation of the neuron and the 
generation of an action potential. This is conveyed along the axon to the central 
terminal within a specific area of the dorsal horn, which depends on its peripheral 
terminal location and also the afferent type.  
 
1.3.2 Central organisation within the dorsal horn 
 
The dorsal horn of the spinal cord is divided into 6 laminae  
that receive and process sensory information (Figure 1.1.) (Rexed, 1952; Molander et 
al., 1984). The order in which primary sensory neurons enter the dorsal horn is 
highly organised, with non-nociceptive Aβ fibres entering lamina III-VI and smaller 
diameter Aδ and C-fibres primarily terminating in lamina I and II (Lamina II is 
usually further subdivided into inner, IIi, and outer, IIo, layers), which make up the 
superficial dorsal horn where a proportion of the cells are nociceptive specific (NS) 
and respond only to noxious stimuli (Christensen and Perl, 1970; Dubner and 
Bennett, 1983; Mason, 2007). The majority of Aδ fibres terminate in lamina I, with 




of the superficial dorsal horn depending on their subclass. The non-peptidergic, IB4-
positive C-fibres terminate almost exclusively in lamina II (Kitchener et al., 1993) 
where they synapse with interneurons, which make up most of the neuronal 
population of lamina II. These then convey information to lamina V projection 
neurons to transmit signals to the brain mainly via the spinothalamic tract (see 1.3.4 
& Figure 1.1.). The SP-containing peptidergic population of C-fibres  terminate in 
lamina I  where the NK1 receptor is found, on approximately 80% (Marshall et al., 
1996) of the projection neurons in this lamina, which transfer nociceptive signals to 
the brainstem and thalamus (Todd et al., 2002; Spike et al., 2003; Braz et al., 2005).  
 
1.3.3 Dorsal horn processing and output: Projection neurons, interneurons and 
glia 
 
The two main cell types within the dorsal horn of the spinal cord receiving peripheral 
input are interneurons (the majority) and projection neurons. Projection neurons are 
mainly located in lamina I and lamina V and project to the thalamus or to the 
brainstem (Gauriau and Bernard, 2002; Todd, 2002). The cells responsible for the 
output from the dorsal horn can be categorized into three types, depending on the 
information they respond to. Low-threshold (LT) neurons are only excited by touch 
(Aβ fibre input), or innocuous temperature (Aδ/C-fibres input). LT neurons are 
mainly found in lamina I, III and IV and have small receptive fields, which would 
suggest that they are able to encode stimulus location (Price and Dubner, 1977; 
Willis and Coggeshall, 1991; Schepers and Ringkamp, 2009). As mentioned 
previously, there are a substantial number of cells within the superficial dorsal horn 
(laminae I and II) that are nociceptive-specific (NS), so will only fire action 
potentials in response to painful stimuli. The third type of neuron found in the dorsal 
horn, predominantly in lamina V, are the wide dynamic range (WDR) neurons 
which, as the name suggests, will respond to a variety of stimuli, noxious or 
innocuous  (Price and Dubner, 1977; Dubner and Bennett, 1983). WDR neurons 
respond to all three types of primary afferents and fire in a graded manner, according 
to the intensity of the stimulus. These WDR cells are able to exhibit a short-lasting 




frequency stimulation, particularly of C-fibre intensity (Mendell, 1966), and may be 
involved in initiating longer-lasting forms of synaptic plasticity such as central 
sensitisation and long term potentiation (1.8.2), which are implicated mechanisms in 
chronic pain states (Ji et al., 2003).  
Excitatory (largely glutamatergic) and inhibitory (largely GABAergic) interneurons 
act on all three types of the above mentioned cells to alter the output from the dorsal 
horn. Interneurons are found throughout the dorsal horn laminae, although they make 
up the majority of the cells in lamina II. The processes of most interneurons are 
restricted to the segment of spinal cord containing their cell body, and these are 
known as local circuit neurons. Other interneurons have longer-range axons which 
extend to different spinal segments. Through activation from primary afferents or 
descending pathways (see 1.3.6) inhibitory and excitatory interneurons are able to 
modulate dorsal horn output by connecting with other interneurons, directly 
contacting the presynaptic terminals of primary afferents, and by directly contacting 
projection neurons (Willis and Coggeshall, 1991; Hunt and Koltzenburg, 2005).  
Glial cells are non-neuronal cells found within the nervous system and are divided 
into microglia and macroglia. Microglia are specialized macrophages which form the 
main immune defence in the CNS. Macroglia are mainly made up of astrocytes and 
oligodendrocytes in the CNS, and regulate the external chemical environment and 
provide nutrients to neurons and produce the myelin sheath, respectively, both of 
which facilitate efficient neurotransmission. Glial cells do not produce action 
potentials but are able to facilitate signalling in the their supportive roles and have 
also been shown to respond to and release neurotransmitters (such as glutamate and 
ATP) and a variety of neuromodulatory cytokines and therefore play an important 
role in nociceptive processing within the dorsal horn (Barres, 1991; Scholz and 
Woolf, 2007). It is only relatively recently that the role of glial cells in nociceptive 
processing has become more widely investigated, particularly following injury (see 
1.6) (Meller et al., 1994; Scholz and Woolf, 2007; Vichaya et al., 2009) in both the 
development and maintenance of chronic pain states (Raghavendra et al., 2003; 
Hains and Waxman, 2006; Ji and Suter, 2007; Vichaya et al., 2009). The signalling 
mechanisms involved within these cells during persistent pain states are currently 




1.3.4 Ascending pathways 
 
Nociceptive and non-nociceptive somatosensory information is transferred rostrally 
from the dorsal horn to the brain via many different pathways (Figure 1.1.). The 
dorsal column-medial lemniscal pathway carries information about touch, vibration 
and proprioception and synapses in the medulla and thalamus before information 
reaches the cortex (Purves and Williams, 2001). The main pathway responsible for 
the transmission of pain signals is the spinothalamic tract (STT) which mostly 
originates from deep dorsal horn laminae and terminates in the ventroposterior and 
ventrobasal thalamus, and the spinoparabrachial pathway (also referred to as part of 
the spinoreticular tract) which originates primarily from the superficial dorsal horn 
and synapses in brainstem, midbrain and limbic areas before reaching the thalamus 
(Dubner and Bennett, 1983; Willis and Westlund, 1997; Hunt and Mantyh, 2001; 
D'Mello and Dickenson, 2008). The STT has previously been thought of as the most 
important pathway in pain signalling, particularly the fast discriminative properties 
of pain, due to the small receptive fields of the STT cells (Willis et al., 1974) and its 
direct contact with the thalamus (see below 1.3.5). Most of the input to this pathway 
arises from laminae I and V (Dubner and Bennett, 1983; Willis and Westlund, 1997), 
which both receive input from nociceptors (1.3.2 and 1.3.3), although neurons within 
the STT are responsive to both noxious and innocuous stimuli, with approximately 
20% of the fibres being of the LT type (Dubner and Bennett, 1983).  More recently 
focus has moved from the STT to the spinoparabrachial pathway. The 
spinoparabrachial pathway is mainly made up of NS neurons whilst a small 
proportion seem to be WDR neurons, with very few neurons responding exclusively 
to innocuous stimuli (Bester et al., 2000). Furthermore, this pathway mainly 
originates from the NK1-positive cells in lamina I of the dorsal horn (McMahon and 
Wall, 1985; Bester et al., 2000), which are thought to signal the intensity of noxious 
stimuli (Doyle and Hunt, 1999). In agreement with this, the cells of the 
spinoparabrachial pathway have been shown to have increased responses to 
increasing stimuli intensity (Bester et al., 2000). Along with the limbic connections 
of the spinoparabrachial tract, these properties suggest that this pathway may 




and unpleasantness, and could potentially also have a role in associated 
comorbidities such as anxiety and depression. In addition to the spinoparabrachial 
tract there are also more direct pathways from the dorsal horn that contact the 
hypothalamus and amygdala (1.2.5). These are considered to arise from cells 
regulated by the non-peptidergic population of C-fibres (see 1.3.2) and may also 
contribute to the affective nature of some pain states (Burstein et al., 1987; Burstein 








Figure 1.1. Diagram to illustrate the laminar organisation of dorsal horn input and its 
ascending (black) and descending pathways (yellow) to and from the brain and 
brainstem (D'Mello and Dickenson, 2008). Nociceptive information enters the dorsal 
horn through Aδ (blue) and C-fibres (red) which terminate in the superficial dorsal 
horn (lamina I and IIo) and in the deep dorsal horn (directly and indirectly) at lamina 
V where they contact wide-dynamic range (WDR) neurons. Nociceptive specific 
(NS) neurons are contacted by C-fibres in the superficial dorsal horn.  Non-noxious 
information is relayed via Aβ fibres (green) which terminate in lamina III-V, where 
they also contact WDR neurons. Information is transferred rostrally from NS neurons 
in the superficial dorsal horn via the spinoparabrachial tract (black arrow) to the 
parabrachial area (PB) before reaching limbic areas and the thalamus. WDR in the 
deep dorsal horn ascend via the spinothalamic tract (black arrow) to reach the 
thalamus. Descending control from noradrenergic and serotonergic pathways 
originates in the periaqueductal grey (PAG) and rostral ventromedial medulla (RVM) 
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Figure 1.2. Simplified diagram of the cortical connections of the spinothalamic tract 
which originates in lamina I and V and connects in the lateral or medial nuclei of the 
thalamus before reaching cortical areas where the two major components of pain, 
sensory-discriminative and affective-emotive are transduced. (Ingvar, 1999)   
 
 
1.3.5 Brain areas 
 
Modern neuroimaging techniques such as PET (Positron Emission Tomography) and 
fMRI (functional Magnetic Resonance Imaging) have allowed non-invasive 
observation of the brain to view the cortical representation of pain. These imaging 
techniques show that multiple areas are activated in response to painful stimuli; 
furthermore, the areas associated with the different components of pain perception 
are beginning to be identified (Peyron et al., 2000). The ascending pathways from the 
spinal cord project to many brainstem and brain areas (see above 1.3.4 and Figure 
1.1.), such as the parabrachial area and limbic areas such as the amygdala and 
hypothalamus, before reaching the thalamus which receives and processes all 
nociceptive information. From the thalamus, pain information is relayed to higher 
cortical areas, referred to as the “pain matrix” (Treede et al., 1999) which includes 




insular, anterior cingulate and prefrontal cortices. It is widely accepted that these 
brain areas represent the different components of the pain response, which can be 
broadly grouped into the sensory-discriminative component (location, intensity, 
type), and the affective-emotive component (anxiety, fear, anticipation) (Treede et 
al., 1999; Brooks and Tracey, 2005; D'Mello and Dickenson, 2008). The sensory-
discriminative component is considered to be processed via the lateral nuclei of the 
thalamus and S1 and S2, and both the thalamus and somatosensory cortex have a 
somatotropic organisation of the receptive fields to convey location, making this 
component of pain similar to the other classical senses (see Figure 1.2). The affective 
nature of pain and its ability to evoke emotive responses is understood to be largely 
mediated by pathways through the medial thalamic nuclei, which have connections 
with the limbic brain and ascend to the insular and anterior cingulate cortex as well 
as S2 (Treede et al., 1999; Price, 2000). Of course this is a simplified view of the 
brain areas involved in pain processing, and there are many interconnecting 
pathways that integrate the various components of a painful experience to facilitate 
suitable physiological responses. 
 
1.3.6 Descending pathways 
 
As well as the ascending spinal pathways to the brain, there are also descending 
pathways from the brain and brainstem which synapse with targets within the dorsal 
horn (primary afferents, interneurons or projection neurons) to influence its output. 
Two of the main areas exerting descending control on the dorsal horn are the 
periaqueductal grey (PAG) and the rostral ventromedial medulla (RVM) in the 
brainstem (Figure 1.1 and section 1.7). These brainstem-spinal pathways were 
previously thought of as predominantly inhibitory, but they may also facilitate 
nociceptive transmission (Basbaum and Fields, 1984; D'Mello and Dickenson, 2008). 
The descending pathways from the brain to the spinal cord are complex. To briefly 
summarize, the PAG and amygdala have few direct projections to the dorsal horn but 
can modulate information from the thalamus and hypothalamus as well as from the 
“pain matrix” (see above 1.3.5) and they project to the dorsal horn via the RVM and 




serotonergic or noradrenergic and their effect is determined by the neuron contacted 
and also the receptor sub-type activated (Millan, 2002). Recent studies have also 
identified an oxytocinergic pathway projecting from the paraventricular nucleus 
(PVN) of the hypothalamus to the superficial dorsal horn where it is proposed to 
exert an inhibitory effect on nociceptive processing via indirect contact with 
GABAergic interneurons (Rojas-Piloni et al., 2007; Condes-Lara et al., 2007; Rojas-
Piloni et al., 2008). This pathway may be important in mediating stress-induced 
analgesia as the PVN is part of the hypothalamo-pituitary-adrenal (HPA) axis which 
is activated in response to stress, and oxytocin neurons in the PVN are activated by a 
variety of stressors (see 1.12).    
Descending pathways from the brain to the spinal cord also contact sympathetic 
neurons in the ventral horn and can modulate sympathetic outflow primarily via 
serotonergic and noradrenergic influences (Millan, 2002); a factor that becomes 
important in chronic pain states (see 1.3.7 and 1.7)  
 
1.3.7 Sympathetic nervous system 
 
The sympathetic nervous system is a branch of the autonomic nervous system (along 
with the parasympathetic nervous system) and is responsible for the “flight or fight” 
response, which is most active during times of stress or fear. Preganglionic spinal 
sympathetic neurons synapse with peripheral sympathetic neurons (postganglionic) 
through a series of ganglia. The principal neurotransmitters at sympathetic synapses 
are acetylcholine, which is released from preganglionic axons, and noradrenaline, 
released from postganglionic fibres, to act on α-adrenoreceptors in target tissues. 
Postganglionic neurons do not usually communicate with the afferent neurons within 
the periphery and are therefore not usually involved in the generation of pain. 
However, in cases of peripheral sensory nerve damage, sympathetic efferents can 
couple with primary afferents and may be involved in the maintenance and 
exacerbation of neuropathic pain states through noradrenergic signalling (McLachlan 






1.4 Sensing Pain: Molecular mediators of peripheral signal detection and 
propagation 
   
Cutaneous nociceptors can be divided into three main types, mechanoreceptors, 
thermoreceptors or chemoreceptors, depending on the stimuli they respond to. C- 
fibres are often broadly described as polymodal as many will respond to all three 
types of stimuli (Bessou and Perl, 1969). Aδ fibres respond to intense mechanical 
stimuli and can also respond to thermal stimuli, especially in sensitised conditions 
such as those that occur in response to nerve injury (Ji et al., 2007). Some 
nociceptive neurons, largely C-fibres, are also referred to as “silent”, as they are not 
normally responsive to noxious stimuli and only function in pathological conditions 
(Schmidt et al., 1995). Centrally, synapses which contain NMDA receptors but lack 
AMPA receptors are postsynaptically “silent” at resting membrane potentials (Isaac 
et al., 1995) due to the voltage-dependant Mg2+ block of the NMDA receptor and 
inability of the postsynaptic neuron to be depolarised in the absence of AMPA 
receptors (see 1.5.3). Trafficking of AMPA receptors to the postsynaptic membrane 
and the subsequent activation of these previously silent synapses has been proposed 
as a potential mechanism for increased synaptic efficacy (Kessels and Malinow, 
2009), a feature associated with central sensitisation in chronic pain states (see 1.5.1 
and 1.8.3 for more detail). Nociceptors are able to respond to such a wide array of 
stimuli due to the broad range of receptors located at their terminals and the signal 
transduction mechanisms accompanying them. Most of these sensory receptors 
require the activation of ionotropic cation channels which allow an influx of cations 
and therefore depolarisation of the nerve when activated. There are also many 
metabotropic receptors that can facilitate transmission indirectly by modification and 
activation of ion channels (Lee et al., 2005).  
 
1.4.1 Transient receptor potential (TRP) ion channels   
 
 TRP ion channels are the main receptors in the periphery responding to noxious heat 
(~>43ºC) and cold (~<15ºC), although they may also respond to mechanical and 




poorly defined, although the TRPA1 channel has been suggested to play a role 
sensing both noxious mechanical and chemical stimuli (Macpherson et al., 2007; 
Petrus et al., 2007). Six types of thermosensitive TRP channels have been identified 
on primary sensory neurons; these are TRPV1-4, and TRPM8 and TRPA1. TRPV1 
and TRPV2 are activated by noxious heat with thresholds above 43 ºC (Caterina et 
al., 1997) and 52 ºC (Caterina et al., 1999) respectively. TRPV1 is also responsive to 
chemical stimuli such as capsaicin, endocannabinoids, acid, spider toxins (e.g. 
vanillotoxins) and it has also been reported to be potentiated by ethanol (Trevisani et 
al., 2002; Siemens et al., 2006; Levine and Alessandri-Haber, 2007). Furthermore, 
TRPV1 is also sensitised by many inflammatory mediators such as bradykinin, 
through phosphorylation-dependent mechanisms, to reduce its activation threshold 
temperature and contribute to the thermal hypersensitivity associated with 
inflammation (Sugiura et al., 2002; Wang and Woolf, 2005; Lee et al., 2005). 
TRPV3 and TRPV4 respond to innocuous warm temperatures (Levine and 
Alessandri-Haber, 2007) and so are not classed as thermal nociceptors, however, 
TRPV4 is responsive to chemical stimuli such as acid and is also implicated in 
mechanical and thermal nociception, from studies on mice lacking TRPV4 (Suzuki et 
al., 2003). Innocuous and noxious cold appear to be detected by TRPM8 and TRPA1, 
which are activated at temperatures below 25-28 ºC and 17 ºC respectively (Peier et 
al., 2002; Story et al., 2003). Although it is unclear whether TRPM8 responds to 
noxious cold (Fleetwood-Walker et al., 2007), it is also activated by menthol and 
icilin which have been shown to provide analgesia in response to nerve injury by 
mechanisms thought to involve inhibitory spinal metabotropic glutamate receptors 
(see 1.5.4) (Proudfoot et al., 2006). TRPA1 is also activated by many chemical 
stimuli including icilin, menthol and mustard oil and has recently been implicated in 
mediating the nocifensive response to formalin (Macpherson et al., 2007; McNamara 
et al., 2007) 
 
1.4.2 Other ligand-gated ion channels involved in nociception 
 
There are many channels found on peripheral afferents that respond to noxious 




ion channels include the acid-sensitive ion channel family (ASIC) and the purinergic 
receptor subtype X channel family (P2X-). ASICs are activated by acid which may 
occur during local acidosis in cases of inflammation or infection, whereas P2X 
channels are activated by ATP (adenosine tripohosphate) which is released from 
damaged cells, following inflammation or mechanical tissue damage (Leffler et al., 
2006; Inoue, 2007).   
 
1.4.3 Metabotropic receptors 
 
Activation of metabotropic receptors (G protein-coupled or tyrosine kinases) results 
in intracellular signal cascades which may ultimately modulate opening or closing of 
ion channels to affect transmission. In inflammatory pain states, following tissue 
damage for example, a number of factors (e.g. 5-HT, bradykinin, histamine, NGF, 
prostaglandins) are released from mast cells and macrophages and can act on 
metabotropic receptors on the primary sensory neuron to generate a series of 
intracellular events which can lead to ion channel activation and may sensitise the 
peripheral terminal (see 1.4.5)(Costigan and Woolf, 2000).  
 




Voltage-gated sodium channels (Nav) open in response to a change in membrane 
potential and are responsible for the rapid depolarisation required for the generation 
of an action potential. Voltage-gated sodium channels exist in three states, which are: 
deactivated (closed), activated (open; by a change in voltage) and inactivated 
(closed; shortly after opening to allow for repolarisation). There are nine voltage-
gated sodium channels expressed in humans and four of these have been implicated 
in nociception based on their distribution, expression profiles and functional 
properties. Nav1.7, 1.8 and 1.9 are expressed preferentially in small diameter 
peripheral neurons whilst Nav1.3 is expressed at high levels during fetal development 




(Waxman et al., 1994). These channels are also classified according to their 
sensitivity to the sodium channel blocker tetrodotoxin (TTX), Nav1.3 and Nav1.7 
(amongst others) are sensitive to TTX (TTX-S) whilst Nav1.8 and Nav1.9 are 
resistant (TTX-R) (Krafte and Bannon, 2008). One of the major modifications to 
occur within the peripheral terminal in response to injury is the phosphorylation of 
Nav1.8 by protein kinase A (PKA) and protein kinase C (PKC) (Gold, 1999) (see 
Figure 1.3.). This lowers the voltage activation threshold of the neuron, facilitating 
propagation of an action potential in response to the detection of noxious stimuli and 
so increases sensitivity in the area it innervates. This may be more important in the 
early stages of hypersensitivity as Nav1.8 deficient mice show a delayed onset of 
thermal sensitivity following inflammation rather than a complete absence of it 
(Akopian et al., 1999). In contrast to these post-translational changes in Nav1.8 
sodium channels, a decrease in Nav1.8 and Nav 1.9 mRNA expression levels have 
been observed in DRG following nerve injury (Dib-Hajj et al., 1999). These 
particular types of sodium channel are expressed exclusively in primary sensory 
neurons and have slower activation kinetics than TTX-S types such as Nav1.3 
(Waxman et al., 1994; Dib-Hajj et al., 1999). The replacement of these TTX-R 
channels with the TTX-S, Nav1.3, in primary sensory neurons will allow the neuron 
to fire repetitively due to faster activation kinetics as well as quicker recovery from 
the inactivation state (Cummins et al., 2001), furthermore this increased excitability 
is likely to be a contributing factor to the hyperalgesia and allodynia observed in 
neuropathies. There is little evidence from knockout studies for an involvement of 
Nav1.7 and Nav1.9 in neuropathic pain states, however they are implicated in 
inflammatory pain states (Nassar et al., 2004; Amaya et al., 2006) and gain of 
function mutations of the Nav1.7 gene have been implicated in human pain disorders 
such as primary erythermalgia, (Drenth and Waxman, 2007) a condition where 
affected individuals experience a severe burning sensation in the extremities in 










Intracellular calcium is involved in regulating a number of biochemical pathways and 
its concentration is therefore usually tightly controlled within the cell. Voltage-gated 
calcium channels (Cav) located in the CNS and periphery play vital roles in pain 
processing by allowing calcium to enter the cell in specific circumstances to alter 
membrane excitability, neurotransmitter release and gene expression. These channels 
can be broadly divided into two groups based on their activation thresholds, which 
are then further divided into subfamilies designated Cav1-3, based on the properties 
of the pore forming α1 subunit that determines the functional properties of the 
channel. High threshold voltage-gated calcium channels include the L (Cav1), type 
and the N, R and P/Q (Cav2) types; low threshold voltage-gated calcium channels are 
the T (Cav3) type calcium channels (Gribkoff, 2006). The high threshold N type, 
Cav2.2 channel is highly expressed in  nociceptive primary sensory neurons (Aδ and 
C-fibres) and has therefore been implicated as one of the most important voltage-
dependent calcium channels in pain processing (Gribkoff, 2006). Furthermore, 
knockouts of the α subunit specific to this channel show reduced reflex responses to 
noxious  mechanical and thermal stimuli and reduced pain behaviour in the second 
phase of the formalin response, indicating a role at the spinal level where this 
channel is abundant on presynaptic terminals (Kim et al., 2001). A number of drugs 
based on modification of calcium channel activity have been utilised to treat chronic 
pain, perhaps the most widely used is the antiepileptic drug, gabapentin. Gabapentin 
selectively binds to voltage-gated calcium channels containing the α2δ-1 or the α2δ-2 
subunit (Marais et al., 2001) which associate with the α1 subunit to regulate current 
amplitude (the α2δ-3 and α2δ-4 also exist but are not affected by gabapentin). The 
high threshold L type and P/Q type channel are thought to be affected by gabapentin, 
although it does not appear to affect the subtypes Cav1.2 Cav2.1 (Lacinova, 2005). 
The α2δ-1 and α2δ-2 subunits are highly expressed in small diameter DRG neurons 
(Yusaf et al., 2001), furthermore, expression of the α2δ-1 subunit is significantly 
upregulated (presynaptically) in the spinal dorsal horn ipsilateral to spinal nerve 
ligation and is thought to be involved in the tactile allodynia associated with this 






Voltage-gated potassium channels (Kv) open following depolarisation to allow 
outward currents and are responsible for the hyperpolarisation phase of an action 
potential and stabilising the cell membrane potential and can therefore, in principle, 
suppress activity of nociceptive neurons. There are many types of Kv channels, which 
are divided into 12 families (Kv1-12), with each family having more than one 
member (Ocana et al., 2004). The Kv4 channel has received recent attention as a 
target for pain plasticity. Decreases in the outward (A-type) currents regulated by this 
channel have been shown to increase neuronal excitability (Hu and Gereau, 2003). 
Mice deficient in the Kv4.2 channel show enhanced basal pain responses to a number 
of sensory tests due to increased excitability of dorsal horn neurons and also an 
altered second phase formalin response. Following intraplantar formalin 
administration in these knockouts, a gradual increase in nocifensive behaviour in the 
second phase is believed to be due to increased firing, which in wild-type animals is 
attributable to ERK (extracellular signal-regulated kinase) activation and subsequent 
phosphorylation of the Kv4.2 channel (see Figure 1.4), leading to its inhibition (Hu et 
al., 2006). ERK is considered to be involved in sensitisation in the dorsal horn 
following injury by increasing excitability, and this study provides a potential 
mechanism for this enhanced excitability. Due to the electrical abnormalities 
associated with injured neurons, the involvement of voltage-gated potassium 
channels has been studied in a number of pain states. Following CCI, for example, 
Kv 1.1, 1.2, 1.4, 2.2, 4.2, and 4.3 mRNA levels are all downregulated ipsilateral to 
injury which suggests the potential involvement of such changes in the generation of 
the hyperexcitability associated with chronic pain states (Kim et al., 2002).  
 
1.4.5 Peripheral sensitisation  
 
Lowering the activation threshold of the nociceptor terminal at the periphery will 
increase its excitability in response to a given stimulus (see Figure 1.3.). This can 
occur by modulating the properties of the various ion channels and ionotropic 




inflammation leads to the production of inflammatory mediators such as bradykinin, 
NGF, prostaglandins and histamine which can increase the sensitivity of the 
nociceptor terminal via their interactions with metabotropic receptors, to initiate 
subsequent signal cascades that lead to the phosphorylation of ion channels (Woolf 













Figure 1.3. Diagrammatic representation of the receptors, and their ligands, found on 
the peripheral terminals of nociceptive neurons, and their responses to tissue 
damage/inflammation which includes activation of PKA and PKC which 
phosphorylate  TTX-R sodium channels, lowering their activation threshold, and 
therefore sensitising the peripheral terminal (Costigan and Woolf, 2000). 
 
 
1.5 Neurotransmission in nociceptive circuits: Glutamate 
 
Glutamate is the main excitatory neurotransmitter in the dorsal horn and is released 
from the terminals of peripheral afferents onto second order dorsal horn neurons 
following stimulation. Glutamate acts on ionotropic glutamate receptors which 




receptors (mGlu1-8) (Bleakman et al., 2006). AMPA (α-amino-3-hydroxyl-5-methyl-
4-isoxazole-propionate) and kainate receptors mediate fast excitatory transmission in 
the dorsal horn (the majority is carried out by AMPA receptors), as the NMDA  
receptor is blocked by Mg2+ in a voltage-dependent manner and this functional 
inhibition can only be removed upon sufficient depolarisation of the postsynaptic 
membrane (Mayer et al., 1984). As the main excitatory pathway in nociception, 
much attention has recently been focused on the role of glutamate, its receptors and 
the resulting second messenger events and signal cascades downstream of receptor 
activation, in the development and maintenance of persistent pain states. In 
particular, research has been focussed on the mechanisms responsible for enhancing 
synaptic efficacy within dorsal horn neurons, a process that is termed central 
sensitisation (see 1.8.2). 
 
1.5.1 AMPA receptors and their molecular interactions 
 
AMPA receptors are tetramers made up of a combination of the subunits GluR1-4, 
(Hollmann and Heinemann, 1994) which confer the pharmacological properties of 
the receptor. The receptor subunits are able to interact with different cytoplasmic 
proteins via their intracellular C-terminal tails, which vary in length and contain 
multiple sites for potential regulatory phosphorylation (Lee, 2006). GluR1 and 
GluR4 subunits have long cytoplasmic tails, GluR3 is short, and GluR2 exists as 2 
alternative splice variants which can be either short (GluR2S) or long (GluR2L) 
(Malinow, 2003). Calcium permeability of the receptor is dependent on the subunit 
composition, those containing GluR 1/3 or 4 make up calcium permeable receptors, 
the presence of  GluR2 reduces calcium permeability and those receptors lacking 
GluR2 have been implicated in plasticity, particularly in response to peripheral 
inflammation (Millan, 2002; Vikman et al., 2008). AMPA receptors are responsible 
for the majority of fast excitatory transmission and changes to their numbers and 
functional properties within the synapse may contribute significantly to central 
sensitisation. Of particular interest are the mechanisms responsible for the trafficking 
of specific AMPA receptor subunits to the synaptic membrane and the subsequent 




density (PSD). A number of studies indicate an essential role for synaptic insertion of 
the GluR1 subunit in particular, in the generation of long-term potentiation (LTP), 
which is thought to be orchestrated by CaMKII (calcium/calmodulin-dependent 
protein kinase) and PKA (Roche et al., 1996; Zamanillo et al., 1999; Hayashi et al., 
2000). Additional studies suggest that receptors formed of subunits with long 
cytoplasmic tails (GluR1 or GluR4), together with a GluR2 subunit, are capable of 
activity dependent trafficking to the synapse to facilitate LTP, and are subsequently 
replaced with GluR2 or 3 subunits (Shi et al., 2001). 
PSD-MAGUKS (membrane-associated guanylate kinases) are known to play an 
important role in the synaptic clustering of AMPA receptors in the mature spinal 
cord. PSD-95 and/or PSD-93 (MAGUKS that are known to interact directly with 
NMDA receptor subunits) have been shown to be crucial in regulating AMPA 
mediated synaptic transmission (Elias et al., 2006). Elias et al (Elias et al., 2006) 
demonstrate the compensatory capacity of the post synaptic density proteins by 
showing that AMPA mediated synaptic transmission is only impaired when both 
PSD-93 and PSD-95 are knocked out, which helps to explain why previous studies 
focusing only on PSD-95 mutations, fail to show any effect on AMPA mediated 
synaptic transmission (Migaud et al., 1998). Such an absence of PSD-93 and 95 may 
result in compensatory changes in remaining members of the PSD-MAGUK family, 
such as SAP 97 and SAP 102. SAP102 is upregulated in double PSD-93 and 95 
knockouts in the adult and is vital for transmission in immature synapses where PSD-
93 and 95 levels are low and increase developmentally (Elias et al., 2006). SAP 97 
binds directly to the GluR1 subunit, (Leonard et al., 1998) (unlike the other PSD-
MAGUKS which bind via transmembrane AMPA receptor regulatory proteins, 
(TARPS) such as stargazin) and has been shown to rescue the reduced AMPA 
mediated synaptic transmission caused by knockdown of PSD-95 (Schluter et al., 









1.5.2 Kainate Receptors  
 
High threshold primary afferent (Aδ and C-fibre) input is required for postsynaptic 
activation of the kainate receptor in the dorsal horn (Li et al., 1999), which suggests 
that kainate receptors may only involve pro-nociceptive stimuli and this receptor is 
becoming much more widely studied to determine its role in chronic pain states 
(Chizh, 2002). Kainate receptors are tetrameric structures formed from a 
combination of high affinity glutamate binding KA1 and KA2 subunits and the lower 
affinity GluR5-7 subunits. The composition of these subunits will confer the 
functional properties of the resulting channel. Furthermore, the GluR5 and GluR6 
subunits undergo post transcriptional mRNA editing of a single residue (from 
glutamine to arginine) (Sommer et al., 1991), which reduces the Ca2+ permeability of 
the channel and therefore the excitability of the cell and subsequent calcium-
dependent cellular events such as receptor trafficking and phosphorylation. 
Conversely, an increase in the unedited forms of these subunits would increase 
channel conductance and lead to neuronal hyperexcitability, and recently an increase 
in the unedited GluR6 subunit has been implicated in inflammatory hyperalgesia 
(Guo et al., 2002).  
 
1.5.3 NMDA receptors and their molecular interactions  
 
The NMDA receptor (NMDAR) is an ionotropic glutamate receptor permeable to 
Ca2+ and Na+ ions. The NMDAR is made up from a combination of two NR1 
subunits and two regulatory NR2 (A-D), or NR3 (A or B) subunits, which confer the 
functional characteristics of the receptor and can be modified by phosphorylation 
(Monyer et al., 1992). NMDA receptor activation requires both the presence of 
glutamate in the synapse, together with the co-agonist glycine or D-serine, as well as 
strong depolarisation of the postsynaptic membrane in order to remove the Mg2+ 
block and allow influx of Ca2+ ions (Wroblewski et al., 1989; Bleakman et al., 2006; 
Ascher and Nowak, 2009).  Non-NMDA glutamatergic activation, via AMPA or 
kainate receptors, can sufficiently depolarise the membrane to relieve the Mg2+ 




magnesium ion. Once the NMDA receptor is activated, Ca2+ ions are allowed to enter 
and can, directly or indirectly, activate many downstream effectors such as the 
kinases; PKA, PKC, CaMKII and tyrosine kinases such as Src, which are able to 
phosphorylate the receptor and subsequently alter its properties (Lee, 2006). The 
relationships between different NMDA subunits and associated proteins have been 
studied in detail to elucidate the specific pathways that lead to receptor 
phosphorylation, trafficking to the synapse and changes in receptor composition 
(Wenthold et al., 2003; Prybylowski et al., 2005; Groc et al., 2009). The NR1 subunit 
has phosphorylation sites that can be targeted by PKA or PKC (Tingley et al., 1997). 
Both phosphorylation at these sites and increased synaptic insertion have been 
associated with the hyperalgesia and allodynia generated in response to peripheral 
inflammation (Caudle et al., 2005; Yang et al., 2009). 
CaMKII is one of the major kinases involved in LTP and synaptic plasticity (Barria 
and Malinow, 2005; Lee et al., 2009) and binds to the C-terminal tail of the NR2B 
subunit with high affinity and also to the NR2A subunit, but with a lower affinity 
(Strack and Colbran, 1998; Barria and Malinow, 2005). A recent study has shown 
that a switch from NR2B to NR2A expression, consequently reducing CaMKII 
binding at the synapse, is able to reduce LTP (Barria and Malinow, 2005). 
Furthermore, inhibition of CaMKII activity leads to a reduction of NR2B levels at 
the synapse and a reduction in LTP (Gardoni et al., 2009). The important interactions 
between the NR2B subunit and CaMKII in facilitating LTP are heavily dependent on 
the postsynaptic density, particularly PSD-95 which allows the clustering of these 
proteins at the synapse and indeed, a disruption of NR2B/PSD-95 binding can also 
disrupt LTP (Gardoni et al., 2009). Due to their importance in modulating synaptic 
efficacy, these crucial postsynaptic interactions have been studied in chronic pain 
states. Garry et al 2003 (Garry et al., 2003) have shown a reduction in pain behaviour 
following nerve injury in mice expressing a truncated PSD-95. These authors have 
also shown a decreased association of CaMKII with NR2A/B subunits in these mice 
which is thought to be responsible for the lack of sensitivity. The tyrosine kinase, Src 
is perhaps one of the most recent NMDA associated kinases to be targeted in the 
chronic pain field. A recent study has shown that by disrupting the association 




neuropathic pain behaviour is reduced (Liu et al., 2008).  These authors showed that 
tyrosine phosphorylation of the NR2B subunit occurs in response to formalin 
injection and that the NMDA-dependent second phase behavioural response can be 
prevented by blocking Src and therefore NR2B subunit phosphorylation. Similarly, 
hypersensitivity as a result of peripheral inflammation (CFA) or nerve injury was 
also suppressed by the blocking peptide (Liu et al., 2008). 
The mitogen-activated protein kinase (MAPK) family include extracellular-regulated 
kinases (ERK), p38, and c-Jun N-terminal kinase (JNK) which all form part of 
different signalling cascades. Activation of the NMDA receptor is required to 
activate the ERK pathway (Ji et al., 1999). Activated ERK, phospho-ERK (pERK), 
has been implicated in the enhancement of nociceptive pathways as its levels are 
markedly increased in response to noxious stimuli, furthermore inhibition of the 
ERK kinase, MEK, is able to reduce the second phase of the formalin response (Ji et 
al., 1999). The exact mechanism for ERK involvement in central sensitisation is 
unknown, although recent studies suggest that phosphorylation of the Kv4.2 channel 
by ERK could be a possible mechanism (see 1.4.4)  (Hu et al., 2006).  
 
1.5.4 Metabotropic glutamate receptors  
 
Metabotropic glutamate receptors (mGluRs) are G protein-coupled receptors, of 
which there are 8 subtypes (mGluR 1-8), which are divided into 3 groups depending 
on their subsequent signalling pathways and their structural and pharmacological 
characteristics (Neugebauer, 2002). To briefly summarise, Group I (mGluR 1 and 5) 
receptor activation leads to the activation of phospholipase C (PLC), and subsequent 
release of calcium from intracellular stores, whereas group II (mGluR 2 and 3) and 
group III (mGluR 4/6-8) are negatively coupled to adenylate cyclase, so inhibit 
cAMP (cyclic adenosine monophosphate) formation and PKA activation 
(Neugebauer, 2002). Generally, activation of group I mGluRs increases neuronal 
excitability and can enhance ionotropic glutamate receptor activity (Bleakman et al., 
1992) by mechanisms such as receptor phosphorylation, and groups II and III are 
generally inhibitory. However, in terms of nociceptive processing, the overall effect 




mGluRs could have excitatory effects if located presynaptically on inhibitory 
interneurons, for example.   
 
1.6 Neurotransmission in nociceptive circuits: GABA and Glycine 
 
Gamma-aminobutyric acid (GABA) and glycine are the main inhibitory 
neurotransmitters in the central nervous system. GABA acts on either ionotropic 
GABAA receptors or metabotropic GABAB receptors, both of which can be found in 
the dorsal horn on primary afferent terminals, as well as on inhibitory interneurons 
(Millan, 1999). Activation of GABAA receptors allows Cl- to run down its 
concentration gradient, which is normally inwards, resulting in hyperpolarisation of 
the cell. Similarly, GABAB activation initiates a signal cascade which ultimately 
leads to a decrease in Ca2+ currents and an increase in K+ currents to hyperpolarise 
the cell and reduce transmitter release (Millan, 1999). Glycine receptors are mainly 
located postsynaptically to primary afferents in the dorsal horn and are permeable to 
Cl- ions and their activation similarly, leads to hyperpolarisation of the neuron 
(Millan, 2002). Chloride homeostasis is regulated by the K+ Cl– co transporter 
(KCC2). A reduction in expression levels of KCC2 would disrupt the transmembrane 
anion gradient, shifting GABA-mediated signalling from hyperpolarising to 
depolarising. Studies have shown that downregulation of KCC2 in dorsal horn 
neurons occurs ipsilateral to peripheral nerve injury and is implicated as a potential 
mechanism underlying hyperexcitability of lamina I neurons (Coull et al., 2003). 
Further studies from Coull et al (Coull et al., 2005) have shown that ATP-stimulated 
microglia are involved in the shift in the anion gradient in GABAergic neurons 
within lamina I following nerve injury. The study shows that stimulated microglia 
transplanted into naïve rats are able to induce a shift in GABA responses from 
hyperpolarising to depolarising which is accompanied by a reduction in paw 
withdrawal threshold. BDNF release from microglia is thought to be mechanism 
responsible for this interaction between activated microglia and GABAergic neurons, 





In chronic pain states there is evidence to suggest that GABAergic interneurons can 
co-express other neurotransmitters such as the endogenous opioid, enkephalin, 
acetylcholine, (see 1.7), or glycine (Millan, 1999). These inhibitory interneurons can 
be activated by both nociceptive (Aδ and C-fibres) and non-nociceptive (Aβ) fibres 
and can subsequently affect dorsal horn output via the connections they make with 
projection neurons (Willis and Coggeshall, 1991). These mechanisms form the basis 
of what was described by the Gate Control Theory, proposed by Ronald Melzack and 
Patrick Wall in 1965 (Melzack and Wall, 1965). According to the Gate Control 
Theory, activation of Aβ fibres by light touch activates inhibitory interneurons in the 
dorsal horn which in turn inhibit output from projection neurons, potentially reducing 
the signal from nociceptive neurons and therefore pain perception. The fine balance 
of these inhibitory mechanisms can be shifted or disrupted in cases of chronic pain 
states such as nerve injury or inflammation (Zeilhofer, 2008). Two of the main 
mechanisms put forward by which inflammation or nerve injury have been shown to 
lead to disinhibition within the dorsal horn are by prostaglandin-mediated inhibition 
of glycinergic signalling or apoptotic cell death of GABAergic neurons, respectively 
(Ahmadi et al., 2002; Moore et al., 2002). Following peripheral inflammation, the 
enzymes necessary for the production of prostaglandins, and specifically PGE2, are 
upregulated in the spinal cord (Claveau et al., 2003). PGE2 acts postsynaptically at 
the EP2 receptor to ultimately activate PKA which leads to phosphorylation-induced 
inhibition of a specific subunit of glycine receptors (GlyRα3) that are expressed in 
the superficial dorsal horn (Ahmadi et al., 2002). Peripheral nerve injury has been 
shown to activate caspase, a protease essential for apoptotic cell death, in dorsal horn 
neurons, which have been shown to be largely GABAergic interneurons (Scholz et 
al., 2005). The authors demonstrated that the mechanism for the induction of cell 
death is mediated by glutamate and activation of NMDARs, and suggest that the 
excitotoxic levels of glutamate released post-injury may be responsible for the cell 
death of GABAergic interneurons (Scholz et al., 2005).  
Ultimately, the result of such disinhibition would be persistent input from primary 
afferents onto WDR neurons lacking inhibitory tone, which may result in central 





1.7 Modulation of dorsal horn transmission   
 
The intensity and duration of the output from projection neurons in the dorsal horn is 
dependent on the balance between excitatory primary afferent input, local excitatory 
and inhibitory circuits within the dorsal horn and supraspinal descending input. 
These systems can all be modified following nerve injury or inflammation, to tip the 
balance towards hyperexcitability of dorsal horn neurons and subsequent central 
sensitisation and the generation of pathological pain states.     
 
1.7.1 Primary afferent input and local spinal circuits 
 
The peptide neurotransmitters SP and CGRP are co-released from C-fibres along 
with glutamate and can further enhance glutamate release (Kangrga and Randic, 
1990) thereby potentially contributing to the depolarisation of the postsynaptic 
neuron. SP receptors (NK1 receptors) are located on lamina I neurons that are 
nocispecific projection neurons and belong to the spinothalamic and 
spinoparabrachial tracts (see 1.3.4). It has also been proposed that these neurons are 
essential in the development of central sensitisation in response to injury, as ablation 
of the receptor is able to reduce hyperalgesia (Mantyh et al., 1997; Khasabov et al., 
2002). Transmission of nociceptive signalling by projection neurons can be 
modulated within the dorsal horn by endogenous opioids, such as endorphins, 
enkephalins and dynorphins (Millan, 2002). Opioid receptors include the mu (µ), 
delta (δ) and kappa (κ) receptor subtypes, and are present within the superficial 
dorsal horn. These receptors are G protein-coupled receptors which are negatively 
coupled to adenylate cyclase to increase K+ currents and decrease Ca2+ in order to 
decrease excitability (Millan, 2002). The mu and delta opioid receptors have 
previously been shown to be colocalised with SP and CGRP in the peptidergic 
population of C-fibres. However, recent studies (Scherrer et al., 2009) indicate a 
differential expression of mu and delta opioid receptors in primary afferents with the 
mu subtype primarily localised within peptidergic C-fibres and the delta receptor 
localised within the non-peptidergic sub-class of C-fibres, as well as within 




in the modulation of heat and mechanical stimuli, respectively (Scherrer et al., 2009). 
In addition to the 3 main subtypes of opioid receptors, the ORL-1 (Opioid Receptor-
Like 1) is a G protein-coupled receptor, negatively coupled to adenylate cyclase with 
a sequence closely related to those of the opioid receptors (Meunier, 1997). 
Activation of the ORL-1 receptor by its endogenous ligand, nociceptin (Meunier et 
al., 1995; Reinscheid et al., 1995), inhibits N-type voltage-gated calcium channels, 
and activates potassium channels, which results in a reduction in neurotransmitter 
release from primary afferents (Henderson and McKnight, 1997). The expression of 
both nociceptin and the ORL-1 receptor has been shown to occur within many 
regions associated with nociceptive processing, such as the thalamus, PAG, and also 
the spinal cord and in small to medium-sized DRG neurons, where these proteins 
have been shown to be upregulated following nerve injury or inflammation (Chen 
and Sommer, 2006). The precise role of this receptor and its ligand in nociceptive 
behaviour is still subject to debate. The name “nociceptin” was originally given as it 
was thought that this ligand induced hypersensitivity based on results from 
intracerebroventricular administration of the ligand, and also from knockdown 
studies (Chen and Sommer, 2006). More recent studies have in fact shown an 
opposite, anti-allodynic, effect when nociceptin is given intrathecally to neuropathic 
rats, an effect which can be potentiated when given with morphine, suggesting an 
opioid-dependent mechanism of action at the spinal cord (Courteix et al., 2004). 
Subsequent studies, however have indicated that the nociceptin/ORL-1 system may 
have an anti-opioid influence, as ORL-1 antagonists administered systemically, are 
able to potentiate morphine anti-allodynia in chronic pain, suggesting that the 
upregulation of the nociceptin/ORL-1 system observed in chronic pain states may 
contribute to the poor efficacy of opioids in treating chronic pain (Khroyan et al., 
2009). The discrepancies and confusion that have arisen regarding the 
nociceptin/ORL-1 system may therefore be partly down to the presence of 
underlying pain states, different routes of administration or agonists and antagonists, 
and mechanisms of action at spinal or supraspinal sites, but its role remains as yet 






1.7.2 Descending control of dorsal horn neurons 
 
The noradrenergic and serotonergic pathways from the RVM (see Figure 1.1) are the 
main descending pathways to the dorsal horn and their overall effects on output can 
be either inhibitory or facilitatory. Inhibitory mechanisms reduce dorsal horn output 
by hyperpolarising superficial dorsal horn neurons, inhibiting transmitter release 
from primary afferents and also increasing inhibitory tone via GABAergic and 
glycine interneurons (Millan, 2002). Noradrenaline acts both pre- and post 
synaptically via the α2 adrenoceptor, which is negatively coupled to adenylate 
cyclase, to reduce transmitter release from primary afferents, and also to prevent 
firing of projection neurons (Li and Zhuo, 2001; Millan, 2002; Pan et al., 2002; 
D'Mello and Dickenson, 2008) both of which will serve to reduce dorsal horn output. 
The α2 adrenoceptor agonist clonidine is able to alleviate the allodynia induced by 
nerve injury and has been used to treat neuropathic pain clinically (Eisenach et al., 
1995). The mechanism responsible for the analgesic effect of clonidine is not fully 
understood. Studies have indicated that intrathecal clonidine may exert its analgesic 
effect by α2R-mediated depolarisation of cholinergic neurons to increase spinal 
acetylcholine, which has been shown to reduce glutamatergic transmission in the 
dorsal horn by inhibition of glutamate release from primary afferents and excitatory 
interneurons, and potentiation of GABAergic tone via activation of different 
muscarinic receptor subtypes (Pan et al., 1999; Pan et al., 2002; Zhang et al., 2007; 
Gassner et al., 2009). Conversely, α1 adrenoceptors are positively linked via G 
protein-coupled receptors to voltage-gated calcium channels and so their actions on 
neuronal activity are largely excitatory, which given their location on projection 
neurons and primary afferent terminals, along with increased expression following 
peripheral nerve injury, indicates a pro-nociceptive role (Millan, 2002).    
Serotonergic pathways are a further source of descending modulation on dorsal horn 
neurons, also originating from the RVM in the brainstem (see Figure 1.1). The 
majority of these neurons terminate in superficial laminae of the spinal cord (Millan, 
2002). Depending on the receptor targeted, the effect on output can either be 
facilitatory or inhibitory. Of the 14 subtypes of serotonin receptor the most abundant 




studies (Millan, 2002). 5-HT1A, 5-HT1B, and 5-HT1D are expressed in the superficial 
dorsal horn and are negatively coupled to adenylate cyclase and lead to the opening 
of K+ channels to exert an inhibitory effect on transmission (Millan, 2002). Studies 
also suggest a role for spinal 5-HT7 receptors in mediating morphine induced anti-
nociception, as this opiate-induced analgesia can be blocked by intrathecal 
administration of antagonists for the 5-HT7 receptor (Dogrul et al., 2009). 
Furthermore, systemic administration of 5-HT7 receptor agonists, is able to dose-
dependently reverse capsaicin-induced mechanical hyperalgesia (Brenchat et al., 
2009), although the basis for the spinal mechanism proposed to explain this is not 
fully understood.  
The 5-HT3 receptor is an ionotropic cation channel located predominantly on C-
fibres in lamina I and activation of this channel by descending serotonergic pathways 
can facilitate nociceptive transmission, particularly in inflammatory pain states 
(Millan, 2002; Yoshimura and Furue, 2006). The pro-nociceptive pathway 
responsible for this facilitation of nociceptive signals is thought to originate in the 
dorsal reticular nucleus (DRt) of the medulla (Brenchat et al., 2009). Nociceptive 
inputs to spinal dorsal horn neurons and the subsequent rostral propagation of these 
signals by NK1 receptor-positive projection neurons is able to activate descending 
serotonergic pathways which act on 5-HT3 receptors to enhance excitability in the 
spinal cord (Suzuki et al., 2002; Rahman et al., 2007). Disruption of this loop, either 
by ablation of NK1-positive projection neurons, brainstem lesions, or antagonism of 
spinal 5-HT3  receptors is able to reduced the hyperalgesia and allodynia associated 
with chronic pain states (Rahman et al., 2007) and could therefore be seen as a 
potential target for therapeutic intervention.  
As discussed above, information about painful stimuli is not simply transmitted 
directly to the brain from the spinal cord unchanged; importantly, nociceptive signals 
can be modulated depending on circumstances. In cases of persistent activation of 
dorsal horn neurons, in chronic pain states for example, modulation of output occurs 
as a result of a number of plastic changes within the spinal cord which can often 






1.8 Plasticity in nociceptive circuits in the spinal dorsal horn  
 
1.8.1 Signalling and second messenger pathways 
 
Many of the modulatory effects necessary for plasticity in nociceptive neurons and 
their pathways arise as a result of complex signalling cascades and second messenger 
systems. Upon activation of membrane receptors such as the NMDAR, a number of 
intracellular responses are initiated in response to the influx of calcium. These 
include activation of protein kinases which are responsible for the phosphorylation of 
receptor subunits and therefore altered function, thus much attention has been 
focused on these pathways and their involvement in synaptic plasticity, and 
specifically the maintenance of persistent pain states (Ji and Woolf, 2001; Lee, 
2006). However, the variety and complexity of these signal transduction mechanisms 
makes selecting specific molecules for possible therapeutic targets difficult.  
 
1.8.2 Synaptic plasticity:  LTP and central sensitisation 
 
Nociception is subject to modification based on previous injuries and experiences, 
such modifications may be long-lasting and can be pathological in cases of chronic 
pain states. It is believed that the modification of synaptic efficacy following 
peripheral injuries primarily takes place within the dorsal horn of the spinal cord and 
is therefore termed central sensitisation. LTP and LTD (long term depression) are 
physiologically opposing mechanisms of synaptic plasticity. As previously discussed 
(1.5.3) there are a number of protein kinases implicated in NMDA-dependent 
potentiation of postsynaptic signalling. Conversely, various protein phosphatases 
(PP1, PP2A and PP2B), are implicated in LTD, and it has been proposed that protein 
phosphatases and protein kinases have higher and lower affinities for Ca2+, 
respectively, and so small increases in calcium would favour protein phosphatase 
activity and LTD, whereas a large increase in Ca2+ would promote protein kinase 
activation and the induction of LTP (Lee, 2006). It has been suggested that central 
sensitisation shares some of the molecular mechanisms associated with LTP in the 




memory (Morris et al., 1986).  LTP is a long lasting increase in synaptic strength 
which results from high frequency repetitive stimulation and in order for this to be 
induced and maintained, changes must occur within the synaptic structure  and 
function; such changes may include altered presynaptic transmitter release and/or 
postsynaptic responsiveness to these transmitters (Ji and Woolf, 2001). Central 
sensitisation is defined by the IASP as “an enhanced responsiveness of nociceptive 
neurons in the CNS to their normal afferent input” (Merskey and Bogduk, 1994). 
Importantly, this facilitatory input can come from more than one source whereas LTP 
results from homosynaptic input, furthermore, nociceptive input at dorsal horn 
neurons is usually low frequency and therefore potentiation of these neurons is more 
likely to arise from low frequency heterosynaptic input (Ji et al., 2003). It is 
important to specify when discussing pain mechanisms that central sensitisation 
refers to the altered response of nociceptive neurons receiving afferent input, as there 
is a need to take into account the influences of inhibitory interneurons as well as 
descending input (see 1.3.2 and 1.3.3) within the dorsal horn. Both LTP and central 
sensitisation have been shown to require NMDA receptor activation and subsequent 
increases in intracellular calcium (Lynch et al., 1983; Morris et al., 1986; Woolf and 
Thompson, 1991), although voltage-gated calcium channels, AMPA receptor 
activation and release from intracellular Ca2+ stores can also contribute to a rise in 
intracellular Ca2+ concentration. Such increases in intracellular Ca2+ concentration 
can lead directly or indirectly to the activation of protein kinases such as CaMKII, 
PKC and PKA, which can mediate changes in synaptic potentiation by 
phosphorylation of glutamate receptors at specific sites to alter their physiological 
properties and also to promote trafficking of receptors to the postsynaptic membrane 
(Ji and Woolf, 2001). Specifically, phosphorylation of the GluR1 subunit of the 
AMPA receptor and the NR2B subunit of the NMDA receptor have received much 
attention recently for their roles in enhancing synaptic efficacy (Wang and Salter, 
1994; Boehm et al., 2006; Kopec et al., 2007). In addition to increasing synaptic 
efficacy by modulation of receptors, increased insertion of AMPA receptors will also 
enhance synaptic transmission and such mechanisms are being extensively studied 
with a view to understand and potentially develop ways to treat the hypersensitivity 










Figure 1.4. Central sensitisation in the dorsal horn. Glutamate (Glu), Substance P 
(SP) and brain-derived neurotropic factor (BDNF) are released from primary 
afferents. Glutamate acts upon NMDA, AMPA or metabotropic glutamate receptor 
(mglu) and SP and BDNF activate the G-protein-coupled neurokinin 1 (NK1) 
receptor or the tyrosine kinase receptor TrkB, respectively. Calcium and downstream 
signalling activates kinases,  CaMKII, Src, PKA and PKC which phosphorylate (red 
arrows) AMPA and NMDA receptors to increase synaptic efficacy. ERK also 
phosphorylates (orange arrow) the Kv4.2 K+ channel which results in inhibition of 
the outward current regulated by this channel to regulate the hyperpolarisation phase 
of the action potential.  (Ji et al., 2003) 
 
 
1.9 Pain in the preterm and newborn 
 
Early-life pain such as that likely to be experienced by human pre-term neonates in 
neonatal intensive care units is poorly understood and requires further investigation. 
It was previously thought that due to an under-developed nervous system, neonates 
lack conscious awareness of medical procedures carried out and are therefore given 
little or no analgesia (Anand et al., 2005). Recent studies are now not only indicating 




Sternberg et al., 2005) and neuropathic pain (Lee and Chung, 1996; Howard et al., 
2005), but also providing evidence for a conscious awareness, indicating higher-level 
processing and potential suffering (Bartocci et al., 2006; Slater et al., 2006). 
 
1.9.1 Development of nociceptive inputs 
 
At birth, the development of the somatosensory system is ongoing. This is true of 
many mammalian species, including in humans (especially in preterm neonates) and 
also the laboratory rodent. Postnatal development of the sensory system allows early 
life events to influence somatosensory sensitivity due to the ongoing organisation of 
sensory connections and receptor expression in the CNS and peripheral nervous 
system (Fitzgerald, 1995; Alvares and Fitzgerald, 1999; Fitzgerald, 2005). One of the 
major differences between the adult and neonatal nociceptive system in the rat is that 
A-fibres have a strong input onto lamina II neurons in the neonate, which normally 
only receive C-fibre input in the adult, the possible exception being in sensitised 
states. A-fibres are the first to reach the dorsal horn at around E13 and are able to 
evoke action potentials in the dorsal horn from P3 (Jennings and Fitzgerald, 1998). 
These fibres begin to withdraw from lamina II over the first 3 postnatal weeks 
(Fitzgerald et al., 1994) and so any insult to the nervous system during this time may 
affect this redistribution within an already “sensitive” system. Peptidergic C-fibres 
reach Lamina II at E18-19 (Mirnics and Koerber, 1995) and the non-peptidergic 
subclass of C-fibres arrive later at around P5 (Benn et al., 2001). However, although 
peptidergic C-fibres can be observed in the dorsal horn early in development, 
evidence suggests that they do not mature in terms of their expression of SP and 
CGRP at primary afferent terminals until P21 and the SP receptor, NK1, does not 
become localised to the superficial dorsal horn until the second postnatal week 
(Charlton and Helke, 1986; Marti et al., 1987). Additionally, the sodium channel 
Nav1.8 is not expressed in C-fibres at adult levels until P7 (Benn et al., 2001). 
Together these developmental changes to C-fibre phenotype indicate that adult-like 
responses to nociceptive stimuli may not be possible until at least the second or third 




As discussed previously (1.5), fast excitatory transmission in the dorsal horn is 
mediated by AMPA and kainate receptors. AMPA receptors are highly expressed in 
the dorsal horn at birth, particularly GluR 1, 2 and 4 subunits (Jakowec et al., 1995). 
Furthermore, compared to adult levels, the ratio of GluR2 subunits to GluR1, 3 and 4 
subunits is lower indicating the likelihood a higher influx of Ca2+ in neonatal dorsal 
horn neurons, due to greater numbers of calcium-permeable AMPA receptors. The 
kainate receptor subunits GluR 5 and 6 are also expressed in the superficial dorsal 
horn at birth, with expression peaking at P10, and declining by the 3rd postnatal week 
(Stegenga and Kalb, 2001). Furthermore there is a developmental switch in the 
mRNA editing of peripheral GluR5 subunits of the kainate receptor (see 1.5.2), in the 
non-peptidergic population of C-fibres (Lee et al., 2001). By postnatal day 7, most of 
the GluR5 subunits are in the edited form (Lee et al., 2001) which have a low 
permeability to Ca2+. Together with the enhanced excitation in the dorsal horn early 
in development, the developmental switch in GluR5 subunit editing in C-fibres is 
thought to allow for growth and the formation of nociceptive connections with 
lamina II dorsal horn neurons, as this switch occurs at the same time as C-fibres 
begin to terminate within the superficial dorsal horn (Lee et al., 2001). As with other 
excitatory glutamate receptors, NMDAR subunit expression in the spinal cord is 
developmentally regulated. NR1 expression declines from P2 to P10 and is relatively 
low in adult tissue in comparison to neonatal levels, NR2B follows a similar 
expression profile to NR1 in that its expression is decreased developmentally, with 
high levels detected in the substantia gelatinosa at P2 and P10 and a decline in 
expression by P22 and in adult tissue. NR2A is expressed at low levels at P2 but 
expression increases by P22 (Stegenga and Kalb, 2001).  
Generally, all three subtypes of ionotropic glutamate receptor, AMPA, kainate and 
NMDA, are highly expressed in the neonatal dorsal horn compared with that of the 
adult. It has been suggested that glutamatergic transmission in the neonate, and  Ca2+ 
influx through the GluR1-containing AMPA receptor, may play a role in activity-
dependent growth and maturation of neurons (Inglis et al., 2002). Furthermore, the 
ongoing reorganisation of glutamate receptors postnatally, and the subsequent 
receptor characteristics brought about by these changes, may make these synapses 




disruption to their usual expression profiles, this could be brought about by injury 
and the consequential changes in signalling within nociceptive circuitry.  
In terms of modulation and output from the dorsal horn, projection neurons are 
present in the superficial dorsal horn prenatally, although representation of paw 
stimulation in the rodent is not present in the somatosensory cortex until P12, and 
interneurons mature slightly later at around P20, (Thairu, 1971; Bicknell, Jr. and 
Beal, 1984), while descending inhibitory connections such as the serotonergic 
pathways, are not developed until the second postnatal week (Galineau et al., 2004). 
Endogenous inhibitory control by interneurons is limited in the early postnatal 
period, and is dependent on GABAergic transmission, and particularly the GABAA 
receptor, with glycinergic signalling appearing by P8 (Baccei and Fitzgerald, 2004). 
The functional significance of these immature inhibitory connections coupled with 
strong A-fibre input and high Ca2+ influx through ionotropic glutamate receptors, 
together with little or no descending inhibitory control, makes the immature dorsal 
horn much more excitable than that of the adult (for a summary of changes see 
Figure 1.5). 
As discussed above, the first 3 postnatal weeks are a crucial time for reorganisation 
and maturation of dorsal horn input, with large diameter A-fibres occupying the same 
laminae as polymodal nociceptive C-fibres. The functional consequence of overlap 
of non-noxious and noxious input postnatally, means that discrimination between the 
two types of stimuli is difficult, receptive field sizes are large and coupled with a 
lack of endogenous inhibition during this period, neonatal nociception is potentially 
greater than that of an adult. Interruption of this normal restructuring of inputs with 
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Figure 1.5. Diagrammatic representation of developmental changes which take place 
in superficial dorsal horn neurons from early postnatal life (top) to adulthood 
(bottom). Blue arrows represent primary afferent input, green arrow represent 













1.10  Early life events and programming  
 
The process by which external events during development exert long-term changes in 
physiological processes is termed “programming”. As well as the obvious need to 
identify the mechanisms which may be involved in human programming of pain 
sensitivities as a result of early life injuries (discussed 1.9), programming in domestic 
species is becoming increasingly more apparent (Jarvis et al., 2006) and poses a 
range of as-yet unanswered questions over animal welfare. This is especially 
important in the pig farming industry where not only are pregnant sows socially 
stressed from mixing with unfamiliar sows, but offspring experience early-life pain, 
with tail-docking and tail biting occurring soon after birth (Compassion in World 
Farming (CIWF), 2009). The effects of this combination of aversive early life stress 
and postnatal pain need to be further explored both in pigs and appropriate laboratory 
models to understand changes that may occur in physiology and behaviour. A full 
appreciation of the overall impact of early life adverse events will require not only 
assessment of the first generation but also in subsequent generations to examine the 
effects of the maternal behaviour of the affected daughters and heritability.  
 
1.11 Animal welfare 
 
As previously mentioned (1.1), pain in animals can often be difficult to assess due to 
an inability to communicate verbally. To overcome this, most of the current 
assessments of pain in animals are based on efferent responses and can be defined as 
follows: 
 
 “Animal pain is an aversive sensory and emotional experience representing an 
awareness by the animal of damage or threat to the integrity of its tissues; (note there 
may not be any damage) it changes the animal’s physiology and behaviour to reduce 
or avoid the damage, to reduce the likelihood of recurrence and to promote 
recovery.”  (Molony, 1997) 
 
Due to the distress and potential incapacitating effects evoked by pain, it has become 
a major animal welfare concern. Of particular importance are chronic pain states 




occur in association with disease states, but also may occur following the absence of 
adequate pre-emptive analgesia prior to surgery or routine husbandry procedures 
such as castration and tail docking (Compassion in World Farming (CIWF), 2009). 
The long-term consequences of such procedures, on both sensory processing and 
affective behaviour, have not yet been fully investigated. Furthermore, the possible 
synergistic effect of adverse prenatal experiences and postnatal pain on animal 
welfare needs further study.   
 
1.12 Prenatal stress 
 
1.12.1 The Hypothalamic-Pituitary-Adrenal axis 
 
Stress can be defined as a potential or existing threat to an organism’s homeostasis, 
and the physiological stress response is an attempt to counteract such threats. There 
are many pathways within the brain that are activated in response to stress and which 
converge onto corticotropin-releasing-hormone (CRH) neurons within the PVN of 
the hypothalamus to activate the hypothalamo-pituitary-adrenal (HPA) axis, (Figure 
1.6) (Johnstone et al., 2000; Russell et al., 2001; Kudielka and Kirschbaum, 2005). 
The HPA axis begins with CRH release from the PVN. CRH, along with arginine 
vasopressin (AVP), are released from PVN terminals at the median eminence into the 
hypophysial portal blood system where they are transported to the anterior pituitary 
to activate CRH type I and AVP (V1a) receptors, respectively, to synergistically 
stimulate release of adrenocorticotropic hormone (ACTH) from corticotrophs within 
the anterior pituitary. ACTH is released into the systemic blood, and acts upon the 
adrenal cortex to stimulate glucocorticoid (i.e., cortisol in humans and corticosterone 
in mice and rats) release. Glucocorticoids exert many metabolic and physiological 
effects throughout the body and also modulate negative feedback at the level of the 
hippocampus, pituitary and PVN to reduce further ACTH and therefore 
glucocorticoid release. The most widely studied effects of glucocorticoids are 
mediated genomically upon binding to intracellular glucocorticoid receptors (GRs), 
which once activated, translocate to the nucleus to bind to the glucocorticoid 




produce the diverse effects mentioned previously and described below with reference 
to prenatal stress. Glucocorticoids are also able to exert their effects via non-genomic 
mechanisms which are independent of GRs and may be mediated through direct 
interactions of the steroid or through interactions with additional partner proteins. 
These non-genomic mechanisms are able to have rapid effects as they are 
independent of transcription and protein synthesis (Haller et al., 2008). As 
mentioned, GRs along with the higher-affinity mineralocorticoid receptor (MR), 
mediate negative feedback of the HPA axis. The highest concentration of MRs in the 
brain is found in the hippocampus where they are bound by low levels of 
glucocorticoids and are important for tonic regulation of basal HPA axis activity. 
GRs are found throughout the brain, but at high concentrations in the hippocampus, 
PVN and pituitary where they mediate feedback control of stress-induced 
glucocorticoid secretion (de Kloet and Reul, 1987), although it is thought that MRs 
are also important for stress-induced negative feedback control (Dallman et al., 
1989).  
It is important to consider the developmental profile of the components of the HPA 
axis and its associated structures when investigating the potential adverse outcomes 
of perinatal stressors. The embryonic development of fetal rat and human brain areas 
is reviewed by Weinstock, 2001 (Weinstock, 2001). An essential component of the 
HPA axis, the PVN, does not develop until the later stages of embryonic life in the 
rat (E13-15) and is responsive to maternal corticosterone by E15 (Fujioka et al., 
1999; Fujioka et al., 2003), whilst the hippocampus and therefore feedback control 
and regulation of the HPA axis, is not fully established until after birth (CA E16-20, 
dentate gyrus P3-15). In the rat brain glucocorticoid receptors are present in the last 
prenatal week, with GRs appearing first and MRs appearing in the hippocampus 
slightly later, with levels remaining low until after birth when they begin to increase 
(Diaz et al., 1998). Given the developmental profile of the components of the stress 
response in the rat, it is clear that the last prenatal week is a particularly sensitive 
window for this system and studies have shown that maternal stress during this time 
has adverse effects on offspring HPA axis activity and also anxiety behaviour 




HPA axis is highly species-specific and therefore different windows may exist where 
perinatal programming of this system is most likely to occur. 
 

















Figure 1.6. Diagrammatic representation of the HPA axis. Corticotropin-releasing 
hormone (CRH) and arginine vasopressin (AVP) are released from the 
paraventricular nucleus (PVN) of the hypothalamus and act upon CRH type I and 
V1a receptors in the anterior pituitary to stimulate release of adrenocorticotropic 
hormone (ACTH). ACTH is released into the systemic blood and stimulates 
corticosterone/cortisol (cort) secretion from the adrenal cortex which is then able to 




1.12.2 Perinatal protective mechanisms 
 
The uterine environment is designed to help protect the developing fetus and ensure 
offspring are well prepared to face their external environment at birth. It has been 
well documented that exposure to excess stress hormones (glucocorticoids) during 




also predispose to a number of other diseases in later life (Clark, 1998; Welberg and 
Seckl, 2001; Seckl, 2004; Moritz et al., 2005). It therefore makes sense, from an 
evolutionary perspective, that the maternal HPA axis undergoes a period of 
hyporesponsivness in late pregnancy (Brunton and Russell, 2008). The mechanisms 
responsible for this hyporesponsive period have recently been identified (Brunton et 
al., 2009) and are due to endogenous opioid inhibition of stress-induced 
noradrenergic input to the PVN, which presynaptically reduces noradrenaline release 
and subsequent CRH secretion. This opioid-mediated inhibition of the stress 
response is thought to be induced by allopregnanolone, a progesterone metabolite 
which is found in the brain at high levels during pregnancy. These mechanisms 
protect the fetus from circulating glucocorticoids during critical developmental 
windows, during which fetal programming is most likely to occur (Johnstone et al., 
2000; Russell et al., 2001). Further protection is provided in the form of placental 
11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) which converts maternal 
corticosterone to inactive 11- dehydrocorticosterone. However, in cases of persistent 
or highly stressful situations, these protective mechanisms may fail, allowing 
increased levels of maternal glucocorticoids to reach the fetus and have the 
aforementioned effects (Welberg et al., 2005). In addition to in utero protection, 
rodents have a postnatal stress hyporesponsive period occurring between postnatal 
days 4 and 14, which also seems to be under maternal control by mother-infant 
interaction (Levine et al., 1991; Levine, 1994). Given the relative immaturity of a rat 
pup at birth, this postnatal protection from high glucocorticoid levels is essential to 
prevent adverse effects on neuroendocrine and CNS development. 
 
1.12.3 Prenatal stress – models and effects 
 
Much of the data obtained from the effect of prenatal stress in humans comes from 
retrospective studies where the stressor has been in the form of natural disasters, war 
or terrorist attacks and also in the form of more personally directed stressors such as 
tensions or abuse at home or in the workplace. The impact of such stressors on 
offspring is, not surprisingly, varied and includes elevated basal and stress induced 




behavioural abnormalities in childhood and adulthood (Weinstock, 2001; Welberg 
and Seckl, 2001; Kapoor et al., 2006; Yehuda and Bierer, 2008; Mastorci et al., 
2009). In the laboratory rat, it is possible to investigate the effects of fetal 
glucocorticoid exposure by administering synthetic glucocorticoids such as 
dexamethasone or increasing endogenous glucocorticoids by exposing the pregnant 
female to a highly stressful situation. Exposure to dexamethasone, prenatally, leads 
to low birth weight, elevated stress responsiveness and diseases such as hypertension 
and hyperglycemia in the adult (Benediktsson et al., 1993; Clark, 1998; Seckl, 2004; 
Moritz et al., 2005). Other models of prenatal stress aim to increase endogenous 
corticosteroids by activating the maternal HPA axis. One of the most commonly used 
prenatal stressors is restraint, which has many documented detrimental effects on 
offspring including changes in pain behaviour (Butkevich et al., 2006; Darnaudery 
and Maccari, 2008). The mechanism by which the maternal stress response can affect 
its offspring is still unknown; there is evidence to support both pre and postnatal 
maternal influences.  Barbazanges et al. (Barbazanges et al., 1996) carried out one of 
the first studies to implicate elevated maternal corticosterone as the potential 
mechanism for producing prenatally programmed offspring. The study shows that 
restraint stress in the last week of pregnancy, which is known to increase 
corticosterone levels, leads to a prolonged stress-induced corticosterone response in 
adult offspring, as well as a decrease in MR, (which are important for negative 
feedback control of glucocorticoid secretion, see section 1.12.1). Both of these 
outcomes can be prevented by removing maternal corticosterone using 
adrenalectomy and can be reinstated in adrenalectomized mothers when 
supplementing with doses of corticosterone to mimic stress-induced levels. Other 
studies have investigated the effects of maternal stress on 11β-HSD2, as another 
possible mechanism to account for the effect the maternal stress response can have 
on offspring. It has been shown that restraint stress is capable of reducing both 
placental and fetal 11β-HSD2 (Mairesse et al., 2007), thus reducing the level of 
protection against elevated maternal glucocorticoids and also increasing the 
availability of corticosterone in pups themselves. In addition to these direct effects of 
maternal corticosterone on the development of offspring’s HPA axis in utero, 




2008), which can negatively affect postnatal programming of offspring’s stress 
responsiveness. Increases in maternal care in the form of licking and grooming have 
been shown to increase hippocampal GR expression, and therefore negative feedback 
sensitivity, via alterations to the epigenome (changes in gene expression without 
altering underlying DNA sequence) through functional modulation of the GR gene 
promoter region (Weaver et al., 2004). This may help to explain how postnatal 
maternal interactions are able to induce long- lasting changes in offspring HPA axis 
responsiveness. It has been known for a number of years that postnatal handling is 
able to reduce HPA responsiveness and stress induced anxiety (Levine, 1962; Meerlo 
et al., 1999) and it is thought that the reason for this is due to the increased maternal 
attention the pup receives once it is returned to the home cage following handling. 
Furthermore, cross-fostering studies, which result in increased attention towards the 
fostered pup, have been shown to reverse the negative HPA axis effects of prenatal 
stress (Maccari et al., 1995). In light of the data discussed, it is important to consider 
the range of complicated interactions which take place between a mother and her 





We hypothesise that the combination of a nerve injury and inflammation will result 
in enhanced sensitivity when compared to the component single injuries. 
Furthermore, we hypothesise that these injuries carried out in early life will lead to 
long-lasting changes in nociceptive processing, which may be further exacerbated by 




This thesis will explore the long-term consequences of chronic pain using a novel 
pain model in laboratory rats that is designed to reflect combined neuropathic and 
inflammatory injury. Such a combination would occur together clinically as a result 




could potentially compromise animal welfare, such as tail-docking in the piglet. We 
will characterise this novel model in the adult, before taking it to the neonate to 
explore its effects on nociceptive responsiveness compared to those elicited by 
component inflammatory or neuropathic injuries. Further we will evaluate whether 
any of these early life injuries are able to bring about long-term plasticity in 
nociceptive processing pathways that may be manifest as amplification or altered 
characteristics of the response to noxious challenge in later life.  Finally, we will ask 
whether prenatal stress can programme stress and pain sensitivity of the offspring, 
either alone or in combination with early life injury such that enhanced endocrine 




CHAPTER 2: MATERIALS AND METHODS 
2.1 Animals 
 
All experiments were carried out in accordance with the UK Animals (Scientific 
Procedures) Act 1986 and associated guidelines, and had received ethical approval 
from the University of Edinburgh ethical committee. Sprague Dawley rats were used 
in all experiments and were given access to food and water ad libitum and housed in 
accordance with Home Office guidelines. Ambient temperature and humidity were 
21°C and 50% respectively; lighting was on a 12h on: 12h off schedule, with lights 
on from 07.00h to 19.00h. Rats were normally housed in same sex groups of up to 6 
per cage. Pups were weaned between postnatal day (P) 22 and P28 and housed with 




2.2.1 Adults  
 
Adult male Sprague Dawley rats (150-200g) were either given an injection of  
Complete Freund’s Adjuvant (CFA), surgery to produce a Chronic Constriction 
Injury (CCI) or a combination of both injuries to the right hindpaw/hind leg (see 
detail below, 2.3.1). Rats were tested from 24 hours onwards following CFA and 
from 6 days onwards following CCI or combined surgery to allow for healing 




Female Sprague Dawley rats were mated and the male removed from the cage once 
females were visibly pregnant. At either post partum day (P) 8 (day of birth =P0) or 
P18 individual litters were divided into experimental and control groups. Control 
groups were either non-handled pups (naïve controls) which were not tested and 
remained with the dam at all times, or rats which were anaesthetised (anaesthetic 




groups at the time of surgery and also tested at the same time as the experimental 
groups. Experimental groups were either CCI, CFA or a combination of the two 
injuries on P8 or P18. Experimental groups and anaesthetic controls were weighed on 
every day of testing to ensure that pups were all gaining weight and therefore being 
allowed to feed and were not in a distressed state which may be accompanied by 
weight loss. Weighing the animals also gave an indication of the developmental 
stage, as pups from larger litters may be smaller than a pup from a smaller litter, 
which may affect sensory thresholds.  
 
2.2.3 Prenatal social stress model – Resident/intruder paradigm 
 
Upon arrival into the unit, male and female Sprague Dawley rats were put on a 
breeding diet, (2019 Teklad, Harlan, UK) which was maintained for the duration of 
the experiment. Animals were not used until at least a week after arrival into the unit 




Nulliparous 14 week old female Sprague-Dawley rats (n=30) were paired with 
experienced adult Sprague Dawley males overnight. Females were checked every 
morning for vaginal plugs, unplugged females were immediately removed from the 
breeding cage and returned to their original cage until the end of the day so as to 
limit the window of conception to overnight. The day of detection of a vaginal plug 
was considered to be Day 0 of pregnancy (E0) and the females were removed and 
individually housed in clear plastic cages in a separate room. The day of birth was 
considered as lactation day 1 (P0).  Pups were regularly monitored and date of birth 
and litter size was noted. Females considered to be inadequate mothers or behaving 








A second set of nulliparous 14 week old females (n=20) were mated (as above) and 
the plug date noted. These females were housed in normal breeding cages in a 
separate room from the residents (see below). Pregnant females with unknown plug 
dates were excluded from the experiment but allowed to give birth to generate pups 
for use as control groups; unused litters (i.e., those never exposed to intruders) from 
the resident group were also added to this control group. 
 
Resident/Intruder social stress paradigm  
  
This paradigm is a well established model of social stress which utilizes maternal 
defence of pups to exert emotional stress on the female intruder (Neumann et al., 
2001). From E16 to E20 (inclusive), pregnant (intruder) females were placed in the 
cage with a lactating resident (lactation day 2-8) and her pups for a 10 minute period 
once daily. Experiments were carried out between 09.00h and 12.00h in a separate 
room from where animals were housed and all lactating (resident) females were 
allowed to habituate to the testing room for at least 30 minutes prior to the 
interaction. The interaction was monitored and recorded using Anymaze software 
(Stoelting C0 Illinois - US) to compare levels of aggression towards the intruder and 
the interaction was scored as high, medium or low. The intruder was returned to its 
own cage at the end of each encounter. All residents were between days 2 to 8 of 
lactation because this is when they are considered to be at their most aggressive and 
were preferably used at the beginning of this period as maternal aggression seems to 
tail off by day 8 (Neumann et al., 2001). Intruders were exposed to a different 
resident on each of the 5 days and each resident was used a maximum of twice per 
day. Any interactions in which residents did not display maternal aggression and 
where the intruder did not seem to be submissive were not considered to be stressful 
to the intruder. A minimum of 4 out of the 5 days (E16-E20) of social stress during 
the last trimester was required for subsequent offspring to be considered to have been 
exposed to sufficient prenatal stress for inclusion in our experiments, although basal 






Rats were anaesthetised by inhalation of an isoflurane/O2 mixture (Zeneca, Cheshire, 
UK), 4-5% for induction and 1.5-3% for maintenance. All animals were carefully 
monitored during surgery/injections; this was especially important in the neonate as 
maintenance of anaesthesia often required adjustment. Following surgery, adults 
were monitored until recovery from anaesthesia and for a short time afterwards. 
Following surgery (and in anaesthetic only controls) at P8 and P18, pups were 
allowed to recover inside an incubator in a plastic container filled with bedding from 
the home cage in an attempt to mask smells from the anaesthetic and surgery. Upon 
recovery from anaesthesia, pups were returned to the home cage and observed until 
acceptance into the litter by the dam. Animals were all marked using permanent 
marker pens (whilst anaesthetised) for identification. P8 pups were marked in the 
same way as adults and P18 pups, with rings around the tail and with a number on 
the back which was regularly re-marked. These markings were also used to check 
whether the mother had accepted the pups back into the litter and was licking and 
grooming the pups as the markings were expected to fade to the same degree in 
experimental and control animals. 
 
2.3.1 Chronic constriction injury (CCI) 
 
Chronic constriction injury is standardly used in our laboratory as a model of 
peripheral nerve injury. This model induces reliable tactile allodynia and thermal 
hyperalgesia which can be quantified over a number of weeks. The surgery involved 
in this pain model is also much easier to adapt to carry out in young animals (e.g. P8) 
than some of the other commonly used models detailed in section 1.2.5.   
Surgery to produce a chronic constriction injury of the sciatic nerve in rats is well 
characterised and has previously been described in detail (Bennett and Xie, 1988). 
Following hair removal and sterilisation of the area (Hibitane 0.05% Zeneca, UK), a 
small incision was made below the pelvis and the right biceps femoris and the 
gluteus superficialis were carefully separated to expose the sciatic nerve. Upon 




trifurcation (Figure 2.1.) using 4-0 chromic catgut (SMI AG, Hunningen, Belgium) 
(5-0 in the neonate – Medgut, South Africa) with a 1mm separation between 
ligatures. This is an adaptation of the classic CCI model which usually consists of 4 
ligatures, we used 2 in both adult and neonate pain models to standardise the injury, 
as 4 ligatures are difficult to place around the sciatic nerve of P8 animals. We have 
compared sensory thresholds of adults with 4 ligatures against those with only two 
and saw no significant differences between the two groups (see Chapter 3, section 
3.2.1).  The nerve was then carefully placed back into position and the wound closed. 
Vetbond (Vetbond, 3M, Loughborough, UK) was used to close the wound in P8 
animals. For the combined neuropathic/inflammatory pain model, CFA was injected 
(see 2.3.2) into the right hindpaw after completion of CCI surgery whilst the animal 





Figure 2.1  
 
 
Figure 2.1. Diagram showing sciatic nerve and the terminal branches of the sciatic 
and saphenous nerves. Red indicates area which is ligated in CCI surgery. (Decosterd 
and Woolf, 2000) 
 
2.3.2 Complete Freund’s adjuvant (CFA) 
 
Following sterilisation (Hibitane 0.05% Zeneca, UK) of the plantar surface of the 
right hindpaw, 150 μl (adult dose) of 50% CFA (Sigma F5881; 1 mg Mycobacterium 
tuberculosis in 0.85 μl mineral oil and 0.15 μl mannide mono-oleate) in 0.9% saline 
was injected between the toes and towards the middle of the paw, avoiding the ankle; 
the needle was withdrawn slowly to minimise leakage. The dose used was similar in 
adults and neonates as we have found that 1μl/g body weight is sufficient to produce 
a long lasting inflammatory response in the adult and causes redness and swelling in 





2.4  Sensory behaviour tests 
 
Measurements of reflex responses to graded mechanical or thermal stimuli were 
recorded in conscious animals prior to injury (not possible for P8 injured animals) 
and regularly post injury to establish a time course of sensitivity. Non-evoked, 
spontaneous pain behaviour was also measured following injury, in adult animals 
only. Unfortunately due to the visible changes induced ipsilateral to injury following 
inflammation and/or nerve injury, it was difficulty to carry out blinded assessments 
of sensory testing. It is therefore possible that although strict testing methods were in 
place, there may have been some degree of experimenter bias, which has been 
previously been shown to result in an overstating of effects (Sackett, 1979; Sena et 
al., 2007). 
 
2.4.1 General notes and observations  
 
Animals were given 5-10 minutes in their new test environment to allow them to 
become habituated before testing. In the adult rat, nociceptive sensitivity testing was 
carried out using both the Hargreaves’ test (55°C, Hargreaves’ thermal stimulator, 
Linton Instrumentation, Diss, UK) and von Frey filaments (Stoelting, Illinois, US) 
(see 2.4.3 and 2.4.2). Due to the continuous growth and development of the neonate, 
only von Frey testing was carried out as the intensity of the beam of the heat source 
used in the Hargreaves’ test would have needed to be constantly adapted as the 
animal grew. In particular, the glabrous surface of the hindpaw foot pad becomes 
larger and the skin thicker as the pup grows, and in younger pups, the beam would 
cover most of the plantar surface. Therefore, to reduce the numbers of potential 
variables, only von Frey tests were carried out on the pups. It is only possible to 
begin testing the neonate on the plantar surface by around P14, before this time pups 
are much too small for the mesh table used and are barely able to walk as testing 
depends on a foot withdrawal response and maturity of the motor system, as noted by 
other groups (Lee and Chung, 1996; Fitzgerald, 2005) 
In the case of the P18 groups we could obtain some baseline measurements at P14-




the sensory system continues to develop. We and others (Alvares et al., 2000), have 
noted a slight increase in baseline threshold on P14. This is the time when the eyes 
begin to open and the increased threshold may be due to the novel exposure to visual 
stimuli, during which time the pups become increasingly mobile and perhaps less 
focused on the sensory test. 
 
2.4.2 Mechanical allodynia – von Frey filament test 
 
Animals were placed on a raised mesh grid and covered with a clear plastic box to 
contain the animal. von Frey filaments were used to determine the threshold force for 
withdrawal of the ipsilateral paw compared to the contralateral paw. Filaments were 
applied to the middle of the plantar surface of each paw from below, (Figure 2.2a) 
until the filament bent; this was done 6-8 times per filament, in order of increasing 
force (Figure 2.2b). The filament at which 50% of the applications (i.e. 3 out of 6) 
resulted in withdrawal was recorded as the paw withdrawal threshold for that 
particular animal. A minimum of 6 applications were carried out and a maximum 
force of approx 28g was used to prevent tissue damage. A withdrawal response was 
considered valid if the animals paw was withdrawn from both the testing platform 
and also away from the hair itself so as to distinguish from the animal allowing its 
paw to be simply lifted by the filament; the cut off point of 28g also reduced the 
possibility of the hair being able to lift the animal’s paw. The paw withdrawal 
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Figure 2.2. Different zones of the plantar surface of the rat hindpaw innervated by 
the sciatic terminal branches (Swett and Woolf, 1985). Red arrow indicates the area 
which was tested using graded von Frey filaments (b) and was also targeted using the 
radiant heat source in the Hargreaves’ test. (Decosterd and Woolf, 2000). 
 
 
2.4.3 Thermal hyperalgesia – Hargreaves’ test 
 
Thermal hyperalgesia was measured using the Hargreaves (Hargreaves et al., 1988) 
plantar test (7370, Ugo Basile, Comerio, Italy). Animals were placed in individual 
plastic boxes on a glass platform (Figure 2.3.) and allowed to habituate for 10-20 
minutes to their new environment. A radiant heat source (Infra red intensity setting 
45) was positioned under the platform and focused on the middle of the plantar 
surface of each hindpaw. The time in seconds at which the animal withdrew its paw 
was recorded. A cut off time of 20 seconds was imposed to avoid tissue damage. The 
test was repeated 3 times for each hindpaw with a 5 minute gap between tests to 
avoid sensitisation. Paw withdrawal latency (PWL) was recorded in seconds and an 




















Figure 2.3. Photograph showing set up for Hargreaves’ test to measure thermal 
hyperalgesia.   
 
 
2.4.4 Spontaneous pain behaviour 
 
Spontaneous foot lifting (SFL) is thought to be an indicator of ongoing/spontaneous 
pain (Choi et al., 1994; Djouhri et al., 2006).  Following injury, adult animals were 
placed in individual plastic observation boxes and the cumulative duration of lifting 
of the ipsilateral hindpaw was recorded over a period of 3 minutes. SFL was often 
associated with aversive behaviour such as flicking of the ipsilateral paw and is 
similar to the nocifensive behaviours recorded in the formalin test (see below, 2.4.5). 
Foot-lifting associated with walking, grooming and other exploratory behaviours was 
not included.     
 
 
2.4.5 Formalin test 
 
After behavioural recovery from previous insult (CCI, CFA or the combined injury) 
adults were subjected to a formalin challenge. Electrophysiological studies 
(Dickenson and Sullivan, 1987) on dorsal horn neurons have shown that 
subcutaneous formalin into the receptive field of these neurons results in a biphasic 




minutes post injection is separated by a short interphase of low activity which 
precedes the longer lasting tonic phase lasting from 20-60 minutes This activity of 
dorsal horn neurons is thought to be due to peripheral drive from C-fibre activity 
(Dickenson and Sullivan, 1987). 
In animals injured during the neonatal period (at P8), this was carried out at 
approximately P42, or at recovery from the initial injury. Under isoflurane 
anaesthesia, 40 μl of a 4% formalin solution, in 0.9% saline, was injected into the 
plantar surface of the right hindpaw; control groups required for hormone 
assessments (2.10) received an equal volume of 0.9% saline. Rats were then placed 
in clear observation boxes to recover from the anaesthesia before recording. Each 
animal was observed for 60 seconds within a 5 minute window and nociceptive 
behaviours were recorded during this time using a stopwatch. The cumulative time in 
seconds was recorded every 5 minutes over 60 minutes or until the termination of 
nocifensive responses to formalin. Nocifensive behaviours recorded included 
flinching, flicking, licking or biting of the injected paw. At the end of the test, 
animals were euthanized by an overdose of carbon dioxide or by conscious 
decapitation for trunk blood collection.  
 
2.5 Drug administration 
 
Drug effects were assessed in P28 animals by measuring thresholds to mechanical 
stimulation (see 2.4.2). Pre-drug tests were performed to establish a mean baseline 
value. Following drug administration, tests were repeated every 10 minutes for 60-80 
minutes until measurements returned to those recorded prior to drug application. 
Trials were carried out blind and the compounds were identified at the end of testing 
for each batch of animals.   
 
2.5.1 Intrathecal application of drugs 
 
The highly selective NMDAR antagonist 3-(2-carboxypiperazin-4-yl) propyl-1-
phosphonic acid, ((R)-CPP), or saline, were administered into the L5/6 intrathecal 




needle (BD Biosciences, Oxford, UK). A tail flick or movement of the hind limbs 
usually indicated that the needle was correctly positioned prior to injection. 
Experiments with Pontamine Sky Blue dye (Merck-BDH, UK) were carried out to 
establish the correct site of injection and ensured that the injected volume of 20µl 
was sufficient to reach the lumbar enlargement which receives sciatic nerve input. 
Behaviour testing commenced 15 minutes after injection to allow recovery from 
anaesthesia and thereby avoid a false analgesic result and also to prevent tissue 
sensitisation. Previous experiments (Moss et al., 2002) have found complete recovery 
from anaesthetic by 15 minutes.  
 
Figure 2.4  
 
 
Figure 2.4. Diagram showing insertion of needle into the intervertebral space for 
intrathecal administration of drugs.  (Hylden and Wilcox, 1980) 
 
2.6 Affective behaviour tests 
 
Affective testing was carried out in a room exclusively used for these tests. Each trial 
was carried out for 5 minutes, as the first 5 minutes of the elevated plus maze (EPM) 
test is when rats typically exhibit the most avoidance of the open arms (Montgomery, 
1955). In our own investigation into an appropriate test length we have compared 10 
and 5 minute testing times for both the EPM and open field test and found that the 




not contribute any significant findings or differences between groups. The testing 
arenas (EPM 2.6.1, or open field 2.6.2) were surrounded by a thin opaque white 
curtain and a thick black curtain to allow control of lighting levels in the test area 
whilst monitoring behaviour in the same room. Overhead lamps where also used to 
illuminate the test area where needed. An overhead camera connected to a laptop was 
used to monitor behaviour from a distance behind a closed curtain and Anymaze 
software (Stoelting C0 Illinois - US) was used to track behaviour automatically, thus 
eliminating human error and bias.  
 
2.6.1 Elevated plus maze 
 
The maze was made of metal sprayed black with two opposing open arms and two 
opposing arms enclosed by walls. The open and closed arms meet in an open centre 
square and form a plus shape. The plus maze was elevated 45cm from the ground. A 
smaller version of the maze was constructed for testing pre-weanling rats (P18-22) 
and was based on dimensions for a mouse elevated plus maze (Stoelting Co Illinois 
US) (See Figure 2.5a. for diagrams and dimensions).  On the day of testing, animals 
(in their home cages) were brought into the testing room and allowed to acclimatise 
to the new environment. Dim lighting was used in the test arena and individual 
animals were  removed from their home cages and placed on the centre square of the 
elevated plus maze facing the open arm and allowed to explore the maze freely for 5 
minutes before the animal was returned to its cage. Anymaze software was used to 
track the animals and therefore monitor various parameters such as time spent in the 
open and closed arms of the maze automatically. The maze was cleaned thoroughly 
with ethanol after each trial to remove any olfactory cues (Walf and Frye, 2007). 
 
2.6.2 Open field testing 
 
The open field apparatus (based on dimensions from Stoelting Co. Illinois US) 
consisted of a square arena 40cm by 40cm with 40cm high perspex walls and was lit 
with overhead lamps. The field was divided into 9 squares, 8 outer squares and 1 




animals (in their home cages) were brought into the testing room and allowed to 
acclimatise to the new environment. Individual animals were removed from their 
home cage and placed in the top left corner of the field and allowed to explore for 5 
minutes before being returned to their cage. Anymaze software was used to track the 
animal’s movement and grooming, rearing and defecation were recorded by the 
tester by holding down a key (G, R or D, respectively) for the duration/number of 
times the behaviour was observed. Anymaze automatically records parameters of 
interest such as mobility, distance travelled and entries/time spent in the centre 
square. After the 5 minute testing period the animal was returned to its home cage 







Open Field Dimensions: 40cmx40cm
Inner Zone Outer Zone




Maze Type Arm Arm Wall Elevation 
Width (A) Length(B) Height(C) (D)
Pre-weanling Rat 5cm 35cm 15cm 45cm






Figure 2.5. Photographs and diagrams to show a) elevated plus maze and b) open 










2.7 Western blotting 
 
Western blotting was used to detect changes in protein levels in DRG or spinal cord 
tissue in naïve animals and in tissue from different pain models carried out at P8, P18 
and in the adult. Tissues were collected at various times post injury, which are 
specified within the results descriptions.  
 
2.7.1 Tissue preparation 
 
Spinal cord and DRG tissue from L4-L6 were collected from live rats under deep 
anaesthesia (isoflurane/oxygen, as outlined above, 2.3), or immediately following 
conscious decapitation. A laminectomy was performed to expose the spinal cord, and 
tissue removed. Spinal cord from injured animals was hemisected longitudinally 
down the midline into ipsilateral and contralateral halves, or further divided to isolate 
only the dorsal horn, this was achieved  by opening out the hemisected cord to reveal 
the dorsal (outer third) and ventral (inner two thirds) grey matter. DRGs were also 
taken. Naive tissue was processed as whole cord and both the left and right DRGs 
were collected. To minimise degradation, tissues were collected on ice-cold foil, 
weighed, and rapidly homogenised in 20 volumes Laemmli lysis buffer (85 % Tris 
buffer (tris-hydroxymethylaminoethane, 50 mM, pH 7.4, Sigma Chemical Co., UK), 
5 % mercaptoethanol (Sigma Chemical Co., UK), and 2 % sodium dodecyl sulphate 
(SDS, Sigma Chemical Co., UK)). Homogenates were then boiled for 5 minutes to 
denature proteins and centrifuged for 10 minutes at 11,500g, 10°C, before extracting 
and aliquoting the supernatant and storing samples at -20°C until needed. 
 
2.7.2 Western blotting procedure 
 
Proteins were separated by SDS-PAGE (sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis) using the NuPage XCell SureLockTM Minicell gel 
electrophoresis system (Invitrogen, Paisley, UK). Samples (3-5 μl) were mixed with 
1 μl loading buffer (0.04%w/v bromophenol blue in glycerol) and loaded into wells 




molecular weight proteins (SeeBlue Plus, Invitrogen, Paisley, UK) were run 
alongside as a guide. Samples were separated by electrophoresis using MOPS 
running buffer (NuPage, Invitrogen, UK), at 200 V for 50 minutes. Proteins were 
transferred to a polyvinylidene difluoride Immobilon-PSQ membrane (Millipore, 
Watford, UK) at 30 V for 90 minutes in transfer buffer (5 % NuPage transfer buffer, 
Invitrogen, UK, 10% methanol). Transfer and protein loading was assessed by 
staining membranes with Coomassie blue (0.1 % in 30 % methanol, 10 % acetic acid, 
GE Healthcare Ltd., UK) and destaining using a solution of 50% methanol, 10% 
acetic acid in distilled water, followed by scanning. Following removal of the 
Coomassie blue stain, the membrane was incubated with blocking buffer (5% non-fat 
dry milk in PBS) overnight at 4oC or 90 min to 2 h at room temperature and probed 
with primary antibodies (CaMKII: Cat No. 13-7300, 1:250, Zymed. NR2B: Cat No. 
32-0700, 1:100-1:250, Zymed. PSD-95: Cat No. 75-028, 1:400, Neuromab) 
overnight at 4 oC or for 2 h at room temperature. Following washes with PBS-Tween, 
blots were probed with appropriate secondary antibodies (anti-mouse: Cat No. 
AP192P, 1:10,000, Chemicon. Anti-rabbit: Cat No. AP182P, 1:7,500, Chemicon) 
and detected by peroxidase-linked secondary antibody enhanced chemiluminescence. 
Blots were also probed for the ubiquitous housekeeping enzyme glyceraldehyde-3-
phosphate dehydrogenase (GAPDH: Cat No. MAB374, 1:750, Chemicon) for protein 
level normalization. Image analysis was carried out by scanning the resulting 
photographic films obtained following chemiluminescence of the western blot. The 
scans were quantified using Photoshop software to measure greyscale values for a 
given band. Background measures were also recorded and subtracted from the 
protein/receptor subunit represented by the band. Greyscale values for receptor 
subunits were calculated as a percentage of that obtained for GAPDH or the co-




Co-immunoprecipitation was used to investigate changes in protein-protein 
interactions within the NMDA receptor complex in the spinal cord at peak 




2.8.1 Tissue preparation 
 
All co-immunoprecipitation experiments were carried out on adult animals (n=7 per 
pain model group, n=4 for naive groups) at 10 days post injury. Tissue dissection 
was as described for western blotting (see 2.7.1). Samples were homogenised in 10 
volumes of IP (immunoprecipitation) buffer (PBS, pH 7.5 containing 10% glycerol, 
1% CHAPS, 0.5% sodium deoxycholate, 1 mM vanadate, 1 mM sodium fluoride, 5-
10 mM sodium molybdate) containing 1% protease inhibitor cocktail III 
(Calbiochem, Merck Biosciences Ltd., Nottingham, UK) and rolled for 1-2 hours at 4 
oC. 
 
2.8.2 Co-immunoprecipitation procedure 
 
Samples were spun at 4°C and 11,500g for 15 minutes and the supernatant extracted 
and aliquoted. Samples were then pre-cleared for 1 hour at 4oC using protein G 
sepharose beads (Sigma) at 20µl/ml to remove traces of endogenous antibody, before 
being incubated overnight at 4 oC with 40µl/ml of protein G sepharose beads and a 
combination of NR2A and NR2B antibodies (Cat No. Sc-9056 and sc-9057 
respectively, 8.8 μl/ml, Santa Cruz). Controls were incubated with non-immune IgGs 
from the same species as the co-immunoprecipitation antibody. Following 
incubation, samples were centrifuged and the supernatant discarded, the remaining 
beads were washed twice in IP buffer and once in PBS before the addition of equal 
volumes of Laemmli lysis buffer. Samples were then boiled for 5 minutes, cooled, 
and stored at -20 oC. Binding partners within the complex of interest (co-
immunoprecipitates of NR2A/B) were detected by western blot, (as described in 
2.7.2) running 15-18μl of sample and 2 μl of loading buffer. 
 
2.9 Immunohistochemistry   
 
Immunohistochemistry was carried out to investigate changes and localisation of 





2.9.1 Tissue preparation 
 
Under deep anaesthesia (isoflurane/O2), rats were perfused transcardially with 
phosphate buffered saline (0.1 M phosphate, 0.9% NaCl pH 7.4) containing 100 units 
heparin/ml, followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. 
Tissues were then removed (as for 2.7.1), post-fixed overnight at 4oC in 4% 
paraformaldehyde, and cryoprotected using increasing concentrations of sucrose in 
PBS (5% for 1hr, 10% 2hrs, 30% 4hrs). DRGs were then embedded in a 
freezing/mounting medium (Tissue Tek O.C.T Compound) and stored at -20 oC (-80 
oC for long-term storage). Spinal cord was stored in PBS-sodium azide at 4 oC. 
 
2.9.2 Immunohistochemistry procedure 
 
10μm tissue sections were cut on a cryostat at temperatures of -20ºC for DRG and 
14ºC for spinal cord and thaw-mounted on poly-L-lysine slides (Merck-BDH, UK). 
Slides were encircled with a hydrophobic barrier pen (ImmEdge, Vector 
Laboratories, CA, USA). Slides were blocked for 1 hour at room temperature in 
block/buffer containing: 10 % normal goat serum (Vector Laboratories, CA, USA), 4 
% fish skin gelatin (Sigma Chemical Co., UK), 0.2 % Triton X-100 (Sigma Chemical 
Co., UK) in 0.1 M PBS. Slides were incubated overnight at room temperature with 
primary antibodies (ATF-3: Cat No. Sc-188, 1:250, Santa Cruz. NF200: Cat No. 
N0142, 1:1,500, Sigma) in buffer (same as block). Slides were then washed in PBS 
and incubated with appropriate secondary antibodies (anti-mouse: Cat No: A11029, 
1:750, Molecular probes. anti-rabbit Cat No: A11036, 1:750, Molecular Probes) in 
buffer (5 % normal goat serum, 2% fish skin gelatin, 0.1 % Triton X-100, 0.1 M 
PBS). Primary antibody was omitted from some sections to serve as a negative 
control. ATF-3 is reliably induced following chronic constriction injury and so this 
particular group served as a positive control. Slides were cover-slipped using 
Vectashield (Vector Laboratories, USA) and sealed with nail varnish. Sections were 
visualised under a Leica TCSNT confocal microscope (Leica Microsystems GMBH, 
Germany). Cells with 50% of the maximum intensity value, as determined by Image 




2.10 Radiommunossays (RIA)                              
 
2.10.1 RIA procedure 
 
Live rats were quickly decapitated and trunk blood was collected into individual 
Falcon tubes containing chilled 5% EDTA (0.2 ml/100 g body weight) and kept on 
ice. Samples were then spun at 9,500g for 5 minutes and plasma was separated, 
aliquoted and stored at -20oC.  Plasma ACTH and corticosterone concentrations were 
determined using commercially available radioimmunoassay kits (Immunodiagnostic 
Systems Ltd., Tyne and Wear, UK) and following the steps outlined in the 
manufacturer’s protocols. ACTH (adrenocorticotropic hormone) was measured using 
a two-site immunoradiometric assay (Euro-Diagnostica) which detects only intact 
ACTH. Corticosterone was measured using a double antibody radioimmunoassay 
with 125I-corticosterone as the tracer. The sensitivity and the intra-assay variation for 
the kits of the kits are as follows: ACTH sensitivity 3.0pg/ml and intra-assay 
variation <4%; Corticosterone sensitivity 7.7ng/ml and intra-assay variation <11%. 
All samples from the experiment were assayed together. Plasma was diluted to 1:200 
for saline treated groups or 1:300 for formalin treated groups (to ensure results were 
within the range of the test) using the steroid diluent; supplied, concentrations were 
standardised at the end of the assay. 
 
2.11 Nerve morphology 
 
Morphological changes to the sciatic nerve were investigated following P8 CCI 
surgery (short duration CCI n=3, long duration CCI n=3) or in naïve animals (n=2). 
Rats were allowed to recover fully from the initial injury (no difference in ipsilateral 
paw withdrawal threshold compared to contralateral) and the sciatic nerve was 
dissected under deep anaesthesia (isoflurane/oxygen) and fixed in 2.5% 
glutaraldehyde and 2% paraformaldehyde in 0.1M sodium cacodylate buffer and 






2.11.1 Light microscopy 
 
1μm resin-embedded transverse sections of sciatic nerve (~7-10mm in length) around 




To determine changes to myelin thickness in the sciatic nerve, the G-ratio of 
individual axons was measured, using images obtained by light microscopy, by 
dividing axonal diameter by the total diameter of axon plus myelin sheath.  
 
2.12  Statistical Analysis 
 
For behavioural measures, all values were calculated as group mean  +/- SEM at each 
time point and data were analysed using SigmaStat software (version 2.03) or SPSS 
(version 14.0). Thermal hyperalgesia was analysed by comparing ipsilateral to 
contralateral measures using a Student’s t-test and post surgery time points were also 
compared to pre-surgery using a One-Way repeated measures ANOVA (Analysis of 
Variance) with Dunnett’s multiple comparisons test. Mechanical allodynia was 
analysed using the equivalent non-parametric tests: Mann-Whitney Rank sum test to 
compare ipsilateral to contralateral and repeated measures ANOVA on ranks 
(Freidman test) with Dunn’s post hoc analysis to compare to pre-surgery. To analyse 
effects of intrathecal drug application, post-drug ipsilateral measures were compared 
to pre-drug baseline using the Friedman test with Dunn’s post hoc test.  
Behaviour in response to formalin and comparing mechanical allodynia in prenatally 
stressed animals compared to controls was analysed using a two-way ANOVA to 
identify variation between groups over time. Multiple comparisons were analysed 
using the Bonferroni post hoc test to compare groups. To compare groups for 
corticosterone measures from RIAs and also P1 birth weights in prenatally stressed 
versus control groups Student’s t- tests were used. In all cases significance was 




CHAPTER 3: ADULT MODELS OF CHRONIC PAIN AND THE 
DEVELOPMENT OF A NOVEL COMBINED PAIN MODEL  
 
3.1 Introduction  
As outlined in 1.2.5, an animal model combining both neuropathic and inflammatory 
pain may yield more realistic and clinically relevant data for a subset of cases. As it 
was hypothesised that this novel combination of injuries would result in greater 
sensitivity, the Home Office Animals in Scientific Procedures Division had asked to 
be notified once 100 animals had been studied and a report was sent detailing 
preliminary findings. Chronic constriction injury (CCI) is one of the most widely 
studied models of peripheral neuropathy and results in spontaneous pain, 
hyperalgesia, and allodynia which are some of the major symptoms suffered by 
neuropathic pain patients that can be assessed in animals.  For these reasons we have 
chosen to utilise this injury as the neuropathic component of the combined model. 
The inflammatory component is achieved using Complete Freund’s Adjuvant (CFA, 
see 1.2.5) which provides immune system-mediated long-lasting inflammation that is 
localised at the site of injection, similar to the type of injury induced upon infection. 
To characterise this novel combined model we will measure the duration and extent 
of both evoked and non-evoked pain behaviour, when compared to nerve injury or 
inflammation alone.  
In addition we will utilise the formalin test as a tool to investigate nocifensive 
responses when the nervous system is challenged following recovery from an initial 
injury (nerve injury, inflammation or the combined pain model). It should be noted 
that in this study the administration of formalin into the plantar hindpaw is carried 
out under anaesthetic to minimise stress, and as a result the first phase behaviour is 
not seen, however the peripheral input which generates the behaviour observed in the 
second phase still occurs (Dickenson and Sullivan, 1987) and, importantly, we are 










3.2.1 Mechanical allodynia and thermal hyperalgesia are greater in a combined 
model of neuropathic and inflammatory pain compared to nerve injury or 
inflammation alone 
 
In adult rats, the combined pain model, utilising co-administration of CCI and CFA 
models of neuropathic (nerve injury) and inflammatory pain, respectively, induced 
sensitisation to mechanical (Figure 3.1 a and b) and thermal stimuli (Figure 3.2), 
(ipsilateral compared to contralateral) which was longer lasting than that in either of 
the single models (n=6-9). The difference in paw withdrawal threshold (PWT) in 
response to von Frey filaments was clearly greater and statistically significant 
(p<0.05) as determined by the Mann-Whitney Rank Sum Test, (ipsilateral compared 
to contralateral paw), from post-surgical day 7-49  in the combined model, compared 
to days 10-21 following nerve injury and days 7-42 following inflammation. 
Additionally, mechanical allodynia was significantly different over time following 
the combined pain model when compared to the individual pain models. Comparing 
the difference in PWT (contralateral-ipsilateral) (as plotted in Figure 3.1a) between 
all three adult pain states revealed a significant effect of treatment (two-way 
ANOVA, F=19.86, p<0.0001) with individual group differences identified by 
Bonferroni post tests occurring between CCI and the combined model at days 7, 14, 
and 49, and between CFA and the combined model at day 7. There were no time 
points where significant differences were identified between CCI and CFA. 
However, similarly, comparing the ipsilateral PWT of the groups over time revealed 
a significant effect of treatment (two-way ANOVA, F=18.44, p<0.0001). 
Contralateral PWT between groups was not significantly affected by treatment. No 
significant differences in PWT were observed in the combined pain model or the CCI 
model when two ligatures were used (see chapter 2, section 2.3.1) instead of four 
ligatures, which are applied in the standard Bennett and Xie CCI model (Bennett and 
Xie, 1988) (data not shown). For these reasons, to standardise the nerve injury across 
adults and neonates, due to the technical difficulty associated with using a 4 ligature 




Paw withdrawal latency (PWL) in response to thermal stimuli in the Hargreaves’ test 
(see Chapter 2, section 2.4.3) was significantly decreased (p<0.05) as determined by 
t-test, ipsilateral compared to contralateral paw, from day 6 to 28  in the combined 
model, days 7-10 following nerve injury and days 1-3 following inflammation 
(Figure 3.2). Thermal hyperalgesia in the combined pain model also outlasted that of 
the single injury models when compared to the pre-injured baseline latency. 
Ipsilateral paw withdrawal latency was significantly different until day 28 post 
surgery compared to day 10 in nerve injured animals and day 3 in inflamed animals 
(one-way repeated measures ANOVA with Dunnett’s post hoc test to compare to 
baseline). Two-way ANOVA revealed a significant effect of treatment between 
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Figure 3.1. Time course of mechanical allodynia in adult rats following injury. Data 
are expressed as mean±SEMs of a) the difference in paw withdrawal threshold 
(PWT), following nerve injury (  ), inflammation (  ) or a combination of these two 
injuries (  ) or b) as absolute values for ipsilateral (open squares) and contralateral 
(filled squares) paws. Data are obtained from calibrated von Frey filaments (1.2-
28.8g). Day of surgery is day 0.  (*p<0.05 Mann-Whitney Rank Sum Test, ipsilateral 
compared to contralateral paw, from day 7-49  in the combined model, days 10-21 
following nerve injury and days 7-42 following inflammation. (†p<0.05 Friedman 
repeated measures ANOVA on Ranks with Dunn’s post hoc test to compare post 






























































































































































































































Figure 3.2. Time course of thermal hyperalgesia in adult rats following a) nerve 
injury, b) inflammation or  c) a combination of these two injuries. Day of surgery is 
day 0. Data are expressed as mean±SEMs for ipsilateral (  ) and contralateral (  ) paw 
withdrawal latency (PWL), measured in seconds. (*p<0.05, t-test, ipsilateral 
compared to contralateral paw, from day 7 to 28  in the combined model, days 7-10 
following nerve injury and days 1-3 following inflammation. († p<0.05 One-Way 
repeated measures ANOVA with Dunnett’s post hoc test to compare post surgery 




3.2.2 Animals with a combination of nerve injury and inflammation display 
significant levels of non-evoked spontaneous pain behaviour 
 
During behavioural assessment of the novel, combined pain model it was noted that 
these animals (n=3-6) displayed significant amounts of spontaneous non-evoked pain 
behaviour, compared to nerve injury or inflammation alone. For this reason we 
quantified this behaviour by measuring the cumulative time over which the animal 
raised its injured paw (spontaneous foot-lifting, SFL) over a 3 minute period (Figure 
3.3). We found SFL to be significantly greater compared to nerve injury alone over a 
number of days (*p<0.05, t-test nerve injury compared to nerve injury plus 
inflammation, days 6-8 and day 12). No SFL of the contralateral paw was observed, 
and no SFL was observed ipsilateral to inflammation alone (data not shown). 























Figure 3.3. Non-evoked spontaneous foot-lifting (SFL) of the injured paw following 
nerve injury (  ), or nerve injury + inflammation (  ) in adult rats. Data are expressed 
as mean±SEMs for the cumulative time over 3 minutes in which the injured paw was 
raised. (*p<0.05, t-test nerve injury + inflammation compared to nerve injury alone; 
n=3-6). No SFL of the contralateral paw was observed and no SFL was observed in 







3.2.3 Increased association of αCaMKII with NR2A/B subunits at peak 
sensitisation following adult injury 
 
In trial experiments, western blots of adult spinal NR2A/B immunoprecipitates (see 
chapter 2, 2.8) probed for αCaMKII showed an increased association of these 
proteins ipsilateral to injury, 10 days (during peak sensitisation) following 
inflammation or a combination of nerve injury and inflammation compared to 
contralateral (n=7 pooled samples) and also to naïve control (n=4 pooled samples). 
Blots were also probed for NR2B to monitor the levels of the receptor pulled-down. 
No immunoreactivity was detected in control lanes from non-immune 
immunoprecipitates. All samples were run on the same gel to allow cross 
comparisons between groups. It was not possible to analyse these data statistically as 
samples were pooled in order to carry out the co-immunoprecipitation. Data are 
calculated as grey scale value relative to NR2B expression (Figure 3.4). Some pilot 
studies were also carried out with PSD-95 immunoprecipitates, which appeared to 
show small increases in association of stargazin and also chapsyn-100/PSD-93 with 
PSD-95 10 days following inflammation (data not shown).  
As the changes in αCaMKII:NR2B association were relatively modest and required 
substantial animal numbers to be pooled to achieve detectability, it was decided not 




















































Figure 3.4. Injury-induced changes in association of αCaMKII with adult spinal 
NR2A/B immunoprecipitates. Data are plotted as the relative grey scale intensity 
(arbitrary grey scale values), relative to NR2B levels, for ipsilateral ( ) and 
contralateral ( ) dorsal horns (n=7 pooled samples) 10 days following injury 
(inflammation, nerve injury, or combined nerve injury and inflammation) or in 
controls (naïve, n=4 pooled samples). Representative images from scanned 




3.2.4 ATF-3 expression in DRG neurons is increased following nerve injury or the 
combination of  nerve injury plus inflammation  
 
As ATF-3 expression in DRG cells is though to be associated with explicit injury to 
their axons (Tsujino et al., 2000), we assessed the expression levels of this marker in 
the three different adult pain models (Figure 3.5). ATF-3 positive cells from 3-4 non-
adjacent sections (100µm) of L4 and L5 DRG per animal (n=6 per group) were 
counted, and expressed as a % of the total number of cells counted in these sections. 
DRG neurons showed ATF-3 expression following nerve injury or nerve injury plus 
inflammation, but not following inflammation alone. One-way ANOVA (Student-
Newman-Keuls post-test for all-pairwise comparisons) indicated that inflammation 
resulted in significantly lower ATF-3 expression compared to nerve injury (p<0.001) 
and nerve injury plus inflammation (p=0.003). ATF-3 expression in DRG cells was 












































































Figure 3.5. ATF-3 expression in adult-injured DRG neurons 10 days post injury 
(n=6). Data are expressed as a percentage of total cells counted per group for nerve 
injury, nerve injury plus inflammation, and inflammation. Inset shows confocal 
image (x10 magnification) of ATF-3 (red) colocalised with NF-200 (green), in DRG 
following nerve injury + inflammation.  (*p<0.05, One-way ANOVA Student-
Newman-Keuls post-test for all-pairwise comparisons, inflammation compared to 
both nerve injury and nerve injury and inflammation) 
 
 
3.2.5 Previous nerve injury or inflammation in adults does not alter the response to 
a subsequent noxious challenge upon recovery  
 
Following recovery from the sensitised state induced by injury (approx 70 days), 
animals were given an injection of formalin (Figure 3.6) into the plantar surface of 
the hindpaw, ipsilateral to the original injury (nerve injury, inflammation or 
combined pain model). The injection was given under brief inhalation anaesthesia to 
minimise stress, and as a result the first phase behavioural response is lost, as has 
previously been demonstrated (Fukuda et al., 2001). However the peripheral input 




and Sullivan, 1987) and, importantly, we are able to measure the nocifensive 
behaviour associated within this phase. The response curve we have obtained 
following formalin administration is similar to the classically described second phase 
response in terms of its magnitude and duration (Fukuda et al., 2001). The formalin 
response of all 3 groups of previously injured adult animals was not significantly 


































































































Figure 3.6. Adult response to a formalin challenge following recovery from prior 
injury. a) Nerve injury (  n=6), b) inflammation (  n=6) or c) a combination of these 
two injuries (   n=5), each compared to naïve controls (  n=8).  Mean±SEM is plotted 
in seconds (s) for cumulative amount of nocifensive behaviour recorded per minute 
for each time point post-formalin injection. There were no significant differences 








3.3.1 A combined neuropathic and inflammatory injury results in longer lasting 
hypersensitivity and spontaneous pain 
 
Animal models of clinical pain are widely studied to improve our understanding of 
the aetiology of persisting pain states and also to identify potential therapeutic targets 
for the development of novel analgesics. There is a continuing need for animal 
models which best represent clinical conditions, both in terms of duration and also 
the symptoms and responses observed. The novel combined pain model was 
designed to encompass both inflammatory and neuropathic injuries, which often 
occur together (Said and Hontebeyrie-Joskowicz, 1992) either clinically or as a result 
of routine animal husbandry procedures. In our novel combined pain model, both 
evoked and non-evoked measures of pain behaviour are enhanced when peripheral 
inflammation accompanies nerve injury (Figures 3.1 to 3.3). In terms of evoked 
measures of nociceptive behaviour, it should be considered that the large difference 
in PWTs in the combined pain model, and indeed the single pain models, could have 
been attributed in part to an increased contralateral PWT due to unwillingness to bear 
weight on the injured ipsilateral paw. However, as contralateral PWTs do not differ 
over time between the groups, it seems likely that significant differences observed 
for changes in PWT (contralateral- ipsilateral) are due to increases in sensitivity of 
the injured paw and not a reduced sensitivity/unwillingness to withdraw the 
contralateral paw. This model provides us with a robust and long-lasting pain state 
which displays symptoms such as hypersensitivity to mechanical and thermal stimuli, 
as well as non-evoked raising of the injured paw, (spontaneous foot-lifting) which is 
thought to be an indicator of spontaneous pain (Bennett and Xie, 1988).   
Spontaneous pain is a major clinical problem, which is not sufficiently represented 
by the basic science studies currently being published, where much of the sensory 
behaviour is focused on withdrawal responses to mechanical or thermal stimuli, 
when in fact 96% of neuropathic pain patients have ongoing, spontaneous pain and 
although still significant, only 64% and 38% have a mechanical or thermal 




behaviours, as measured using von Frey filaments and the Hargreaves’ test, although 
useful and reproducible, has been questioned recently in favour of implementing 
more spontaneous pain measures,  or operant evoked measures (Mogil, 2009). Such 
operant evoked measures consider motivational responses to noxious stimuli and 
may provide a way to reflect the emotionality associated with some chronic pain 
states which is a major problem in human subjects, who often report that symptoms 
can worsen following emotional upset (Backonja and Stacey, 2004). For these 
reasons it may have been useful to assess evoked and non-evoked measures 
following affective testing on the elevated plus maze and open field test for example, 
which were carried out to assess any affective component associated with the novel 
combined pain model compared to single models. Interestingly, pilot studies in these 
tests of affective state did not highlight any differences in the three pain models 
investigated compared to non-injured naïve animals (data not shown).  
The possible reasons for the increased sensitivities to mechanical and thermal 
stimuli, and also the spontaneous pain component observed in the novel pain model 
have not yet been sufficiently clarified. Previous work has suggested that 
spontaneous pain is associated with spontaneous firing of intact C-fibres (Djouhri et 
al., 2006). The study describes how a spinal-nerve axotomy (L5) and a spinal-nerve 
axotomy combined with loose-ligation of a neighbouring (L4) spinal nerve, both 
produce spontaneous activity in intact nociceptive C-fibres but only the latter version 
is associated with spontaneous foot-lifting behaviour (SFL). The study also reports 
SFL following CFA, but only on day 1 after injection and not on day 4, which is 
consistent with our study which finds no SFL from day 6 onwards, although we have 
not looked at earlier time points as animals with nerve injury were allowed to recover 
from the muscle damage incurred as a result of surgery during this interim period. 
The authors reported a correlation between the rate of spontaneous firing of intact C-
fibres and the observation of SFL in all three models, and suggest that inflammatory 
mediators may contribute to the enhanced spontaneous firing rate in the modified 
spinal-nerve axotomy/L4 ligation model. The findings of this study may help to 
explain the degree of spontaneous behaviour observed in our combined nerve injury 
and inflammation model. Inflammatory mediators, such as interleukins (IL) and 




al., 2002) and have been linked with spontaneous activity in DRG neurons (Schafers 
et al., 2003). Furthermore, the upregulation of NGF, induced in response to the 
increase in TNFα following peripheral inflammation (Woolf et al., 1997), has also 
been shown to lead to spontaneous activity in DRG neurons (Djouhri et al., 2001).  
Although the site of peripheral inflammation in our combined pain model is not at 
the nerve trunk, the combined neurogenic inflammation associated with the CCI 
component, and the peripheral inflammation following CFA may exert a cumulative 
effect, which may be required to increase the rate of spontaneous activity of 
nociceptive C-fibres to the levels necessarily for the generation of spontaneous 
behaviour.   
This combined pain model may be a useful model to utilise in future basic science 
studies to assess the basis for the greater mechanical and thermal sensitivities 
induced in this model compared to single models, and perhaps more importantly to 
investigate the clinically-relevant spontaneous pain component.  Further lines of 
investigation into the spontaneous component of this model would have been useful. 
Pharmacological studies may be helpful to dissect the major underlying mechanisms 
which may be responsible for the enhanced evoked and non-evoked pain behaviours.   
 
3.3.2 Increased association of CaMKII with NR2A/B subunits in response to injury 
 
This study has focused on the NMDA receptor and its associated proteins as a 
potential mechanism for sensitisation. For this reason we looked at the association of 
the NR2A/B complex with CaMKII, an association thought to be involved in LTP 
and synaptic plasticity (Barria and Malinow, 2005; Lee et al., 2009). Although we 
can not perform statistical analyses on the data, due to sample pooling to achieve 
sufficient material, the study has indicated that there is an increased αCaMKII:NR2B 
association following inflammation and also when inflammation and nerve injury 
were combined (Figure 3.4). As previously discussed (1.5.3) the NMDA receptor has 
been linked with injury-induced nociceptive behaviours (Mao et al., 1992; Yaksh et 
al., 1995; Chaplan et al., 1997) and its downstream signalling pathways, particularly 
the association with CaMKII have been implicated in sensitisation induced by nerve 




(Garry et al., 2003) show that both autophosphorylated (constitutively activated) 
phospho-Thr (286) αCaMKII  and total αCaMKII are upregulated ipsilateral to injury 
in spinal NR2A/B immunoprecipitates and that this upregulation is dependent on 
NMDA receptor activity. Interestingly, recent studies using mutants with a point 
mutation at this phosphorylation site (position 286 of the αCaMKII gene) suggest 
that autophosphorylated αCaMKII is important in the generation of spontaneous, 
non-evoked, pain (Zeitz et al., 2004), which, importantly, seems to be a 
differentiating feature of the combined pain model. 
 
3.3.3 The addition of peripheral inflammation to a nerve injury in the novel 
combined pain model does not enhance explicit nerve damage, as revealed by 
ATF-3 expression 
 
To determine the extent of neuronal damage following the combined pain model, 
ATF-3 expression was compared to single-injury adult pain models (Figure 3.5). 
ATF-3 is known to be a marker of nerve injury and is induced in models of 
neuropathic pain (Tsujino et al., 2000). We have shown that although there is more 
nociceptive sensitisation associated with the combined pain model, this is not due to 
a greater degree of nerve injury, as shown by similar levels of ATF-3 expression 
between the combined pain model and the CCI model or nerve injury. As a marker of 
explicit nerve injury,  ATF-3 is generally not induced in response to peripheral 
inflammation (Palm et al., 2008; Segond von et al., 2009). We have shown that there 
is little or no ATF-3 expression in response to CFA, in agreement with other studies, 
and it is likely that the CFA component of the combined pain model does not 
enhance the induction of ATF-3.  
 
3.3.4 Prior adult injury does not induce long-lasting changes in nocifensive 
behaviour in response to formalin  
 
The formalin response of previously injured adult animals was not different between 
the groups, nor was it different to that of naïve animals (Figure 3.6). A previous 




nerve injury, shows enhanced pain associated with the formalin response  (LaBuda et 
al., 2001). This is unsurprising given that formalin was administered relatively soon 
after the initial injury, when withdrawal thresholds in response to nerve injury were 
still likely to be low (i.e. sensitised). Conversely, a similar study using the same 
model of neuropathic pain (spinal nerve ligation) reported that the formalin response 
is reduced in animals four weeks after nerve injury compared to sham controls (Kaku 
et al., 2007). The possible reasons for these opposing results may be due to timing of 
formalin injection relative to the time course of the injury and also possibly due to 
the differing formalin concentrations used. In agreement with the latter study, Vissers 
et al (Vissers et al., 2003) have shown a reduction in the formalin response in both 
the ipsilateral and contralateral paw of animals 8 days following CCI, suggesting that 
the activation of supraspinal, descending inhibitory pathways may account for the 
reduction when there has been a prior injury. These studies highlight the importance 
of the timing at which formalin is given following a prior injury, as well as the nature 
of the specific nerve injury model used. It seems that our study is the first to address 
the effect of a subsequent noxious challenge upon complete behavioural recovery 
from the initial insult. In our work, formalin was administered under brief 
anaesthesia, upon recovery from the initial injury, to minimise stress, but it might 
have been useful to have carried out the formalin challenge without anaesthesia, thus 
leaving the first phase intact. This phase is thought to reflect acute nociception due to 
the activation of nociceptors on primary afferents, and although our data represent an 
intact and robust second phase due to the initial nociceptor activation, it might be 
interesting to assess the first phase following a prior injury, as it is highly likely that 




We have introduced a novel model of chronic pain which combines both neuropathic 
and inflammatory events which are clinically relevant occurrences. This model may 
prove to be a useful tool in investigating the mechanisms of the clinically relevant 




hyperalgesia associated with this model and this may potentially lead to the 




CHAPTER 4: PAIN BEHAVIOUR IN THE EARLY POSTNATAL PERIOD  
4.1 Introduction  
In the adult, the plasticity of the nervous system allows for the development of long-
lasting sensitised states following experimental nerve injuries such as CCI (Bennett 
and Xie, 1988) and also in inflammatory pain models. In the neonate however, the 
impact of similar injuries is unclear, as the nervous system continues to develop new 
connections and is undergoing constant reorganization. This may mean that the 
neonatal nervous system is able to compensate in some way to certain insults, or that 
long-lasting deleterious changes are put in place. There is a need for further 
investigation of the long-term effects of invasive procedures such as those that may 
occur clinically in preterm human infants and also in the previously unexplored tail-
docked piglet. Previous studies have shown varying long-term effects of early life 
injury. It has been reported that peripheral nerve injury does not induce sensitisation 
when carried out in young animals aged 3-21 days, and adult-like allodynia is not 
induced until P33 (Howard et al., 2005).  However, other studies have indicated that 
the neonatal nervous system is capable of generating nociceptive responses in 
response to nerve injury within the first two postnatal weeks  (Lee and Chung, 1996; 
Back et al., 2008). There seems to be less confusion as to the degree to which young 
animals are able to respond to an inflammatory insult. Some studies have reported 
sensitisation in response to rather large doses of CFA, in the first postnatal week, 
with adverse long-term effects upon re-inflammation later in life (Ruda et al., 2000; 
Tachibana et al., 2001). Similar responses have been observed with another well 







4.2 Results  
 
4.2.1 Sustained mechanical allodynia is induced following nerve injury at P8 but 
only transiently following peripheral inflammation 
 
Mechanical allodynia between P8 injured males and females was compared in each 
model and found not to be different (not shown); for this reason all data discussed, 
unless otherwise stated, refer to groups containing both males and females. Nerve 
injury, or a combination of nerve injury and inflammation, at P8 induced sensitivity 
to mechanical stimuli that was significant for 21 days post injury (Figure 4.1, p<0.05 
Mann-Whitney Rank Sum Test, ipsilateral compared to contralateral paw). It was not 
possible to begin nociceptive reflex testing until around 10 days post injury (i.e., 
P18), and therefore pre-surgery baselines are not possible, as animals are too small 
and immature at this point. Furthermore there is evidence that reflex behavioural 
responses to stimuli do not become fine tuned until after P10, and gradually improve 
thereafter, becoming adult-like and appropriately scaled to the applied stimuli by 
around P20 (Holmberg and Schouenborg, 1996; Waldenstrom et al., 2003). In 
response to inflammation at P8, there was a delayed and transient change in PWT, 
which was significant at 35 days post injury (p<0.05 Mann-Whitney Rank Sum Test, 
ipsilateral compared to contralateral paw) despite an increase in oedema (Figure 4.2) 
in the injured paw, which significantly increased the dorsoventral distance of the 
injured paw until post-injury day 7 (** p<0.01, *p<0.05, t-test, comparing ipsilateral 
to contralateral); a shorter-lasting response than that which occurs in the adult, which 
is maintained up to day 20 (Figure 4.2, p<0.05 at day 20). 
In addition to the relatively short-lasting sensitivity (for 3 weeks post-injury) 
observed following nerve injury (nerve injury alone or in combination with 
inflammation), we also found that a subset of animals remained sensitive to 
mechanical stimuli for much longer (greater than 21 days) (Figure 4.3), up to 105 
days following nerve injury, and 70 days in the combined pain model (p<0.05 Mann-
Whitney Rank Sum Test, ipsilateral compared to contralateral paw). It should be 
noted that day 87 in the combined pain model (Figure 4.3b) fails to reach 




on the graph, and this may be due to a low number (n=3) of animals at this point. 
Additionally, day 105 in the long-lasting combined pain model is just below the level 
for significance (Figure 4.3b, p=0.057).  Two-way ANOVA revealed that the curves 
representing the time-course for long-lasting or short-lasting mechanical allodynia 
(Figure 4.3) are significantly different from one another for both nerve injury (Figure 
4.3a, F=29.43, p<0.0001) and also for the combined pain model (F=47.95, p<0.0001, 
with significance over time indicated from day 35 onwards, p=0.0003). We also 
carried out light microscopy analysis of semi-thin sections of sciatic nerves from 
animals that had long or short-lasting responses to nerve injury (both n=3) or from 
naïve animals (n=2) and found no significant difference in G-ratios between the 
groups (data not shown).       
As a combined pain model at P8 does not appear to be different, in terms of the 
degree and duration of mechanical sensitivity, to nerve injury alone (as it is in the 
adult), it was decided that future studies would focus on only the nerve injury alone 
or inflammation alone, in order to refine experiments and reduce the number of 
animals used. Control animals were anaesthetised and removed from their home cage 
for the same duration as injured animals and mechanical PWTs were tested. There 
were no differences between the PWT of the hindpaws in anaesthetic controls, and 
PWTs for both paws increases with development, as expected (Holmberg and 
Schouenborg, 1996).  
Animals were weighed regularly to identify any signs of distress. Weight gain was 
not different between naive animals and injured animals with both long and short-
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Figure 4.1. Time course of mechanical allodynia following P8 injury. Data are 
expressed as mean±SEMs of a) the difference in paw withdrawal threshold (PWT) 
following P8 nerve injury (  ), P8 inflammation (  ) or a combination of these two 
injuries (  ) or b) as absolute values for ipsilateral (open squares) and contralateral 
(filled squares) paws. Data are obtained from calibrated von Frey filaments (1.2-
28.8g) Day of surgery is day 0. (*p<0.05 Mann-Whitney Rank Sum Test, ipsilateral 



































































Figure 4.2. Inflammation induced changes in dorsoventral distance of the ipsilateral 
hindpaw (compared to contralateral), in adult (  ) and P8 injured animals (  ) post 
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Figure 4.3. Differing durations of sensitisation of behavioural reflex responses to 
mechanical stimuli following a) P8 nerve injury, or b) a combination of nerve injury 
and inflammation to compare the long (solid line) and short (dotted line)-lasting 
variations of the injuries. Long-lasting sensitisation was defined as that lasting longer 
than 21 days. Day of surgery is day 0. Data are expressed as mean±SEMs of the 
difference in paw withdrawal threshold (PWT), contralateral-ipsilateral, from 
calibrated von Frey filaments (1.2-28.8g) (*p<0.05 Mann-Whitney Rank Sum Test, 










4.2.2 The time at which nerve injury occurs in the neonatal period is crucial in 
determining whether mechanical allodynia is elicited 
 
Interestingly, when nerve injury was performed two days later than P8, at P10, we 
found that the degree of sensitisation achieved did not reach significance (Figure 
4.4). This experiment was carried out to compare our data with a study that appears 
to contradict our finding that neonatal nerve injury can induce sensitisation (Howard 
et al., 2005). We have shown that we are able to replicate the finding of that study, 
which shows that P10 CCI does not induce mechanical allodynia (Figure 4.4). These 
data therefore provide evidence that the precise age at which neonatal injury is 
carried out may be crucial. It should, however, be noted that this preliminary study 
on the effects of P10 nerve injury was carried out using one whole litter (n=12), 
whereas P8 and P18 studies were carried out on animals from a range of different 
litters. It is therefore possible that the lack of effect seen following P10 injury may be 
due to subtle differences existing between litters. It would therefore be useful to 
repeat this study using pups from a range of different litters to confirm this finding.   
We have also carried out these injuries at P18 in some pilot studies. At this age, 
responses were intermediate between those observed in the adult and those at P8 
(Figure 4.5). Mechanical allodynia was induced in all three models at P18, and the 
combined pain model displayed higher levels of sensitisation, although some points 




















































































Figure 4.4. Time course of mechanical allodynia following P8 nerve injury ( ), or 
P10 nerve injury ( ). Day of surgery is day 0. Data are expressed as mean±SEMs of 
the difference in paw withdrawal threshold (PWT), contralateral-ipsilateral, from 
calibrated von Frey filaments (1.2-28.8g) (*p<0.05 Mann-Whitney Rank Sum Test, 
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Figure 4.5. Time course of mechanical allodynia following P18 injury. Data are 
expressed as mean±SEMs of a) the difference in paw withdrawal threshold (PWT) 
following P18 nerve injury (  ), P18 inflammation (  ) or a combination of these two 
injuries (  ) or b) as absolute values for ipsilateral (open squares) and contralateral 
(filled squares) paws. Data are obtained from calibrated von Frey filaments (1.2-
28.8g) Day of surgery is day 0. (*p<0.05 Mann-Whitney Rank Sum Test, ipsilateral 





4.2.3 Injury at P8 induces greater ATF-3 expression in DRG neurons compared to 
adult injury  
 
ATF-3 expression in DRG cells is though to be associated with explicit injury to 
their axons (Tsujino et al., 2000). We have assessed expression levels following adult 
injury (Chapter 3, Figure 3.6) and also compared this to that of P8-injured animals 
(Figure 4.6). ATF-3 positive cells from 3-4 non-adjacent (100µm) sections of L4 and 
L5 DRG per animal (n=6 per group) were counted, and expressed as a % of the total 
number of cells counted in these sections. The proportion of cells showing ATF-3 
expression in DRG neurons was significantly higher (t-test) in all 3 pain models 10 
days after injury in P8-injured animals compared to adult injury. As observed in 
adult-injured neurons, ATF-3 expression remained extremely low in response to 
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Figure 4.6. ATF-3 expression in DRG neurons 10 days post adult or P8 injury. Data 
are expressed as a percentage of total cells counted per group for nerve injury (  ), 
nerve injury plus inflammation (  ), and inflammation (  ). Inset shows confocal 
image (x10 magnification) of ATF-3 (red) colocalised with NF-200 (green), in DRG 
following nerve injury + inflammation.  (*p<0.05, ***p<0.0001, t-test comparing 





4.2.4 Mechanical allodynia in response to P8 nerve injury is reversed following 
intrathecal administration of the NMDA antagonist (R)-CPP 
 
Mechanical allodynia was reversed, without any motor impairment, following 
intrathecal administration of the NMDA receptor antagonist (R)-CPP. Careful dose 
titration to determine the optimum dose in P28 animals revealed that the NMDA 
antagonist (R)-CPP (1.2nmol) was able to reverse mechanical allodynia (Figure 4.7 
a) 20 days after P8 nerve injury (during peak sensitisation). The ipsilateral reversal 
was statistically significant at 15-35 minutes post-intrathecal injection (n=6), as 
revealed by one-way repeated measures ANOVA on ranks with Dunn’s post test to 
compare to pre-drug, baseline. Saline (vehicle) injection (Figure 4.6 b) of an 
equivalent volume (20µl), did not alter the PWT of the ipsilateral hindpaw (n=5).  
Trials were also carried out on a separate set of animals using the AMPA receptor 
antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-
dione), however it proved difficult to determine an appropriate dose with the limited 
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Figure 4.7 The effect of intrathecal application of a) (R)-CPP (20µl, n=6) or b) 
saline (n=5) at 20 days post P8 nerve injury (P28 males). Data are expressed as mean 
PWT±SEM from calibrated von Frey filaments (1.2-28.8g) for baselines and from 
15-65 minutes post-intrathecal injection for ipsilateral ( ) and contralateral ( ) paws 
(*p<0.05 Mann-Whitney Rank Sum Test, ipsilateral compared to contralateral. † 
p<0.001, One-way repeated measures ANOVA on Ranks with Dunn’s post test to 
compare post injection ipsilateral to baseline). 
 
 
4.2.5 Key spinal cord proteins that are thought to be involved in the sensitisation 
associated with adult pain states are developmentally regulated 
 
The NR2B NMDAR subunit and its associated proteins in the spinal cord are 
developmentally regulated (Figure 4.8). Our data show that NR2B expression 




and P28 (n=1). αCaMKII expression remains low from P3 to P10 (n=3) but is 
increased by P18 and P28 (n=1). PSD-95 appeared to increase slightly from P3 to P6 
but expression remained relatively unaltered from P3 to P28 (n=1-3). Data are 
plotted as the relative grey scale intensity (arbitrary grey scale values), relative to 
levels of GAPDH. It was not possible to investigate the NR2A NMDAR subunit and 






















































Figure 4.8. Developmental changes in the spinal cord expression of the NR2B 
NMDAR subunit and its associated proteins. NR2B expression decreased with 
development from P3 to P10 (n=3). PSD-95 expression appeared relatively low at P3 
and increased by a small amount from P3 to P28 (n=1-3). The low level of PSD-95 
shown here at P3 was not typical and was partially compensated for by relatively low 
GAPDH levels at P3. αCaMKII remained low from P3 to P10 (n=3) but was 
increased by P18 and P28 (n=1). Data are plotted as the relative grey scale intensity 







4.2.6 P8 nerve injury enhances nocifensive responses to formalin at P42 but not at 
P68 
  
Although mechanical allodynia, measured using von Frey filaments was not different 
in young males compared to females, the response to formalin was found to be 
different and therefore male and female responses have been analysed separately. We 
have also investigated the effects of handling and maternal separation as a distinct 
postnatal event by comparing the formalin response of animals anaesthetised and 
tested using von Frey filaments at the same time as injured animals, to the response 
of naive/undisturbed animals. We found that in both males and females, there is no 
difference in the nocifensive responses of handled animals compared to naives, and 
we have therefore used naive animals as the control group in subsequent formalin 
tests to compare against responses of previously injured animals.     
The formalin response at P42 was enhanced in female animals that had nerve injury 
at P8 (n=10) compared to age-matched naives (n=9) (Figure 4.9, c). The 
enhancement in nocifensive behaviour was significant (p<0.05) at 25 and 35 minutes 
post formalin injection, which represents peak second phase responses, that are 
thought to reflect central sensitisation induced by afferent drive from the first phase 
(two-way ANOVA with Bonferroni post test). There were no significant differences 
observed in the formalin responses of male animals following P8 inflammation (n=8) 
or nerve injury (n=7) (Figure 4.9 b and d, respectively) compared to controls (n=15) 
or between females following P8 inflammation (n=7) compared to naïve (Figure 4.9 
a).  There are no significant differences when analysing area under the curve data at 
different stages of the second phase formalin response (Figure 4.9 e and f).. 
When formalin was administered at P68 (Figure 4.10), in animals that had received 
nerve injury at P8, the overall time course was significantly different in both male 
(p<0.0001) and females (p=0.0259) when compared to age matched naives (two-way 
ANOVA with Bonferroni post test), although no individual time points were 
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Figure 4.9. P42 female (left, a, c and e) and male (right, b a, d and f) nocifensive 
responses to a formalin challenge following recovery from prior injury at P8. Nerve 
injury ( ) or inflammation ( ) are compared to naïve controls ( ) (a-d) and area under 
the curve is shown for females (e) and males (f) at early (0-20 minutes) peak (20-40 
minutes) and late (40-60 minutes) stages of the second phase of the formalin 
response. Mean±SEM are plotted in seconds (s) for cumulative amount of 
nocifensive behaviour recorded per minute for each time point (a-d) post-formalin 
injection. Area under the curve (e and f) was calculated using the trapezoidal rule for 
different satges of the second phase formalin response.  (*p<0.05 two-way ANOVA 
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Figure 4.10. P68 female and male responses to a formalin challenge following 
recovery from prior injury at P8. Nerve injury (n=9  ) compared to naïve controls (  
n=5  ).  Mean±SEM is plotted in seconds (s) for cumulative amount of nocifensive 
behaviour recorded per minute for each time point post-formalin injection. Two-way 
ANOVA with Bonferroni post-tests showed that there was a significant overall effect 
of treatment in a) p=0.0259 and b) p<0.0001, suggesting that the formalin response 





























4.3 Discussion  
 
4.3.1 Long-lasting sensitisation to mechanical stimuli can be induced in the 
neonatal period but is age and injury specific  
 
There is currently some confusion regarding the consequences of neonatal injuries 
such as nerve injury or inflammation in the rodent. Some studies have reported an 
absence of any behavioural sensitisation in response to peripheral nerve injury 
(Howard et al., 2005), whereas others have reported that nerve injury is able to 
induce short-lasting sensitisation from as early as first postnatal week (Lee and 
Chung, 1996). Similarly, the degree to which peripheral inflammation in the neonatal 
period is able to alter nociceptive processing is unclear and seems to be dependent on 
the developmental age and inflammatory agent used, with some studies reporting 
sensitisation as well as altered nociceptive responses to noxious stimuli in later life 
(Ruda et al., 2000; Tachibana et al., 2001; Lidow et al., 2001). Additionally there is 
similar discrepancy over the consequences of neonatal injuries in human patients 
(Johnston and Stevens, 1996; Taddio et al., 1997; Whitfield and Grunau, 2000). It 
seems that there is no clear answer as to the way in which nociceptive processing can 
be altered in response to any given neonatal injury and it is dependent on the timing 
and type or injury incurred (Lidow, 2002).  
Our results suggest that the age and type of injury carried out is crucial in 
determining whether or not mechanical allodynia can be induced (Figure 4.1-4.5). 
We have shown that it is possible to induce mechanical allodynia in response to 
nerve injury carried out at P8 (Figures 4.1 and 4.3), but not when this injury is 
carried out at P10 (Figure 4.4). We have carried out P10 CCI to corroborate our 
finding that neonatal nerve injury is able to induce mechanical allodynia, in the face 
of findings from other studies which report that early life nerve injury fails to induce 
sensitisation at P10 (Howard et al., 2005). Howard et al (Howard et al., 2005) 
reported that both CCI and SNI are unable to induce mechanical allodynia when 
carried out at P10, furthermore, they show that SNI within the first 3 postnatal weeks 
does not lead to mechanical allodynia. However, although this study is partly in 




allodynia (Figure 4.4), the authors also fail to observe any sensitisation in response to 
SNI over a range of ages up to P33, whereas we have shown that nerve injury at both 
P8 and P18 is able to induce allodynia (Figure 4.5). There are however, some 
differences in the experimental procedures in that study compared to our own, 
mainly the SNI model is different to the CCI model that we have used, but also 
sensory testing methods are different. Howard et al carry out their assessments of 
mechanical allodynia using von Frey filaments applied to the dorsal surface of the 
hindpaw, presumably whilst restraining these animals, whereas we have tested the 
glabrous, plantar surface of the hindpaw, and these two testing methods have been 
shown to have slightly differing outcomes (Kauppila et al., 1998). Furthermore, P8 
injuries were carried out to include animals from a number of different litters, were 
as our assessments of P10 nerve injured animals were carried out on animals from 
within a single litter. It is therefore important that this study is extended to include 
animals from a range of litters to rule out the possibility of inter litter variability 
being responsible for the observed discrepancies between injury at P8 and P10.  
Nevertheless, our preliminary results indicate that we may have uncovered a 
developmental window at P8 when it is possible to induce allodynia. Although it 
seems perplexing that it is possible to have two differing outcomes when the same 
injury is carried out at different times within a 48 hour window, the changes 
occurring within developing nociceptive circuitry during this time are so dynamic 
that it is possible that the state of the nervous system at P8 is such that long-lasting 
changes can be induced. Major pathways to mature after these developmental time 
points include the descending inhibitory pathways which are not developed until the 
second postnatal week (Galineau et al., 2004). It is possible that molecular and 
cellular responses to nerve injury that may occur in response to the increased afferent 
drive induced by P8 nerve injury are suppressed by the presence of newly developed 
inhibitory pathways that are in place by P10.  
In addition to the nerve-injured animals which recover by approximately 21 days 
post injury, we also find that a subset of animals remain hypersensitive for much 
longer (Figure 4.3). Although the magnitude of sensitisation reached is similar 
between the peak of the short-lasting subset and that reached in the long-lasting 




for over 100 days. Interestingly, in addition to the duration of mechanical allodynia, 
we also observe that the majority of animals with long-lasting mechanical allodynia 
also develop abnormal posture of the injured paw, to a noticeably greater extent than 
that which normally accompanies peripheral nerve injury in adults (Bennett and Xie, 
1988). CCI is known to produce motor disturbances in the adult (Bennett and Xie, 
1988), which is thought to be due to motor denervation (Daemen et al., 1998). The 
tibial branch of the sciatic nerve innervates the gastrocnemius muscle which is 
responsible for plantar flexion of the hindpaw, and it is this particular movement is 
diminished ipsilateral to injury the long-lasting P8 CCI subset. This may suggest that 
more damage to the tibial nerve has occurred in this subset of animals, possibly due 
to variation in the tightness of the ligation at the time of surgery and also following 
surgery and throughout growth. Furthermore, as the injury and resulting nerve 
damage occurs just before these animals become more mobile and begin to walk it is 
possible that the damage incurred makes it difficult to correct for this and animals 
compensate by dragging the injured paw behind, and fail to bear much weight on this 
paw, a factor which has been shown to result in lower thresholds following 
assessment of mechanical allodynia (Kauppila et al., 1998).  Interestingly, such 
motor disturbances and apparent longer-lasting hypersensitivity to mechanical 
stimuli are not induced following injury at P18 (Figure 4.5), when animals have 
already begun walking.  
As previously mentioned, the inflammation model at P8 induced only delayed and 
transient mechanical allodynia (Figure 4.1), despite the induction of oedema in 
response to the CFA injection (Figure 4.2), although this was relatively short in 
duration compared to that observed in the adult. This is in agreement with other 
studies that fail to show mechanical allodynia following similar doses of CFA in the 
first postnatal week, even in the presence of swelling of the injured paw (Walker et 
al., 2003). There are however some studies that report longer-lasting consequences of 
neonatal inflammation (Ruda et al., 2000), however such responses were a result of 
relatively large doses of CFA, that would be equivalent to approximately 3x the 
standard adult dose (1µl/g body weight). As there was little mechanical allodynia in 
response to inflammation alone, it is reasonable to assume that this is the reason that 




compared to nerve injury alone that we see in the adult. In addition, we have shown 
as in the adult, that neonatal inflammation does not induce ATF-3 expression in 
DRG, confirming the expected lack of injury to axons of sensory afferents.  
We have shown that as well as being able to induce behavioural sensitisation, nerve 
injury at P8 also causes explicit nerve damage, as revealed by ATF-3 expression, 
which is significantly greater than that induced in adult-injured DRG neurons (Figure 
4.6). It may be perceived that the extent of damage incurred to neonatally injured 
DRG neurons is greater than that in adult neurons based on this expression profile, 
and this damage may subsequently translate to alterations in nociceptive processing 
in response to noxious stimuli within the dermatomes of the damaged nerve in later 
life. However, Tsujino et al (Tsujino et al., 2000) reported that time course of ATF-3 
expression is dependent on the distance between injury site and the DRG. It is 
therefore also possible that the greater induction of ATF-3 expression 10 days 
following neonatal injury compared to the same duration after adult injury is simply 
because the distance between the injury site and the DRG is smaller in the neonate. 
To further address this it would be helpful in future studies to determine the time 
course of ATF-3 expression in both adult and neonatally nerve injured animals to 
compare the magnitude of expression over a range of ages and times post injury. 
Similarly, it would be useful to compare ATF-3 expression between the long and 
short-lasting P8 nerve-injured animals over a number of time points to identify 
whether or not there is a greater extent of nerve damage in those animals where 
sensitisation seems to persist for greater than 4 weeks.  
 
4.3.2 Mechanical allodynia induced by P8 nerve injury is dependent on NMDA 
receptor activity    
 
We have shown that, similar to adult nerve injuries (Wilson et al., 2005), the 
sensitisation to mechanical stimuli following P8 nerve injury is dependent on NMDA 
receptor activity (Figure 4.7). This result suggests that the underlying mechanisms 
responsible for mechanical allodynia are similar in adults and neonates. However, we 
have also shown that spinal proteins involved in NMDA receptor signalling are 




neonatal injury compared to adult levels (Figure 4.8). Interestingly, the levels of 
these proteins, particularly αCaMKII, begin to reach adult levels at around the time 
that we see peak sensitisation (P28). We have further shown that an increased 
amount of αCaMKII is associated with NR2A/B complexes ipsilateral to injury 
following adult pain states (Chapter 3, Figure 3.5).  It may be that sensitisation is 
only possible when αCaMKII reaches adult-like levels, and can then potentiate 
postsynaptic signalling within spinal circuits in response to NMDA receptor 
activation, which had been suggested as a mechanism for LTP and central 
sensitisation (Bayer et al., 2001; Ji et al., 2003). Our current data suggest that NMDA 
receptor signalling is crucial in maintaining mechanical allodynia in P8 injured 
animals, although further investigation is required in order to determine the specific 
mechanisms responsible, and in particular the involvement of αCaMKII ipsilateral to 
injury, in a similar way to that used to assess changes following adult injuries.     
  
4.3.3 Nerve injury in early life results in an alteration in the response to formalin 
upon behavioural recovery from the initial insult 
 
As discussed in chapter 3 (3.3.4) the nocifensive response to the formalin test seems 
to be dependent on the timing at which formalin was given following the initial 
injury. Although in our studies, all animals had fully recovered in terms of PWT in 
response to mechanical stimuli before formalin was given at P42 (Figure 4.9) or at 
P68 (Figure 4.10), we cannot rule out the possibility that animals may still have been 
sensitised to other modalities such as thermal stimuli, which would imply altered 
nociceptive processing and therefore a greater impact of formalin in an already 
sensitive animal. As P42 is closer to the end of mechanical allodynia than P68, it is 
possible that the enhanced response observed at 25- 35 minutes in P42 nerve-injured 
females (Figure 4.9 c) is due to some degree of residual sensitisation. It has been 
reported that female rats are more susceptible to long-lasting changes in sensory 
processing compared to males, which may potentially explain the observed 
enhancement in females and not males (LaPrairie and Murphy, 2007).Area under the 
curve analysis of the data (Figure 4.9 e) suggests that the differences between naive 




animals with a prior nerve injury, rather than an overall enhancement in nocifensive 
behaviour. Similar leftward shifted stimulus/response curves to those observed for 
female P8 nerve-injured animals (Figure 4.9 c) have been shown in other studies 
following inflammatory insults where long-lasting changes in sensory circuits have 
been reported (Ruda et al., 2000). The authors suggested that the shift may be due to 
an earlier onset of nociceptor activation and/or a reduction in the descending 
inhibition which usually occurs between the first and second phase of the formalin 
response. It is possible that P8-injured females are relatively more susceptible to 
changes in sensory processing induced by nerve injury and that these changes persist 
until later life to cause this shift in the formalin response compared to controls. 
Further investigations with greater numbers of animals are needed to identify the 
pathways responsible for this apparently enhanced signalling during the earlier part 
of the second phase of the response to a formalin challenge.  
   
4.4 Conclusions 
 
Our data show for the first time that early-life nerve injury, within a very specific 
developmental window at P8 but not P10 in neonates is able to induce NMDA-
dependent mechanical allodynia. Furthermore, we have also shown that such injuries 
are able induce lasting alterations to nociceptive processing, particularly in females, 
as revealed by altered responses to a formalin challenge in later life. Further 
investigations into the specific mechanisms responsible for these changes will 
provide a greater insight into the capabilities of the immature nervous system to 
respond to noxious insults and how such interactions may result in long lasting 
consequences. A greater understanding of these processes should help to inform 
clinicians of the consequences of such injuries and potential measures which could 





CHAPTER 5: PRENATAL STRESS AND POSTNATAL PAIN 
5.1 Introduction 
Elevation of maternal corticosteroids is thought to be one of the mechanisms by 
which prenatal stress can adversely affect the HPA axis responsiveness of offspring. 
However, with respect to the impact of prenatal stress on postnatal pain, the role of 
maternal glucocorticoids on the development of nociceptive systems and their 
associated connections is complicated and little understood. Butkevich et al 
(Butkevich et al., 2009) have shown that removing maternal corticosteroids 
(adrenalectomy prior to mating) does not seem to affect the nocifensive response to 
formalin observed in prenatally stressed offspring compared to offspring from non-
adrenalectomized, intact dams. The authors suggest that maternal serotonergic 
systems may be important in prenatal programming of pain behaviour, as previous 
studies from this group have shown that a reduction of maternal and fetal serotonin 
during critical windows of serotonergic development (P11-12) is able to significantly 
increase the intensity of the second phase formalin response in adult prenatally 
stressed male and female offspring when compared to offspring from intact stressed 
dams (Butkevich et al., 2005). It is difficult to determine exactly how serotonin 
depletion in gestation might affect offspring pain behaviour due to its many roles in 
stress and pain processing. Serotonin is able to modulate HPA axis responsiveness 
via projections from the raphe nuclei of the midbrain which act upon serotonin 2C 
receptors (5-HT(2C)Rs) present in CRH-containing neurons in the PVN (Heisler et 
al., 2007) and the last trimester is the most critical period for adverse effects of 
prenatal stress on the developing serotonergic system (Peters, 1988). Furthermore 
serotonergic neurons have direct inhibitory and excitatory descending connections 
with nociceptive pathways in the dorsal horn, that begin to develop in the last 
trimester and are not adult-like until the third postnatal week (Rajaofetra et al., 
1989). Studies on prenatally stressed neonatal rats (P7) show that the formalin 
response is elevated compared to non-stressed controls. Additionally the formalin 
response in prenatally stressed rats is composed of a clear first phase, interphase and 
second phase whereas controls display a prolonged continuous response (Butkevich 




second postnatal week, around the time that descending serotonergic pathways are 
developing (Barr, 1998). It is suggested that a decrease in descending inhibition and 
increased monoaminergic facilitation as well as a change in the developmental time 
course of these processes may occur with prenatal stress, to help explain these 
alterations to the formalin response (Butkevich et al., 2006). Interestingly, spinal 
GABAergic neurons have been shown to mature earlier following a reduction of 5-
HT (Allain et al., 2005), which can occur following prenatal stress (Huizink et al., 
2004). 
In addition to its effects on descending pathways, prenatal stress may also alter 
nociceptive processing more directly, at the level of the spinal dorsal horn. Studies 
have shown that central GRs are involved in the upregulation of NMDA receptors 
following nerve injury, and that blockade of spinal GRs by intrathecal antagonists or 
antisense oligonucleotides prevents nerve injury-induced upregulation of NMDARs 
and can reduce associated pain behaviour, while the GR agonist, dexamethasone is 
able to exacerbate neuropathic pain  (Wang et al., 2005). In light of this study, it is 
possible to speculate that the basal and stress-induced increases in glucocorticoids 
observed in prenatally stressed animals may affect the development of neuropathic or 
other NMDA associated pain states or may even affect the postnatal development of 
NMDARs in the spinal dorsal horn.  
The impact of prenatal stress on postnatal pain has not yet been studied extensively.  
The effect of the combination of these two adverse events in the perinatal period has 
received very limited attention and given the likelihood of both perinatal stress and 
pain occurring together in both animal husbandry practices and also in pre-term 
human patients where these two events are not always mutually exclusive, it is 
imperative that this area is more widely studied. The formalin challenge can be used 
as both a measure of nociceptive responsiveness and also as a stressor to measure the 
HPA axis responsiveness of an animal (Taylor et al., 1998) and as such we have 
utilised this test in this study to achieve measures of stress and pain responsiveness 
from a single cohort of animals and thus refining animal usage.   
 The present work uses the resident-intruder paradigm as a model of prenatal stress 
which has a strong psychological component as well as a physical component, in the 




compared to some of the above mentioned models, not only with respect to 
husbandry practices, which are, in part, the focus of this thesis, but also in the type of 
stress experienced by pregnant women, in the form of domestic violence, which can 





5.2.1 Prenatal stress does not affect the mechanical allodynia induced as a result 
of P8 or adult nerve injury   
 
In adult male nerve-injured animals, or animals with the combined nerve injury and 
inflammation we observed no difference in the mechanical thresholds of the plantar 
surface of the hindpaw of compared to non-stressed controls (Figure 5.1 a and c). 
However prenatally stressed (PNS) animals with adult inflammation appeared to 
display higher levels of mechanical allodynia over time compared to non-stressed 
injured animals (Figure 5.1 b) which was significantly different at day 6 post injury 
(two-way ANOVA with Bonferroni post test, F=9.14, p=0.0036). There was no 
difference in the mechanical thresholds of the plantar surface of the hindpaw in 
females compared to males with the combined nerve injury and inflammation, nor 
was there any difference due to the addition of prenatal stress in either of these 
groups (data not shown).  
Mechanical allodynia following P8 nerve injury (Figure 5.2 a) or inflammation 
(Figure 5.2 b) was not altered in prenatally stressed animals compared to controls 
(two-way ANOVA), although the days when significant sensitisation occurred in 
response to P8 inflammation were slightly earlier in prenatally stressed animals 
compared to controls.  
It is worth noting that the failure to reach statistically significant mechanical 
allodynia in prenatally stressed and nerve injured models (Figure 5.1 and 5.2 a) is 
probably due to low numbers of prenatally stressed animals available for these tests, 
but it is important to note that the time course does not differ compared to the non-




models makes it necessary to include a larger number of animals in order to reach 
significance. This is not the case to such an extent in the inflammatory pain models 
where a known volume of inflammatory agent can be reproducibly administered 
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Figure 5.1 Time course of mechanical allodynia following adult a) nerve injury (  ), 
b) inflammation (  ) or c) a combination of these two injuries (  ) in prenatally 
stressed (PNS, open bars) male animals compared to non-stressed animals (solid 
bars). Day of surgery is day 0. Data are expressed as mean±SEMs of the difference 
in paw withdrawal threshold (PWT), contralateral-ipsilateral, from calibrated von 
Frey filaments (1.2-28.8g) (†p<0.05 two-way ANOVA with Bonferroni post test, 
PNS compared to control group. *p<0.05 Mann-Whitney Rank Sum Test, ipsilateral 
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Figure 5.2. Time course of mechanical allodynia following P8 a) nerve injury (short-
lasting sub-group    ), or b) inflammation (  ) in prenatally stressed (PNS, open bars) 
animals compared to non-stressed animals (solid bars). Day of surgery is day 0. Data 
are expressed as mean±SEMs of the difference in paw withdrawal threshold (PWT), 
contralateral-ipsilateral, from calibrated von Frey filaments (1.2-28.8g) (*p<0.05 











5.2.2 Prenatal stress does not affect the adult formalin response following recovery 
from adult injury but enhances the response in animals which had 
inflammation at P8   
 
Prenatally stressed animals differed in their nocifensive responses to a formalin 
challenge depending on the age at which they received the initial insult. The formalin 
response of prenatally stressed males (n=3-6) which were injured in adulthood was 
not significantly different (two-way ANOVA) from non-stressed, adult injured 
animals (Figure 5.3). 
Adult males which had prenatal stress along with early life injury, in the form of P8 
inflammation (n=5), displayed significantly greater (F=3.43, p=0.0177), early 
responses in the time course of nocifensive behaviour in response to formalin (Figure 
5.4) when compared to naïve (n=10) males (two-way ANOVA with Bonferroni post 
test). Specifically, at the 25 minute time point post-formalin, nocifensive responses 
in prenatally stressed, P8 inflamed animals were significantly greater than those of 
naïve controls (p<0.05). It should be noted that the number of animals in the non-
stressed, P8 inflammation group was low (n=3) and increasing these numbers may 
also reveal differences comparing this group to the prenatally stressed, P8 inflamed 
group as there seemed to be an indication of differences between the curves with the 
current data, which would further strengthen the suggestion of an additive affect of 
prenatal stress (Figure 5.4). Additionally, the time course of the formalin response of 
prenatally stressed naïve animals also seemed to be shifted leftward slightly 
compared to the non-stressed, control naives, which might indicate an effect of 
prenatal stress alone on the formalin response, although again, this did not reach 
statistical significance in the present study. 
There were no significant effects of treatment in prenatally stressed and P8 nerve-
injured animals compared to controls (data not shown). Prenatally stressed females 
were also included in this study, as they were available as prenatally stressed 
littermates, although it is known that nociceptive responses may be affected by the 
phase of the estrous cycle (Kayser et al., 1996). As these animals were cycling at the 
time of the formalin response, swabs were taken to determine estrous which are still 
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Figure 5.3. Adult male response to a formalin challenge in prenatally stressed 
animals (PNS dotted lines) compared to non-stressed animals (solid lines) following 
recovery from a) adult nerve injury (  n=3-5), b) adult inflammation (  n=4-6) or in 
uninjured (naive) animals ( n=6-8). Mean±SEM is plotted in seconds (s) for 
cumulative amount of nocifensive behaviour recorded per minute for each time point 





Figure 5.4  
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Figure 5.4. Adult male response to a formalin challenge in prenatally stressed 
animals (PNS, red) compared to non-stressed animals (black) following recovery 
from P8 inflammation (solid lines, n=3-5) or in uninjured (naïve) animals (dotted 
line n=6-10).  Mean±SEM is plotted in seconds (s) for cumulative amount of 
nocifensive behaviour recorded per minute for each time point post-formalin 
injection. (*p<0.05, two way ANOVA with Bonferroni post test, PNS + P8 
inflammation is different to naïve). 
 
 
5.2.3 Prenatal stress reduces birth weight and enhances stress-induced HPA-axis 
responsiveness 
 
Prenatally stressed male and female rats were found to have a significantly lower 
birth weight (P1) compared to non-stressed controls (Figure 5.5).  Prenatally stressed 
females (n=32) and males (n=36) were significantly (p=0.002, and 0.005 
respectively) lighter than controls (n=36 and n=30 respectively) of the same age (t-
test). Additionally, prenatally stressed adult animals displayed higher stress-induced 
levels of plasma corticosterone (Figure 5.6). The formalin test that we use to assess 
the magnitude of nocifensive responsiveness also acts as a stressor as it is known to 
induce ACTH and corticosterone secretion (Taylor et al., 1998). Formalin 




prenatally stressed adult males (t-test, p=0.00015) and importantly there was a 
significantly higher level of plasma corticosterone in response to formalin injection 
in prenatally stressed males compared to non-stressed animals (p=0.047). Adult 
female prenatally stressed animals also had higher levels of corticosterone in 
response to formalin compared to saline, although this did not reach statistical 
significance (p=0.082).  
We also attempted to measured plasma ACTH in the same samples, (taken 60 
minutes after formalin or saline injection) although these data were compromised due 
to lysed red blood cells (data not shown).  
In addition to physiological assessments of possible programming in response to 
prenatal stress, we also carried out some pilot evaluations of affective behaviours 
using the EPM and open field tests in both pre-weanling and adult animals in 
response to early life (P8) or adult injury (nerve injury or inflammation). In these 
tests a reduced latency to enter, or reduced time spent in the open arms of the EPM 
or the exposed centre-square of the open field test reflects increased anxiety. 
However we did not observe any discernable differences in EPM performance 
between any of the groups, although numbers for each group were relatively small. 
We have however revealed a significant reduction (t-test, p<0.05) in the time spent 
grooming in the open-field test (Figure 5.7) in adult male prenatally stressed animals 
compared to non-stressed controls following recovery (2 months) from adult 
inflammation (n=4) or nerve injury (n=4), with a trend observed in naive (non-








































Figure 5.5. Effect of prenatal stress on birth weight (P1) of male (n=30-36) and 






















































































Figure 5.6. Plasma corticosterone concentrations (ng/ml, mean±SEM) in a) males 
(n=4-6) and b) females (n=4-5) following intraplantar injection of saline ( ) or 
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Figure 5.7. Time spent grooming during the open field test in prenatally stressed 
(PNS) or control males following recovery from adult inflammation (    n=4), nerve 























5.3.1 Prenatal stress does not affect mechanical allodynia in response to early life 
or adult injury 
 
Our data show that prenatal stress does not alter the mechanical allodynia observed 
following nerve injury or inflammation carried out at P8 (Figure 5.2). Similarly, 
there is little effect of prenatal stress on the nociceptive responses of adult-injured 
animals, although we did observe an increase in mechanical allodynia at day 6 after 
adult inflammation in prenatally stressed animals (Figure 5.1). Prenatal stress has 
been shown to alter immune function in offspring, although the effects seem to be 
entirely dependent on the type of maternal stress, and timing after birth when 
immune measures are taken (Merlot et al., 2008). Furthermore a recent study has 
shown that altered immune function is observed in offspring following maternal 
restraint stress towards the end of gestation, with no effects observed in juveniles (7 
weeks old) but enhanced levels of pro-inflammatory cytokines by 6 months of age 
(Vanbesien-Mailliot et al., 2007). These data suggests that altered immune function 
could at least in part be responsible for the enhanced pain behaviour in response to 
inflammatory stimuli in prenatally stressed adult animals. Although we have not 
investigated this with direct measures of immune function, pro-inflammatory 
cytokines are known to be involved in chronic pain states (Sommer and Kress, 2004), 
so it is possible that increased circulating levels of pro-inflammatory cytokines in 
prenatally stressed animals may be involved in the enhanced sensitisation to 
mechanical stimuli in adult inflamed animals (Figure 5.1). Additionally, adult 
nociceptive thresholds have been shown to increase in animals exposed to prenatal 
stress during the last week of gestation, although this effect was reversed with 
repeated postnatal handling (Sternberg and Ridgway, 2003). This is an important 
observation, as in our study, adult injured animals remained with the mother until 
weaning, and so were not handled in the early postnatal period, whereas neonatally 
injured animals were repeatedly removed from the home cage for surgery and also 
for behaviour testing and so this raises the possibility that maternal behaviour 




observed nociceptive responses. However it should be noted that we did not observe 
any obvious differences in maternal behaviour in the present study and other studies 
have reported that behaviour does not change in response to neonatal injury 
(LaPrairie and Murphy, 2007). Our work did not directly compare the effects of 
maternal care in mothers following gestational stress compared to non-stressed 
mothers, which has been reported to be altered in other studies (Baker et al., 2008),  
and therefore to address this, an interesting study might have been to cross-foster 
prenatally stressed and non-stressed offspring after birth to assess adult nociceptive 
behaviour following injury, to elucidate the importance of maternal behaviour on 
these thresholds. Furthermore, as we have only assessed mechanical allodynia as a 
measure of sensitisation in prenatally stressed versus non-stressed injured animals, it 
is possible that we may have missed differences which may have occurred in other 
modalities and so it might have been useful to have carried out tests using thermal 
stimuli for example.  
 
5.3.2 Prenatal stress together with early life injury enhances nocifensive behaviour 
in response to formalin in later life  
 
Our data show an enhanced nocifensive response to formalin in prenatally stressed 
and P8 inflamed animals in the early part of the second phase compared to naive 
controls (Figure 5.4). This effect occurs at around the same time as the interphase 
(between first and second phase) usually occurs. The interphase of the formalin 
response is thought to be dependent on active inhibitory pathways in response to 
afferent activity from the first phase (Henry et al., 1999; Gaumond et al., 2007). 
Furthermore, females and males differ in their nocifensive responses to formalin, and 
in particular, the interphase has been shown to be less suppressed in females 
compared to males, which is thought to be a result of two different inhibitory 
mechanisms; in females there appears to be an opioidergic involvement, believed to 
be related to sex hormones, whereas in males, GABA is thought to be the main 
transmitter involved (Kaneko and Hammond, 1997; Aloisi and Ceccarelli, 2000; 
Gaumond et al., 2007). Our results show that male prenatally stressed offspring have 




inhibition of nocifensive behaviour in the “interphase” compared to non-stressed 
controls, although the effect is only significant in the prenatally stressed and 
postnatally injured group compared to naïve controls. Demasculinisation has been 
shown to occur in prenatally stressed male offspring (Weinstock, 2001), and it is 
possible that this may help to explain the leftward, and more female-like, shift in the 
time course of nocifensive behaviour in response to formalin, which might suggest 
an involvement of opioids in the interphase as opposed to testosterone-mediated 
mechanisms (Ceccarelli et al., 2003) in male prenatally stressed, postnatally injured 
males. Additionally there is evidence to suggest that descending oxytocin pathways 
from the PVN, part of the HPA axis, to the spinal cord are important in mediating 
descending inhibition, and have been suggested as a possible pathway involved in 
stress-induced analgesia (Robinson et al., 2002). Activation of the PVN in response 
to stress in known to result in release of oxytocin (Nishioka et al., 1998). 
Furthermore, oxytocin has been reported to be released in the spinal cord in response 
to stress (Miaskowski et al., 1988). As nociception is not altered in mice lacking 
oxytocin, it is thought that this pathway does not tonically regulate pain responses 
and is specifically activated and alters nociceptive thresholds in response to stress 
(Robinson et al., 2002). Furthermore, the spinal cord does not produce oxytocin, but 
expresses the oxytocin receptor (Reiter et al., 1994), so any influence of oxytocin 
might be expected to reflect supraspinal control. These pathways are thought to 
specifically inhibit activation of WDR neurons, which form part of the spinothalamic 
tract, by presynaptically inhibiting the nociceptive Aδ and C-fibres contacting these 
neurons (Rojas-Piloni et al., 2008). The inhibitory capability of this pathway is 
thought to involve recruitment of GABAergic interneurons, and also a possible 
opioid involvement (Breton et al., 2008; Condes-Lara et al., 2009). 
Studies have shown that there is a reduction in oxytocin mRNA in the PVN in 
prenatally stressed animals (Lee et al., 2007) which may suggest a reduction in 
endogenous pain control via the PVN-spinal pathway. However this does not explain 
the lack of any altered responses to formalin in prenatally stressed and adult injured 
animals (Figure 5.3) and so it is likely that early postnatal pain is also an important 
factor in the “programming” of the formalin response following prenatal stress and 




P3 and P5) are able to alter the stress responsiveness of the adult which is thought to 
be due to alterations to negative feedback control of ACTH by glucocorticoids 
(Shanks et al., 1995). In light of these studies and also now with our current data, it is 
becoming increasingly more apparent that both adverse pre and postnatal events can 
induce long-lasting changes in physiological responses to stress and pain in later life.  
 
5.3.3 Prenatal social stress reduces birth weight and increases stress-induced 
corticosterone secretion 
 
We have used a model of prenatal social stress that has been used by other groups 
and has shown robust changes in HPA axis responsiveness (Neumann et al., 2001). 
Although this social stress model is far more ethologically relevant, it is quite labour-
intensive and wasteful in the numbers of animals needed (lactators and their pups) to 
generate experimental litters. For these reasons our experiments were designed in 
order to gain as much information from any one set of animals as possible, without 
compromising other important assessments. Unfortunately this means that robust 
assessment of HPA axis responsiveness has not been possible, and our measurements 
include those at the beginning and end of the life of the animals so as not to interfere 
with assessments of pain behaviour. We can never be sure how much offspring have 
been directly affected by maternal stress prenatally, as it is impossible to measure 
changes in fetal corticosterone in utero. However, the measures that we have been 
able to obtain indicate that a prenatal stress phenotype is present in the offspring 
from our socially stressed animals. These measures include low birth weight in 
prenatally stressed males and females compared to non-stressed controls (Figure 
5.5), and an increased stress-induced corticosterone response (Figure 5.6) both of 
which are indicators of a prenatal stress phenotype, thought to occur in response to 
elevated maternal corticosterone, in agreement with other studies  (Barbazanges et 
al., 1996; Welberg et al., 2000; Neumann et al., 2001).  
Measures of affective behaviour (EPM and open field) were also taken to establish a 
prenatal stress phenotype, to compare our studies to those which report behaviours 
thought to represent increased anxiety in prenatally stressed animals (Weinstock, 




not observe any significant changes in classic signs of anxiety behaviour on the EPM 
or open field between prenatally stressed and non-stressed animals which may be due 
to small group sizes. However we did observe a decreased amount of time spent 
grooming during the open field test in prenatally stressed animals compared to non-
stressed controls (Figure 5.7). This observation was only significantly different 
between prenatally stressed animals compared with non stressed, adult injured 
animals upon recovery from sensitisation, although there was also a trend in 
prenatally stressed naives compared to naïve, non-stressed controls. It is unclear what 
changes in this kind of behaviour might mean, grooming behaviours are thought to 
be a sign of habituation to a particular environment (Brenes et al., 2009) and it is 
possible that this may infer some signs of anxiety in animals with reduced grooming 
behaviours, although this is only interpretation and further studies would need to be 
carried out to clarify this.  
 
5.4 Conclusions  
 
Although it can only be described as preliminary due to the low numbers in most of 
the experimental groups, the current data suggest that adverse pre and postnatal 
events can both contribute to the induction of long-lasting changes in physiological 
responses to stress and pain in later life. Importantly, it seems that responses to early 
life (P8) or adult inflammatory insults are altered in prenatally stressed animals and 
in particular, males seem to be adversely affected. Further robust studies are needed 
to fully ascertain the effects of prenatal stress on female pain processing. Notable 
alterations of nocifensive behaviour in prenatally stressed animals were produced in 
response to inflammatory insults, which are common in clinical and husbandry 
practices. It is therefore important that further study following the combination of 
these two adverse events is carried out in order to elucidate the mechanisms 
responsible with the hope of preventing lasting negative changes in nociceptive 




CHAPTER 6: SUMMARY DISCUSSION AND CONCLUSIONS 
6.1 Summary of findings 
The aim of this study was to introduce a novel model of chronic neuropathic and 
inflammatory pain designed to model the injuries which occur in clinical situations 
where nerve injury may be accompanied by inflammation as a result of post-surgical 
infection. Once established in the adult, this model was then investigated in neonatal 
animals. We have shown that in the adult this combined pain model results in robust 
mechanical allodynia and thermal hyperalgesia which outlasts that observed 
following the single component injuries of this model. Furthermore, spontaneous 
pain is reliably induced in the combined pain model and lasts for a number of days. 
As spontaneous pain is one of the most commonly reported symptoms in chronic 
pain patients, it is important that this behaviour becomes more widely studied and 
this model may help to facilitate such investigations.  
The development of the pathways necessary to experience and respond to painful or 
stressful stimuli can be modified at various levels and at a number of critical 
windows. Our data suggest that certain types of neonatal injury are capable of 
causing long-lasting changes to nociceptive processing. Specifically, young animals 
do not seem to respond to an inflammatory insult in the same way as an adult in 
terms of the sensitisation induced and this is perhaps the reason why the novel 
combined pain model does not enhance sensitisation compared to nerve injury alone, 
as it does in the adult. However, we have not investigated acute responses to an 
inflammatory insult at a young age and this would be beneficial to better assess the 
capabilities of neonatal animals to respond to an inflammatory agents.  
It is important to highlight that these studies suggest, for the first time that early-life 
nerve injury, within a very specific developmental window at P8 but not P10, seems 
to be able to induce lasting NMDA-dependent mechanical allodynia. This finding is 
in agreement with other studies which suggest that nerve injury cannot induce 
neuropathic pain in young rats at P10 (Howard et al., 2005), but suggests that the 
timing of injury is critical. Additionally, P8 nerve-injured animals display altered 
nocifensive responses following formalin administration, particularly in females, 




alterations to nociceptive processing. As the formalin response is not altered in 
response to adult injuries, our data highlight the vulnerability of the immature 
nervous system to such injuries. Further investigations into the specific mechanisms 
responsible for these changes will provide a greater insight into the capabilities of the 
immature nervous system to respond to noxious insults and how such interactions 
may result in long-lasting consequences. 
A further aim of this study was to investigate the effects that prenatal social stress 
may have on these pain models. Our data suggest that prenatal stress alters 
nociceptive responses to inflammatory insults, which are common in clinical and 
husbandry practices. Specifically, adult prenatally stressed animals display greater 
sensitisation to mechanical stimuli following inflammation compared to non-stressed 
controls. Additionally, prenatally stressed and P8 inflamed animals display enhanced 
nocifensive behaviour in response to formalin in later-life.    
 
6.2 Criticisms and future directions 
 
The main criticism of this study has been the relatively low numbers of animals used 
in behavioural assessments, particularly within the data described in Chapter 5, 
where the nature of the prenatal stress studies has meant a limited number of animals 
have been used; this data can therefore only be presented as preliminarily data as it is 
largely incomplete. The compromise of utilising animals to achieve a range of 
different measures, and perhaps being too optimistic in what we set out to achieve 
has meant that group sizes have suffered and it is possible that sample sizes have 
been too small to obtain a statistical significance where small effects exist with the 
population. Power analysis would have been a beneficial addition to the experimental 
design of these experiments so that a small number of measures could have been 
carried out confidently, to give reliable and reproducible outcomes.     
A further criticism lies within the testing methods we have employed in this study in 
an attempt to quantify pain following differing insults. Such measures have largely 
relied on spinally-mediated reflex responses to von Frey filaments. The use of such 
measures allows for a relatively quick and easily quantifiable output, however, there 
are limitations with both the nature of this type of test and also of the testing 




filaments themselves, which have been shown to vary with humidity and also with 
repeated use and so require regular calibration (Moller et al., 1998). Furthermore, the 
discrete nature of the data obtained means that precise thresholds are rarely 
achievable and the graded nature of the upper range of the hairs is such that a one 
hair difference can actually translate to a difference of more than 10g. This means 
that it is impossible to dissect out subtle differences within this range and instead the 
next available threshold is recorded. It is entirely possible that some of the 
differences recorded between ipsilateral and contralateral paws are exaggerated from 
von Frey hairs in the upper range, this may be the case in some of the adult data 
(Chapters 3 and 5) where this range is often needed to evoke responses. The lower 
range hairs were required for assessments in young animals (Chapter 4) and so the 
incremental increase is lower within this range, although it is still possible that 
thresholds are overestimated, and as there are such small apparent differences 
between the injured and uninjured paws in young animals, it is important that these 
measures are as accurate as possible so as to avoid false positives. Electronic devices 
which provide continuous data and accurate measurements of applied force have 
been reported (Moller et al., 1998) and may allow for a much more reliable means of 
assessing mechanical allodynia in both young and adult animals.  However, there has 
also been some suggestion (Vierck et al., 2008) that these reflex measures are not 
entirely clinically relevant and that pre-clinical pain assessment should attempt to 
incorporate tests with a cortical dependency to allow for better translational pain 
research.  In addition to the testing methods employed in this study, the way in which 
the experiments are carried out could have been improved to achieve more robust 
and reliable data. As previously mentioned (Chapter 2, 2.4), it was difficult to be 
blinded during the behavioural assessments due to the visible changes induced in 
response to injury. However, the inclusion of sham controls may have helped to 
minimise experimenter bias as the gait and posture of the animal would also be 
altered in these animals as in nerve injured animals, similarly, saline injected controls 









Our studies have identified new animal models of pain that may occur as a result of 
clinical and husbandry practices, which, with further investigation, may help to 
inform us of the potentially adverse consequences of these practices. These data 
suggest, in accordance with other studies (Mastorci et al., 2009) that prenatal stress 
does not dramatically change normal functioning, but given a further insult, either 
adult inflammation or P8 inflammation plus formalin in later life, prenatally stressed 
animals are more susceptible than non-stressed animals, and this is when their 
pathophysiology is revealed. Given the many challenges an organism is likely to face 
during its life time, it is important that we understand the long-term impact that 
adverse perinatal events can have, and importantly, how and when such pathologies 
are likely to manifest themselves and what effect this will have on the individuals 
quality of life. Ultimately, once the mechanisms of perinatal programming of stress 
and pain processing are fully elucidated, it would be beneficial to be able to intervene 
to prevent those changes which result in negative outcomes in later life, whether this 
be by prevention, in raising awareness to enable avoidance of the perinatal events 
responsible, or by way of a cure to reverse a particular pathology either in its 
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LONG-LASTING CHANGES IN SENSORY PROCESSING FOLLOWING 
PERIPHERAL NERVE INJURY IN THE NEONATE 
 
Hayley L Gooding, Andrew J Allchorne and Susan Fleetwood-Walker. Centre for 
Neuroscience Research, University of Edinburgh, Edinburgh, UK.   
 
Aim of Investigation: The plasticity of the adult nervous system allows the 
development of long-lasting sensitised states following nerve injury or inflammation. 
In the neonate however, the impact of similar injuries is unclear. We hypothesise that 
neonatal nerve injury or inflammation will result in long-lasting changes to sensory 
processing, as revealed by a subsequent noxious challenge. 
Methods: Adult or Postnatal day 8 (P8) Sprague-Dawley rats were either given an 
intraplantar injection of Complete Freund’s adjuvant (1:1 CFA: saline, 1µl/g body 
weight) or a chronic constriction injury (CCI). Surgery to produce CCI consisted of 
two loose chromic gut sutures (5/0: P8 4/0: adult) tied proximal to the sciatic nerve 
trifurcation. Mechanical thresholds of the plantar surface of the ipsilateral and 
contralateral hindpaw were measured using von Frey filaments. Following recovery 
from the initial insult (>6 weeks) animals were subjected to a formalin challenge 
(intraplantar injection of 4% formalin solution 40 μl) and nocifensive behaviours 
were recorded. 
Results: An inflammatory or neuropathic injury in adults produces long-lasting 
mechanical allodynia ipsilateral to injury. The equivalent insults carried out in 
neonates revealed insignificant differences in sensory thresholds following neonatal 
inflammation and a short-lasting decrease in thresholds following CCI. Interestingly, 
in response to a formalin challenge, neither of the adult pain models differed from 




neuropathic insult at P8 displayed significantly greater nocifensive behaviour than 
controls.  
Conclusions: Neonatal nerve injury at a critical developmental time point can result 
in long-lasting and maybe permanent changes to nociceptive processing and could 
have adverse consequences in both clinical and certain husbandry practices. 
Acknowledgements: This work is supported by a grant from the BBSRC Animal 
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A COMPARISON OF THE EXPRESSION OF NEURONAL ACTIVATING 
TRANSCRIPTION FACTOR-3 IN THE NEONATE AND THE ADULT RAT 
FOLLOWING PERIPHERAL NERVE INJURY. 
 
Andrew J Allchorne, Hayley L Gooding, Susan Fleetwood-Walker 
 
Aim: Activating Transcription Factor-3 (ATF3) is induced in dorsal root ganglia 
(DRG) sensory neurons following chronic constriction nerve injury (CCI) and is 
accompanied by increased sensitivity in adult rats. Neonatal rats are known to 
respond differently to nerve injury, so to address this we compared the DRG 
expression of ATF3 following CCI in rats at postnatal day 8 (P8) and in adults. 
Methods:CCI nerve injury was carried out in P8 and adult Sprague Dawley rats 
using 2 loose chromic gut sutures tied proximal to the trifurcation of the sciatic nerve 
(size 5/0 suture for P8; 4/0 for adult). Mechanical withdrawal thresholds of the 
plantar surface of both ipsilateral and contralateral hindpaws were then measured 
using von Frey filaments. In a separate group of rats immunostaining for ATF3, 
neurofilament 200 (NF200) and peripherin (A and C fibre markers respectively) was 
carried out in fixed lumbar (L4-6) DRG 10 days after nerve injury. 
Results:Adult rats showed a robust and significant decrease in mechanical 
nociceptive thresholds ipsilateral to injury and the neonate also showed an ipsilateral 
reduction. Although ATF3 immunoreactivity was observed both in adult and 
neonatal DRG neurons 10 days after injury, a time point when both groups show 
mechanical sensitivity, interestingly the expression level in the neonate was 3 fold 
greater compared to the adult (28.9±2% vs 9.9±2.1%, respectively). Co-localisation 
of ATF3 with NF200 and peripherin showed that ATF3 is found in both A and C 




expression: 22.6±3.3% vs 11.3±3.2% and 34.6±1.6% vs 12.2±2.3% NF200 and  
peripherin positive neurons in neonate compared to adult, respectively. 
Conclusions: Following CCI nerve injury there is a greater upregulation of the 
injury marker ATF3 in neonatal DRG compared to the adult, despite both neonates 
and adults developing sensitisation. This highlights the complex differences in 
response of the neonatal versus the adult nervous system to injury. 
Acknowledgements: This work is supported by a BBSRC Animal Welfare 
Programme Award 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
